id	sid	tid	token	lemma	pos
cord-275041-fcdwitxy	1	1	key	key	JJ
cord-275041-fcdwitxy	1	2	:	:	:
cord-275041-fcdwitxy	1	3	cord-275041-fcdwitxy	cord-275041-fcdwitxy	NNP
cord-275041-fcdwitxy	2	1	authors	author	NNS
cord-275041-fcdwitxy	2	2	:	:	:
cord-275041-fcdwitxy	2	3	Ayerbe	Ayerbe	NNP
cord-275041-fcdwitxy	2	4	,	,	,
cord-275041-fcdwitxy	2	5	Luis	Luis	NNP
cord-275041-fcdwitxy	2	6	;	;	:
cord-275041-fcdwitxy	2	7	Risco	Risco	NNP
cord-275041-fcdwitxy	2	8	-	-	HYPH
cord-275041-fcdwitxy	2	9	Risco	Risco	NNP
cord-275041-fcdwitxy	2	10	,	,	,
cord-275041-fcdwitxy	2	11	Carlos	Carlos	NNP
cord-275041-fcdwitxy	2	12	;	;	:
cord-275041-fcdwitxy	2	13	Ayis	Ayis	NNP
cord-275041-fcdwitxy	2	14	,	,	,
cord-275041-fcdwitxy	2	15	Salma	Salma	NNP
cord-275041-fcdwitxy	2	16	title	title	NN
cord-275041-fcdwitxy	2	17	:	:	:
cord-275041-fcdwitxy	3	1	The	the	DT
cord-275041-fcdwitxy	3	2	association	association	NN
cord-275041-fcdwitxy	3	3	of	of	IN
cord-275041-fcdwitxy	3	4	treatment	treatment	NN
cord-275041-fcdwitxy	3	5	with	with	IN
cord-275041-fcdwitxy	3	6	hydroxychloroquine	hydroxychloroquine	NN
cord-275041-fcdwitxy	3	7	and	and	CC
cord-275041-fcdwitxy	3	8	hospital	hospital	NN
cord-275041-fcdwitxy	3	9	mortality	mortality	NN
cord-275041-fcdwitxy	3	10	in	in	IN
cord-275041-fcdwitxy	3	11	COVID-19	covid-19	JJ
cord-275041-fcdwitxy	3	12	patients	patient	NNS
cord-275041-fcdwitxy	3	13	date	date	NN
cord-275041-fcdwitxy	3	14	:	:	:
cord-275041-fcdwitxy	3	15	2020	2020	CD
cord-275041-fcdwitxy	3	16	-	-	HYPH
cord-275041-fcdwitxy	3	17	09	09	CD
cord-275041-fcdwitxy	3	18	-	-	SYM
cord-275041-fcdwitxy	3	19	30	30	CD
cord-275041-fcdwitxy	3	20	journal	journal	NN
cord-275041-fcdwitxy	3	21	:	:	:
cord-275041-fcdwitxy	3	22	Intern	Intern	NNP
cord-275041-fcdwitxy	3	23	Emerg	Emerg	NNP
cord-275041-fcdwitxy	3	24	Med	Med	NNP
cord-275041-fcdwitxy	3	25	DOI	doi	NN
cord-275041-fcdwitxy	3	26	:	:	:
cord-275041-fcdwitxy	4	1	10.1007	10.1007	CD
cord-275041-fcdwitxy	4	2	/	/	SYM
cord-275041-fcdwitxy	4	3	s11739	s11739	CD
cord-275041-fcdwitxy	4	4	-	-	HYPH
cord-275041-fcdwitxy	4	5	020	020	CD
cord-275041-fcdwitxy	4	6	-	-	HYPH
cord-275041-fcdwitxy	4	7	02505-x	02505-x	CD
cord-275041-fcdwitxy	4	8	sha	sha	NNP
cord-275041-fcdwitxy	4	9	:	:	:
cord-275041-fcdwitxy	5	1	b6b20213545c070c391312c7a4a1e516fc1c6d8a	b6b20213545c070c391312c7a4a1e516fc1c6d8a	NNP
cord-275041-fcdwitxy	5	2	doc_id	doc_id	NNP
cord-275041-fcdwitxy	5	3	:	:	:
cord-275041-fcdwitxy	6	1	275041	275041	CD
cord-275041-fcdwitxy	6	2	cord_uid	cord_uid	NNS
cord-275041-fcdwitxy	6	3	:	:	:
cord-275041-fcdwitxy	6	4	fcdwitxy	fcdwitxy	NNP
cord-275041-fcdwitxy	7	1	This	this	DT
cord-275041-fcdwitxy	7	2	study	study	NN
cord-275041-fcdwitxy	7	3	investigates	investigate	VBZ
cord-275041-fcdwitxy	7	4	the	the	DT
cord-275041-fcdwitxy	7	5	association	association	NN
cord-275041-fcdwitxy	7	6	between	between	IN
cord-275041-fcdwitxy	7	7	the	the	DT
cord-275041-fcdwitxy	7	8	treatment	treatment	NN
cord-275041-fcdwitxy	7	9	with	with	IN
cord-275041-fcdwitxy	7	10	hydroxychloroquine	hydroxychloroquine	NN
cord-275041-fcdwitxy	7	11	and	and	CC
cord-275041-fcdwitxy	7	12	mortality	mortality	NN
cord-275041-fcdwitxy	7	13	in	in	IN
cord-275041-fcdwitxy	7	14	patients	patient	NNS
cord-275041-fcdwitxy	7	15	admitted	admit	VBN
cord-275041-fcdwitxy	7	16	with	with	IN
cord-275041-fcdwitxy	7	17	COVID-19	COVID-19	NNP
cord-275041-fcdwitxy	7	18	.	.	.
cord-275041-fcdwitxy	8	1	Routinely	routinely	RB
cord-275041-fcdwitxy	8	2	recorded	record	VBN
cord-275041-fcdwitxy	8	3	,	,	,
cord-275041-fcdwitxy	8	4	clinical	clinical	JJ
cord-275041-fcdwitxy	8	5	data	datum	NNS
cord-275041-fcdwitxy	8	6	,	,	,
cord-275041-fcdwitxy	8	7	up	up	IN
cord-275041-fcdwitxy	8	8	to	to	IN
cord-275041-fcdwitxy	8	9	the	the	DT
cord-275041-fcdwitxy	8	10	24th	24th	NN
cord-275041-fcdwitxy	8	11	of	of	IN
cord-275041-fcdwitxy	8	12	April	April	NNP
cord-275041-fcdwitxy	8	13	2020	2020	CD
cord-275041-fcdwitxy	8	14	,	,	,
cord-275041-fcdwitxy	8	15	from	from	IN
cord-275041-fcdwitxy	8	16	the	the	DT
cord-275041-fcdwitxy	8	17	2075	2075	CD
cord-275041-fcdwitxy	8	18	patients	patient	NNS
cord-275041-fcdwitxy	8	19	with	with	IN
cord-275041-fcdwitxy	8	20	COVID-19	COVID-19	NNP
cord-275041-fcdwitxy	8	21	,	,	,
cord-275041-fcdwitxy	8	22	admitted	admit	VBN
cord-275041-fcdwitxy	8	23	in	in	IN
cord-275041-fcdwitxy	8	24	17	17	CD
cord-275041-fcdwitxy	8	25	hospitals	hospital	NNS
cord-275041-fcdwitxy	8	26	in	in	IN
cord-275041-fcdwitxy	8	27	Spain	Spain	NNP
cord-275041-fcdwitxy	8	28	between	between	IN
cord-275041-fcdwitxy	8	29	the	the	DT
cord-275041-fcdwitxy	8	30	1st	1st	NN
cord-275041-fcdwitxy	8	31	of	of	IN
cord-275041-fcdwitxy	8	32	March	March	NNP
cord-275041-fcdwitxy	8	33	and	and	CC
cord-275041-fcdwitxy	8	34	the	the	DT
cord-275041-fcdwitxy	8	35	20th	20th	NN
cord-275041-fcdwitxy	8	36	of	of	IN
cord-275041-fcdwitxy	8	37	April	April	NNP
cord-275041-fcdwitxy	8	38	2020	2020	CD
cord-275041-fcdwitxy	8	39	were	be	VBD
cord-275041-fcdwitxy	8	40	used	use	VBN
cord-275041-fcdwitxy	8	41	.	.	.
cord-275041-fcdwitxy	9	1	The	the	DT
cord-275041-fcdwitxy	9	2	following	follow	VBG
cord-275041-fcdwitxy	9	3	variables	variable	NNS
cord-275041-fcdwitxy	9	4	were	be	VBD
cord-275041-fcdwitxy	9	5	extracted	extract	VBN
cord-275041-fcdwitxy	9	6	for	for	IN
cord-275041-fcdwitxy	9	7	this	this	DT
cord-275041-fcdwitxy	9	8	study	study	NN
cord-275041-fcdwitxy	9	9	:	:	:
cord-275041-fcdwitxy	9	10	age	age	NN
cord-275041-fcdwitxy	9	11	,	,	,
cord-275041-fcdwitxy	9	12	gender	gender	NN
cord-275041-fcdwitxy	9	13	,	,	,
cord-275041-fcdwitxy	9	14	temperature	temperature	NN
cord-275041-fcdwitxy	9	15	,	,	,
cord-275041-fcdwitxy	9	16	and	and	CC
cord-275041-fcdwitxy	9	17	saturation	saturation	NN
cord-275041-fcdwitxy	9	18	of	of	IN
cord-275041-fcdwitxy	9	19	oxygen	oxygen	NN
cord-275041-fcdwitxy	9	20	on	on	IN
cord-275041-fcdwitxy	9	21	admission	admission	NN
cord-275041-fcdwitxy	9	22	,	,	,
cord-275041-fcdwitxy	9	23	treatment	treatment	NN
cord-275041-fcdwitxy	9	24	with	with	IN
cord-275041-fcdwitxy	9	25	hydroxychloroquine	hydroxychloroquine	NNP
cord-275041-fcdwitxy	9	26	,	,	,
cord-275041-fcdwitxy	9	27	azithromycin	azithromycin	NNP
cord-275041-fcdwitxy	9	28	,	,	,
cord-275041-fcdwitxy	9	29	heparin	heparin	NN
cord-275041-fcdwitxy	9	30	,	,	,
cord-275041-fcdwitxy	9	31	steroids	steroid	NNS
cord-275041-fcdwitxy	9	32	,	,	,
cord-275041-fcdwitxy	9	33	tocilizumab	tocilizumab	NNP
cord-275041-fcdwitxy	9	34	,	,	,
cord-275041-fcdwitxy	9	35	a	a	DT
cord-275041-fcdwitxy	9	36	combination	combination	NN
cord-275041-fcdwitxy	9	37	of	of	IN
cord-275041-fcdwitxy	9	38	lopinavir	lopinavir	NNS
cord-275041-fcdwitxy	9	39	with	with	IN
cord-275041-fcdwitxy	9	40	ritonavir	ritonavir	NNP
cord-275041-fcdwitxy	9	41	,	,	,
cord-275041-fcdwitxy	9	42	and	and	CC
cord-275041-fcdwitxy	9	43	oseltamivir	oseltamivir	FW
cord-275041-fcdwitxy	9	44	,	,	,
cord-275041-fcdwitxy	9	45	together	together	RB
cord-275041-fcdwitxy	9	46	with	with	IN
cord-275041-fcdwitxy	9	47	data	datum	NNS
cord-275041-fcdwitxy	9	48	on	on	IN
cord-275041-fcdwitxy	9	49	mortality	mortality	NN
cord-275041-fcdwitxy	9	50	.	.	.
cord-275041-fcdwitxy	10	1	Multivariable	multivariable	JJ
cord-275041-fcdwitxy	10	2	logistic	logistic	JJ
cord-275041-fcdwitxy	10	3	regression	regression	NN
cord-275041-fcdwitxy	10	4	models	model	NNS
cord-275041-fcdwitxy	10	5	were	be	VBD
cord-275041-fcdwitxy	10	6	used	use	VBN
cord-275041-fcdwitxy	10	7	to	to	TO
cord-275041-fcdwitxy	10	8	investigate	investigate	VB
cord-275041-fcdwitxy	10	9	the	the	DT
cord-275041-fcdwitxy	10	10	associations	association	NNS
cord-275041-fcdwitxy	10	11	.	.	.
cord-275041-fcdwitxy	11	1	At	at	IN
cord-275041-fcdwitxy	11	2	the	the	DT
cord-275041-fcdwitxy	11	3	time	time	NN
cord-275041-fcdwitxy	11	4	of	of	IN
cord-275041-fcdwitxy	11	5	collecting	collect	VBG
cord-275041-fcdwitxy	11	6	the	the	DT
cord-275041-fcdwitxy	11	7	data	datum	NNS
cord-275041-fcdwitxy	11	8	,	,	,
cord-275041-fcdwitxy	11	9	301	301	CD
cord-275041-fcdwitxy	11	10	patients	patient	NNS
cord-275041-fcdwitxy	11	11	had	have	VBD
cord-275041-fcdwitxy	11	12	died	die	VBN
cord-275041-fcdwitxy	11	13	,	,	,
cord-275041-fcdwitxy	11	14	1449	1449	CD
cord-275041-fcdwitxy	11	15	had	have	VBD
cord-275041-fcdwitxy	11	16	been	be	VBN
cord-275041-fcdwitxy	11	17	discharged	discharge	VBN
cord-275041-fcdwitxy	11	18	home	home	RB
cord-275041-fcdwitxy	11	19	from	from	IN
cord-275041-fcdwitxy	11	20	the	the	DT
cord-275041-fcdwitxy	11	21	hospitals	hospital	NNS
cord-275041-fcdwitxy	11	22	,	,	,
cord-275041-fcdwitxy	11	23	240	240	CD
cord-275041-fcdwitxy	11	24	were	be	VBD
cord-275041-fcdwitxy	11	25	still	still	RB
cord-275041-fcdwitxy	11	26	admitted	admit	VBN
cord-275041-fcdwitxy	11	27	,	,	,
cord-275041-fcdwitxy	11	28	and	and	CC
cord-275041-fcdwitxy	11	29	85	85	CD
cord-275041-fcdwitxy	11	30	had	have	VBD
cord-275041-fcdwitxy	11	31	been	be	VBN
cord-275041-fcdwitxy	11	32	transferred	transfer	VBN
cord-275041-fcdwitxy	11	33	to	to	IN
cord-275041-fcdwitxy	11	34	hospitals	hospital	NNS
cord-275041-fcdwitxy	11	35	not	not	RB
cord-275041-fcdwitxy	11	36	included	include	VBN
cord-275041-fcdwitxy	11	37	in	in	IN
cord-275041-fcdwitxy	11	38	the	the	DT
cord-275041-fcdwitxy	11	39	study	study	NN
cord-275041-fcdwitxy	11	40	.	.	.
cord-275041-fcdwitxy	12	1	Median	median	JJ
cord-275041-fcdwitxy	12	2	follow	follow	NN
cord-275041-fcdwitxy	12	3	-	-	HYPH
cord-275041-fcdwitxy	12	4	up	up	RP
cord-275041-fcdwitxy	12	5	time	time	NN
cord-275041-fcdwitxy	12	6	was	be	VBD
cord-275041-fcdwitxy	12	7	8	8	CD
cord-275041-fcdwitxy	12	8	(	(	-LRB-
cord-275041-fcdwitxy	12	9	IQR	IQR	NNP
cord-275041-fcdwitxy	12	10	5–12	5–12	NNP
cord-275041-fcdwitxy	12	11	)	)	-RRB-
cord-275041-fcdwitxy	12	12	days	day	NNS
cord-275041-fcdwitxy	12	13	.	.	.
cord-275041-fcdwitxy	13	1	Hydroxychloroquine	Hydroxychloroquine	NNP
cord-275041-fcdwitxy	13	2	had	have	VBD
cord-275041-fcdwitxy	13	3	been	be	VBN
cord-275041-fcdwitxy	13	4	used	use	VBN
cord-275041-fcdwitxy	13	5	in	in	IN
cord-275041-fcdwitxy	13	6	1857	1857	CD
cord-275041-fcdwitxy	13	7	patients	patient	NNS
cord-275041-fcdwitxy	13	8	.	.	.
cord-275041-fcdwitxy	14	1	Hydroxychloroquine	Hydroxychloroquine	NNP
cord-275041-fcdwitxy	14	2	was	be	VBD
cord-275041-fcdwitxy	14	3	associated	associate	VBN
cord-275041-fcdwitxy	14	4	with	with	IN
cord-275041-fcdwitxy	14	5	lower	low	JJR
cord-275041-fcdwitxy	14	6	mortality	mortality	NN
cord-275041-fcdwitxy	14	7	when	when	WRB
cord-275041-fcdwitxy	14	8	the	the	DT
cord-275041-fcdwitxy	14	9	model	model	NN
cord-275041-fcdwitxy	14	10	was	be	VBD
cord-275041-fcdwitxy	14	11	adjusted	adjust	VBN
cord-275041-fcdwitxy	14	12	for	for	IN
cord-275041-fcdwitxy	14	13	age	age	NN
cord-275041-fcdwitxy	14	14	and	and	CC
cord-275041-fcdwitxy	14	15	gender	gender	NN
cord-275041-fcdwitxy	14	16	,	,	,
cord-275041-fcdwitxy	14	17	with	with	IN
cord-275041-fcdwitxy	14	18	OR	or	CC
cord-275041-fcdwitxy	14	19	(	(	-LRB-
cord-275041-fcdwitxy	14	20	95	95	CD
cord-275041-fcdwitxy	14	21	%	%	NN
cord-275041-fcdwitxy	14	22	CI	CI	NNP
cord-275041-fcdwitxy	14	23	)	)	-RRB-
cord-275041-fcdwitxy	14	24	:	:	:
cord-275041-fcdwitxy	14	25	0.44	0.44	CD
cord-275041-fcdwitxy	14	26	(	(	-LRB-
cord-275041-fcdwitxy	14	27	0.29–0.67	0.29–0.67	NNP
cord-275041-fcdwitxy	14	28	)	)	-RRB-
cord-275041-fcdwitxy	14	29	.	.	.
cord-275041-fcdwitxy	15	1	This	this	DT
cord-275041-fcdwitxy	15	2	association	association	NN
cord-275041-fcdwitxy	15	3	remained	remain	VBD
cord-275041-fcdwitxy	15	4	significant	significant	JJ
cord-275041-fcdwitxy	15	5	when	when	WRB
cord-275041-fcdwitxy	15	6	saturation	saturation	NN
cord-275041-fcdwitxy	15	7	of	of	IN
cord-275041-fcdwitxy	15	8	oxygen	oxygen	NN
cord-275041-fcdwitxy	15	9	<	<	XX
cord-275041-fcdwitxy	15	10	90	90	CD
cord-275041-fcdwitxy	15	11	%	%	NN
cord-275041-fcdwitxy	15	12	and	and	CC
cord-275041-fcdwitxy	15	13	temperature	temperature	NN
cord-275041-fcdwitxy	15	14	>	>	XX
cord-275041-fcdwitxy	15	15	37	37	CD
cord-275041-fcdwitxy	15	16	°	°	NN
cord-275041-fcdwitxy	15	17	C	C	NNP
cord-275041-fcdwitxy	15	18	were	be	VBD
cord-275041-fcdwitxy	15	19	added	add	VBN
cord-275041-fcdwitxy	15	20	to	to	IN
cord-275041-fcdwitxy	15	21	de	de	NNP
cord-275041-fcdwitxy	15	22	model	model	NN
cord-275041-fcdwitxy	15	23	with	with	IN
cord-275041-fcdwitxy	15	24	OR	or	CC
cord-275041-fcdwitxy	15	25	0.45	0.45	CD
cord-275041-fcdwitxy	15	26	(	(	-LRB-
cord-275041-fcdwitxy	15	27	0.30–0.68	0.30–0.68	CD
cord-275041-fcdwitxy	15	28	)	)	-RRB-
cord-275041-fcdwitxy	16	1	p	p	NN
cord-275041-fcdwitxy	16	2	<	<	XX
cord-275041-fcdwitxy	16	3	0.001	0.001	CD
cord-275041-fcdwitxy	16	4	,	,	,
cord-275041-fcdwitxy	16	5	and	and	CC
cord-275041-fcdwitxy	16	6	also	also	RB
cord-275041-fcdwitxy	17	1	when	when	WRB
cord-275041-fcdwitxy	17	2	all	all	PDT
cord-275041-fcdwitxy	17	3	the	the	DT
cord-275041-fcdwitxy	17	4	other	other	JJ
cord-275041-fcdwitxy	17	5	drugs	drug	NNS
cord-275041-fcdwitxy	17	6	,	,	,
cord-275041-fcdwitxy	17	7	and	and	CC
cord-275041-fcdwitxy	17	8	time	time	NN
cord-275041-fcdwitxy	17	9	of	of	IN
cord-275041-fcdwitxy	17	10	admission	admission	NN
cord-275041-fcdwitxy	17	11	,	,	,
cord-275041-fcdwitxy	17	12	were	be	VBD
cord-275041-fcdwitxy	17	13	included	include	VBN
cord-275041-fcdwitxy	17	14	as	as	IN
cord-275041-fcdwitxy	17	15	covariates	covariate	NNS
cord-275041-fcdwitxy	17	16	.	.	.
cord-275041-fcdwitxy	18	1	The	the	DT
cord-275041-fcdwitxy	18	2	association	association	NN
cord-275041-fcdwitxy	18	3	between	between	IN
cord-275041-fcdwitxy	18	4	hydroxychloroquine	hydroxychloroquine	NNP
cord-275041-fcdwitxy	18	5	and	and	CC
cord-275041-fcdwitxy	18	6	lower	low	JJR
cord-275041-fcdwitxy	18	7	mortality	mortality	NN
cord-275041-fcdwitxy	18	8	observed	observe	VBN
cord-275041-fcdwitxy	18	9	in	in	IN
cord-275041-fcdwitxy	18	10	this	this	DT
cord-275041-fcdwitxy	18	11	study	study	NN
cord-275041-fcdwitxy	18	12	can	can	MD
cord-275041-fcdwitxy	18	13	be	be	VB
cord-275041-fcdwitxy	18	14	acknowledged	acknowledge	VBN
cord-275041-fcdwitxy	18	15	by	by	IN
cord-275041-fcdwitxy	18	16	clinicians	clinician	NNS
cord-275041-fcdwitxy	18	17	in	in	IN
cord-275041-fcdwitxy	18	18	hospitals	hospital	NNS
cord-275041-fcdwitxy	18	19	and	and	CC
cord-275041-fcdwitxy	18	20	in	in	IN
cord-275041-fcdwitxy	18	21	the	the	DT
cord-275041-fcdwitxy	18	22	community	community	NN
cord-275041-fcdwitxy	18	23	.	.	.
cord-275041-fcdwitxy	19	1	Randomized	randomize	VBN
cord-275041-fcdwitxy	19	2	-	-	HYPH
cord-275041-fcdwitxy	19	3	controlled	control	VBN
cord-275041-fcdwitxy	19	4	trials	trial	NNS
cord-275041-fcdwitxy	19	5	to	to	TO
cord-275041-fcdwitxy	19	6	assess	assess	VB
cord-275041-fcdwitxy	19	7	the	the	DT
cord-275041-fcdwitxy	19	8	causal	causal	JJ
cord-275041-fcdwitxy	19	9	effects	effect	NNS
cord-275041-fcdwitxy	19	10	of	of	IN
cord-275041-fcdwitxy	19	11	hydroxychloroquine	hydroxychloroquine	NN
cord-275041-fcdwitxy	19	12	in	in	IN
cord-275041-fcdwitxy	19	13	different	different	JJ
cord-275041-fcdwitxy	19	14	therapeutic	therapeutic	JJ
cord-275041-fcdwitxy	19	15	regimes	regime	NNS
cord-275041-fcdwitxy	19	16	are	be	VBP
cord-275041-fcdwitxy	19	17	required	require	VBN
cord-275041-fcdwitxy	19	18	.	.	.
cord-275041-fcdwitxy	20	1	In	in	IN
cord-275041-fcdwitxy	20	2	December	December	NNP
cord-275041-fcdwitxy	20	3	2019	2019	CD
cord-275041-fcdwitxy	20	4	,	,	,
cord-275041-fcdwitxy	20	5	an	an	DT
cord-275041-fcdwitxy	20	6	outbreak	outbreak	NN
cord-275041-fcdwitxy	20	7	of	of	IN
cord-275041-fcdwitxy	20	8	COVID-19	COVID-19	NNP
cord-275041-fcdwitxy	20	9	,	,	,
cord-275041-fcdwitxy	20	10	a	a	DT
cord-275041-fcdwitxy	20	11	novel	novel	JJ
cord-275041-fcdwitxy	20	12	disease	disease	NN
cord-275041-fcdwitxy	20	13	caused	cause	VBN
cord-275041-fcdwitxy	20	14	by	by	IN
cord-275041-fcdwitxy	20	15	the	the	DT
cord-275041-fcdwitxy	20	16	virus	virus	NN
cord-275041-fcdwitxy	20	17	SARS	SARS	NNP
cord-275041-fcdwitxy	20	18	-	-	HYPH
cord-275041-fcdwitxy	20	19	CoV-2	CoV-2	NNP
cord-275041-fcdwitxy	20	20	,	,	,
cord-275041-fcdwitxy	20	21	was	be	VBD
cord-275041-fcdwitxy	20	22	declared	declare	VBN
cord-275041-fcdwitxy	20	23	in	in	IN
cord-275041-fcdwitxy	20	24	China	China	NNP
cord-275041-fcdwitxy	20	25	.	.	.
cord-275041-fcdwitxy	21	1	In	in	IN
cord-275041-fcdwitxy	21	2	the	the	DT
cord-275041-fcdwitxy	21	3	first	first	JJ
cord-275041-fcdwitxy	21	4	months	month	NNS
cord-275041-fcdwitxy	21	5	of	of	IN
cord-275041-fcdwitxy	21	6	2020	2020	CD
cord-275041-fcdwitxy	21	7	,	,	,
cord-275041-fcdwitxy	21	8	COVID-19	COVID-19	NNP
cord-275041-fcdwitxy	21	9	spread	spread	VBN
cord-275041-fcdwitxy	21	10	throughout	throughout	IN
cord-275041-fcdwitxy	21	11	the	the	DT
cord-275041-fcdwitxy	21	12	world	world	NN
cord-275041-fcdwitxy	21	13	[	[	-LRB-
cord-275041-fcdwitxy	21	14	1	1	CD
cord-275041-fcdwitxy	21	15	,	,	,
cord-275041-fcdwitxy	21	16	2	2	CD
cord-275041-fcdwitxy	21	17	]	]	-RRB-
cord-275041-fcdwitxy	21	18	.	.	.
cord-275041-fcdwitxy	22	1	The	the	DT
cord-275041-fcdwitxy	22	2	number	number	NN
cord-275041-fcdwitxy	22	3	of	of	IN
cord-275041-fcdwitxy	22	4	new	new	JJ
cord-275041-fcdwitxy	22	5	cases	case	NNS
cord-275041-fcdwitxy	22	6	in	in	IN
cord-275041-fcdwitxy	22	7	some	some	DT
cord-275041-fcdwitxy	22	8	areas	area	NNS
cord-275041-fcdwitxy	22	9	of	of	IN
cord-275041-fcdwitxy	22	10	the	the	DT
cord-275041-fcdwitxy	22	11	world	world	NN
cord-275041-fcdwitxy	22	12	is	be	VBZ
cord-275041-fcdwitxy	22	13	currently	currently	RB
cord-275041-fcdwitxy	22	14	declining	decline	VBG
cord-275041-fcdwitxy	22	15	;	;	:
cord-275041-fcdwitxy	22	16	however	however	RB
cord-275041-fcdwitxy	22	17	,	,	,
cord-275041-fcdwitxy	22	18	it	-PRON-	PRP
cord-275041-fcdwitxy	22	19	continues	continue	VBZ
cord-275041-fcdwitxy	22	20	to	to	TO
cord-275041-fcdwitxy	22	21	rise	rise	VB
cord-275041-fcdwitxy	22	22	worldwide	worldwide	RB
cord-275041-fcdwitxy	22	23	with	with	IN
cord-275041-fcdwitxy	22	24	many	many	JJ
cord-275041-fcdwitxy	22	25	countries	country	NNS
cord-275041-fcdwitxy	22	26	having	have	VBG
cord-275041-fcdwitxy	22	27	second	second	JJ
cord-275041-fcdwitxy	22	28	outbreaks	outbreak	NNS
cord-275041-fcdwitxy	22	29	[	[	-LRB-
cord-275041-fcdwitxy	22	30	3	3	CD
cord-275041-fcdwitxy	22	31	]	]	-RRB-
cord-275041-fcdwitxy	22	32	.	.	.
cord-275041-fcdwitxy	23	1	It	-PRON-	PRP
cord-275041-fcdwitxy	23	2	has	have	VBZ
cord-275041-fcdwitxy	23	3	been	be	VBN
cord-275041-fcdwitxy	23	4	estimated	estimate	VBN
cord-275041-fcdwitxy	23	5	that	that	IN
cord-275041-fcdwitxy	23	6	80	80	CD
cord-275041-fcdwitxy	23	7	%	%	NN
cord-275041-fcdwitxy	23	8	of	of	IN
cord-275041-fcdwitxy	23	9	affected	affect	VBN
cord-275041-fcdwitxy	23	10	patients	patient	NNS
cord-275041-fcdwitxy	23	11	have	have	VBP
cord-275041-fcdwitxy	23	12	mild	mild	JJ
cord-275041-fcdwitxy	23	13	symptoms	symptom	NNS
cord-275041-fcdwitxy	23	14	,	,	,
cord-275041-fcdwitxy	23	15	and	and	CC
cord-275041-fcdwitxy	23	16	in	in	IN
cord-275041-fcdwitxy	23	17	the	the	DT
cord-275041-fcdwitxy	23	18	rest	rest	NN
cord-275041-fcdwitxy	23	19	,	,	,
cord-275041-fcdwitxy	23	20	hospital	hospital	NN
cord-275041-fcdwitxy	23	21	care	care	NN
cord-275041-fcdwitxy	23	22	can	can	MD
cord-275041-fcdwitxy	23	23	be	be	VB
cord-275041-fcdwitxy	23	24	necessary	necessary	JJ
cord-275041-fcdwitxy	23	25	,	,	,
cord-275041-fcdwitxy	23	26	and	and	CC
cord-275041-fcdwitxy	23	27	mortality	mortality	NN
cord-275041-fcdwitxy	23	28	is	be	VBZ
cord-275041-fcdwitxy	23	29	less	less	JJR
cord-275041-fcdwitxy	23	30	than	than	IN
cord-275041-fcdwitxy	23	31	2	2	CD
cord-275041-fcdwitxy	23	32	%	%	NN
cord-275041-fcdwitxy	23	33	[	[	-LRB-
cord-275041-fcdwitxy	23	34	2	2	CD
cord-275041-fcdwitxy	23	35	,	,	,
cord-275041-fcdwitxy	23	36	4	4	CD
cord-275041-fcdwitxy	23	37	,	,	,
cord-275041-fcdwitxy	23	38	5	5	CD
cord-275041-fcdwitxy	23	39	]	]	-RRB-
cord-275041-fcdwitxy	23	40	.	.	.
cord-275041-fcdwitxy	24	1	The	the	DT
cord-275041-fcdwitxy	24	2	large	large	JJ
cord-275041-fcdwitxy	24	3	number	number	NN
cord-275041-fcdwitxy	24	4	of	of	IN
cord-275041-fcdwitxy	24	5	simultaneous	simultaneous	JJ
cord-275041-fcdwitxy	24	6	cases	case	NNS
cord-275041-fcdwitxy	24	7	of	of	IN
cord-275041-fcdwitxy	24	8	COVID-19	COVID-19	NNP
cord-275041-fcdwitxy	24	9	has	have	VBZ
cord-275041-fcdwitxy	24	10	overloaded	overload	VBN
cord-275041-fcdwitxy	24	11	hospitals	hospital	NNS
cord-275041-fcdwitxy	24	12	in	in	IN
cord-275041-fcdwitxy	24	13	many	many	JJ
cord-275041-fcdwitxy	24	14	countries	country	NNS
cord-275041-fcdwitxy	24	15	,	,	,
cord-275041-fcdwitxy	24	16	making	make	VBG
cord-275041-fcdwitxy	24	17	it	-PRON-	PRP
cord-275041-fcdwitxy	24	18	very	very	RB
cord-275041-fcdwitxy	24	19	difficult	difficult	JJ
cord-275041-fcdwitxy	24	20	to	to	TO
cord-275041-fcdwitxy	24	21	provide	provide	VB
cord-275041-fcdwitxy	24	22	an	an	DT
cord-275041-fcdwitxy	24	23	adequate	adequate	JJ
cord-275041-fcdwitxy	24	24	care	care	NN
cord-275041-fcdwitxy	24	25	.	.	.
cord-275041-fcdwitxy	25	1	Many	many	JJ
cord-275041-fcdwitxy	25	2	governments	government	NNS
cord-275041-fcdwitxy	25	3	have	have	VBP
cord-275041-fcdwitxy	25	4	used	use	VBN
cord-275041-fcdwitxy	25	5	costly	costly	JJ
cord-275041-fcdwitxy	25	6	and	and	CC
cord-275041-fcdwitxy	25	7	disruptive	disruptive	JJ
cord-275041-fcdwitxy	25	8	policies	policy	NNS
cord-275041-fcdwitxy	25	9	to	to	TO
cord-275041-fcdwitxy	25	10	confine	confine	VB
cord-275041-fcdwitxy	25	11	and	and	CC
cord-275041-fcdwitxy	25	12	distance	distance	VB
cord-275041-fcdwitxy	25	13	the	the	DT
cord-275041-fcdwitxy	25	14	population	population	NN
cord-275041-fcdwitxy	25	15	to	to	TO
cord-275041-fcdwitxy	25	16	reduce	reduce	VB
cord-275041-fcdwitxy	25	17	the	the	DT
cord-275041-fcdwitxy	25	18	transmission	transmission	NN
cord-275041-fcdwitxy	25	19	of	of	IN
cord-275041-fcdwitxy	25	20	the	the	DT
cord-275041-fcdwitxy	25	21	disease	disease	NN
cord-275041-fcdwitxy	25	22	and	and	CC
cord-275041-fcdwitxy	25	23	prevent	prevent	VB
cord-275041-fcdwitxy	25	24	a	a	DT
cord-275041-fcdwitxy	25	25	second	second	JJ
cord-275041-fcdwitxy	25	26	wave	wave	NN
cord-275041-fcdwitxy	25	27	[	[	-LRB-
cord-275041-fcdwitxy	25	28	5	5	CD
cord-275041-fcdwitxy	25	29	]	]	-RRB-
cord-275041-fcdwitxy	25	30	[	[	-LRB-
cord-275041-fcdwitxy	25	31	6	6	CD
cord-275041-fcdwitxy	25	32	]	]	-RRB-
cord-275041-fcdwitxy	25	33	[	[	-LRB-
cord-275041-fcdwitxy	25	34	7	7	CD
cord-275041-fcdwitxy	25	35	]	]	-RRB-
cord-275041-fcdwitxy	25	36	.	.	.
cord-275041-fcdwitxy	26	1	These	these	DT
cord-275041-fcdwitxy	26	2	measures	measure	NNS
cord-275041-fcdwitxy	26	3	will	will	MD
cord-275041-fcdwitxy	26	4	need	need	VB
cord-275041-fcdwitxy	26	5	to	to	TO
cord-275041-fcdwitxy	26	6	be	be	VB
cord-275041-fcdwitxy	26	7	maintained	maintain	VBN
cord-275041-fcdwitxy	26	8	in	in	IN
cord-275041-fcdwitxy	26	9	some	some	DT
cord-275041-fcdwitxy	26	10	manner	manner	NN
cord-275041-fcdwitxy	26	11	until	until	IN
cord-275041-fcdwitxy	26	12	vaccines	vaccine	NNS
cord-275041-fcdwitxy	26	13	or	or	CC
cord-275041-fcdwitxy	26	14	effective	effective	JJ
cord-275041-fcdwitxy	26	15	treatments	treatment	NNS
cord-275041-fcdwitxy	26	16	become	become	VBP
cord-275041-fcdwitxy	26	17	available	available	JJ
cord-275041-fcdwitxy	26	18	to	to	TO
cord-275041-fcdwitxy	26	19	avoid	avoid	VB
cord-275041-fcdwitxy	26	20	the	the	DT
cord-275041-fcdwitxy	26	21	risk	risk	NN
cord-275041-fcdwitxy	26	22	of	of	IN
cord-275041-fcdwitxy	26	23	later	later	JJ
cord-275041-fcdwitxy	26	24	epidemics	epidemic	NNS
cord-275041-fcdwitxy	26	25	[	[	-LRB-
cord-275041-fcdwitxy	26	26	5	5	CD
cord-275041-fcdwitxy	26	27	,	,	,
cord-275041-fcdwitxy	26	28	8	8	CD
cord-275041-fcdwitxy	26	29	]	]	-RRB-
cord-275041-fcdwitxy	26	30	.	.	.
cord-275041-fcdwitxy	27	1	COVID-19	COVID-19	NNP
cord-275041-fcdwitxy	27	2	is	be	VBZ
cord-275041-fcdwitxy	27	3	negatively	negatively	RB
cord-275041-fcdwitxy	27	4	affecting	affect	VBG
cord-275041-fcdwitxy	27	5	all	all	DT
cord-275041-fcdwitxy	27	6	areas	area	NNS
cord-275041-fcdwitxy	27	7	of	of	IN
cord-275041-fcdwitxy	27	8	healthcare	healthcare	NN
cord-275041-fcdwitxy	27	9	,	,	,
cord-275041-fcdwitxy	27	10	and	and	CC
cord-275041-fcdwitxy	27	11	is	be	VBZ
cord-275041-fcdwitxy	27	12	also	also	RB
cord-275041-fcdwitxy	27	13	having	have	VBG
cord-275041-fcdwitxy	27	14	an	an	DT
cord-275041-fcdwitxy	27	15	adverse	adverse	JJ
cord-275041-fcdwitxy	27	16	impact	impact	NN
cord-275041-fcdwitxy	27	17	on	on	IN
cord-275041-fcdwitxy	27	18	the	the	DT
cord-275041-fcdwitxy	27	19	entire	entire	JJ
cord-275041-fcdwitxy	27	20	society	society	NN
cord-275041-fcdwitxy	27	21	and	and	CC
cord-275041-fcdwitxy	27	22	the	the	DT
cord-275041-fcdwitxy	27	23	international	international	JJ
cord-275041-fcdwitxy	27	24	economy	economy	NN
cord-275041-fcdwitxy	27	25	.	.	.
cord-275041-fcdwitxy	28	1	Using	use	VBG
cord-275041-fcdwitxy	28	2	limited	limited	JJ
cord-275041-fcdwitxy	28	3	evidence	evidence	NN
cord-275041-fcdwitxy	28	4	and	and	CC
cord-275041-fcdwitxy	28	5	clinical	clinical	JJ
cord-275041-fcdwitxy	28	6	experience	experience	NN
cord-275041-fcdwitxy	28	7	,	,	,
cord-275041-fcdwitxy	28	8	doctors	doctor	NNS
cord-275041-fcdwitxy	28	9	have	have	VBP
cord-275041-fcdwitxy	28	10	treated	treat	VBN
cord-275041-fcdwitxy	28	11	COVID-19	covid-19	CD
cord-275041-fcdwitxy	28	12	patients	patient	NNS
cord-275041-fcdwitxy	28	13	with	with	IN
cord-275041-fcdwitxy	28	14	different	different	JJ
cord-275041-fcdwitxy	28	15	drugs	drug	NNS
cord-275041-fcdwitxy	28	16	to	to	TO
cord-275041-fcdwitxy	28	17	eliminate	eliminate	VB
cord-275041-fcdwitxy	28	18	or	or	CC
cord-275041-fcdwitxy	28	19	reduce	reduce	VB
cord-275041-fcdwitxy	28	20	the	the	DT
cord-275041-fcdwitxy	28	21	presence	presence	NN
cord-275041-fcdwitxy	28	22	of	of	IN
cord-275041-fcdwitxy	28	23	the	the	DT
cord-275041-fcdwitxy	28	24	virus	virus	NN
cord-275041-fcdwitxy	28	25	,	,	,
cord-275041-fcdwitxy	28	26	including	include	VBG
cord-275041-fcdwitxy	28	27	hydroxychloroquine	hydroxychloroquine	NN
cord-275041-fcdwitxy	28	28	(	(	-LRB-
cord-275041-fcdwitxy	28	29	HCQ	HCQ	NNP
cord-275041-fcdwitxy	28	30	)	)	-RRB-
cord-275041-fcdwitxy	28	31	[	[	-LRB-
cord-275041-fcdwitxy	28	32	9	9	CD
cord-275041-fcdwitxy	28	33	]	]	-RRB-
cord-275041-fcdwitxy	28	34	[	[	-LRB-
cord-275041-fcdwitxy	28	35	10	10	CD
cord-275041-fcdwitxy	28	36	]	]	-RRB-
cord-275041-fcdwitxy	28	37	[	[	-LRB-
cord-275041-fcdwitxy	28	38	11	11	CD
cord-275041-fcdwitxy	28	39	]	]	-RRB-
cord-275041-fcdwitxy	28	40	[	[	-LRB-
cord-275041-fcdwitxy	28	41	12	12	CD
cord-275041-fcdwitxy	28	42	]	]	-RRB-
cord-275041-fcdwitxy	28	43	.	.	.
cord-275041-fcdwitxy	29	1	The	the	DT
cord-275041-fcdwitxy	29	2	use	use	NN
cord-275041-fcdwitxy	29	3	of	of	IN
cord-275041-fcdwitxy	29	4	this	this	DT
cord-275041-fcdwitxy	29	5	drug	drug	NN
cord-275041-fcdwitxy	29	6	is	be	VBZ
cord-275041-fcdwitxy	29	7	based	base	VBN
cord-275041-fcdwitxy	29	8	on	on	IN
cord-275041-fcdwitxy	29	9	its	-PRON-	PRP$
cord-275041-fcdwitxy	29	10	anti	anti	JJ
cord-275041-fcdwitxy	29	11	-	-	JJ
cord-275041-fcdwitxy	29	12	inflammatory	inflammatory	JJ
cord-275041-fcdwitxy	29	13	and	and	CC
cord-275041-fcdwitxy	29	14	antiviral	antiviral	JJ
cord-275041-fcdwitxy	29	15	effect	effect	NN
cord-275041-fcdwitxy	29	16	[	[	-LRB-
cord-275041-fcdwitxy	29	17	11	11	CD
cord-275041-fcdwitxy	29	18	,	,	,
cord-275041-fcdwitxy	29	19	12	12	CD
cord-275041-fcdwitxy	29	20	]	]	-RRB-
cord-275041-fcdwitxy	29	21	.	.	.
cord-275041-fcdwitxy	30	1	There	there	EX
cord-275041-fcdwitxy	30	2	are	be	VBP
cord-275041-fcdwitxy	30	3	some	some	DT
cord-275041-fcdwitxy	30	4	in	in	IN
cord-275041-fcdwitxy	30	5	vitro	vitro	FW
cord-275041-fcdwitxy	30	6	data	datum	NNS
cord-275041-fcdwitxy	30	7	supporting	support	VBG
cord-275041-fcdwitxy	30	8	the	the	DT
cord-275041-fcdwitxy	30	9	ability	ability	NN
cord-275041-fcdwitxy	30	10	of	of	IN
cord-275041-fcdwitxy	30	11	HCQ	HCQ	NNP
cord-275041-fcdwitxy	30	12	to	to	TO
cord-275041-fcdwitxy	30	13	inhibit	inhibit	VB
cord-275041-fcdwitxy	30	14	SARS	SARS	NNP
cord-275041-fcdwitxy	30	15	-	-	HYPH
cord-275041-fcdwitxy	30	16	CoV-2	CoV-2	NNP
cord-275041-fcdwitxy	30	17	activity	activity	NN
cord-275041-fcdwitxy	30	18	[	[	-LRB-
cord-275041-fcdwitxy	30	19	13	13	CD
cord-275041-fcdwitxy	30	20	,	,	,
cord-275041-fcdwitxy	30	21	14	14	CD
cord-275041-fcdwitxy	30	22	]	]	-RRB-
cord-275041-fcdwitxy	30	23	.	.	.
cord-275041-fcdwitxy	31	1	HCQ	HCQ	NNP
cord-275041-fcdwitxy	31	2	may	may	MD
cord-275041-fcdwitxy	31	3	lead	lead	VB
cord-275041-fcdwitxy	31	4	to	to	IN
cord-275041-fcdwitxy	31	5	the	the	DT
cord-275041-fcdwitxy	31	6	clinical	clinical	JJ
cord-275041-fcdwitxy	31	7	improvement	improvement	NN
cord-275041-fcdwitxy	31	8	of	of	IN
cord-275041-fcdwitxy	31	9	the	the	DT
cord-275041-fcdwitxy	31	10	patients	patient	NNS
cord-275041-fcdwitxy	31	11	,	,	,
cord-275041-fcdwitxy	31	12	it	-PRON-	PRP
cord-275041-fcdwitxy	31	13	is	be	VBZ
cord-275041-fcdwitxy	31	14	safe	safe	JJ
cord-275041-fcdwitxy	31	15	,	,	,
cord-275041-fcdwitxy	31	16	economical	economical	JJ
cord-275041-fcdwitxy	31	17	,	,	,
cord-275041-fcdwitxy	31	18	and	and	CC
cord-275041-fcdwitxy	31	19	easy	easy	JJ
cord-275041-fcdwitxy	31	20	to	to	TO
cord-275041-fcdwitxy	31	21	use	use	VB
cord-275041-fcdwitxy	31	22	,	,	,
cord-275041-fcdwitxy	31	23	and	and	CC
cord-275041-fcdwitxy	31	24	it	-PRON-	PRP
cord-275041-fcdwitxy	31	25	can	can	MD
cord-275041-fcdwitxy	31	26	be	be	VB
cord-275041-fcdwitxy	31	27	given	give	VBN
cord-275041-fcdwitxy	31	28	both	both	DT
cord-275041-fcdwitxy	31	29	to	to	IN
cord-275041-fcdwitxy	31	30	admitted	admit	VBN
cord-275041-fcdwitxy	31	31	and	and	CC
cord-275041-fcdwitxy	31	32	outpatients	outpatient	NNS
cord-275041-fcdwitxy	31	33	.	.	.
cord-275041-fcdwitxy	32	1	If	if	IN
cord-275041-fcdwitxy	32	2	the	the	DT
cord-275041-fcdwitxy	32	3	treatment	treatment	NN
cord-275041-fcdwitxy	32	4	with	with	IN
cord-275041-fcdwitxy	32	5	HCQ	HCQ	NNP
cord-275041-fcdwitxy	32	6	is	be	VBZ
cord-275041-fcdwitxy	32	7	confirmed	confirm	VBN
cord-275041-fcdwitxy	32	8	to	to	TO
cord-275041-fcdwitxy	32	9	be	be	VB
cord-275041-fcdwitxy	32	10	effective	effective	JJ
cord-275041-fcdwitxy	32	11	,	,	,
cord-275041-fcdwitxy	32	12	it	-PRON-	PRP
cord-275041-fcdwitxy	32	13	could	could	MD
cord-275041-fcdwitxy	32	14	be	be	VB
cord-275041-fcdwitxy	32	15	used	use	VBN
cord-275041-fcdwitxy	32	16	in	in	IN
cord-275041-fcdwitxy	32	17	the	the	DT
cord-275041-fcdwitxy	32	18	early	early	JJ
cord-275041-fcdwitxy	32	19	stages	stage	NNS
cord-275041-fcdwitxy	32	20	of	of	IN
cord-275041-fcdwitxy	32	21	the	the	DT
cord-275041-fcdwitxy	32	22	disease	disease	NN
cord-275041-fcdwitxy	32	23	,	,	,
cord-275041-fcdwitxy	32	24	and	and	CC
cord-275041-fcdwitxy	32	25	decrease	decrease	VB
cord-275041-fcdwitxy	32	26	the	the	DT
cord-275041-fcdwitxy	32	27	need	need	NN
cord-275041-fcdwitxy	32	28	for	for	IN
cord-275041-fcdwitxy	32	29	admissions	admission	NNS
cord-275041-fcdwitxy	32	30	,	,	,
cord-275041-fcdwitxy	32	31	the	the	DT
cord-275041-fcdwitxy	32	32	mortality	mortality	NN
cord-275041-fcdwitxy	32	33	,	,	,
cord-275041-fcdwitxy	32	34	the	the	DT
cord-275041-fcdwitxy	32	35	transmission	transmission	NN
cord-275041-fcdwitxy	32	36	of	of	IN
cord-275041-fcdwitxy	32	37	the	the	DT
cord-275041-fcdwitxy	32	38	infection	infection	NN
cord-275041-fcdwitxy	32	39	,	,	,
cord-275041-fcdwitxy	32	40	and	and	CC
cord-275041-fcdwitxy	32	41	its	-PRON-	PRP$
cord-275041-fcdwitxy	32	42	impact	impact	NN
cord-275041-fcdwitxy	32	43	on	on	IN
cord-275041-fcdwitxy	32	44	other	other	JJ
cord-275041-fcdwitxy	32	45	areas	area	NNS
cord-275041-fcdwitxy	32	46	of	of	IN
cord-275041-fcdwitxy	32	47	health	health	NN
cord-275041-fcdwitxy	32	48	care	care	NN
cord-275041-fcdwitxy	32	49	.	.	.
cord-275041-fcdwitxy	33	1	However	however	RB
cord-275041-fcdwitxy	33	2	,	,	,
cord-275041-fcdwitxy	33	3	the	the	DT
cord-275041-fcdwitxy	33	4	use	use	NN
cord-275041-fcdwitxy	33	5	of	of	IN
cord-275041-fcdwitxy	33	6	HCQ	HCQ	NNP
cord-275041-fcdwitxy	33	7	is	be	VBZ
cord-275041-fcdwitxy	33	8	supported	support	VBN
cord-275041-fcdwitxy	33	9	by	by	IN
cord-275041-fcdwitxy	33	10	limited	limited	JJ
cord-275041-fcdwitxy	33	11	evidence	evidence	NN
cord-275041-fcdwitxy	33	12	,	,	,
cord-275041-fcdwitxy	33	13	and	and	CC
cord-275041-fcdwitxy	33	14	it	-PRON-	PRP
cord-275041-fcdwitxy	33	15	may	may	MD
cord-275041-fcdwitxy	33	16	not	not	RB
cord-275041-fcdwitxy	33	17	lead	lead	VB
cord-275041-fcdwitxy	33	18	to	to	IN
cord-275041-fcdwitxy	33	19	any	any	DT
cord-275041-fcdwitxy	33	20	clinical	clinical	JJ
cord-275041-fcdwitxy	33	21	benefit	benefit	NN
cord-275041-fcdwitxy	33	22	.	.	.
cord-275041-fcdwitxy	34	1	Studies	study	NNS
cord-275041-fcdwitxy	34	2	on	on	IN
cord-275041-fcdwitxy	34	3	the	the	DT
cord-275041-fcdwitxy	34	4	clinical	clinical	JJ
cord-275041-fcdwitxy	34	5	outcomes	outcome	NNS
cord-275041-fcdwitxy	34	6	associated	associate	VBN
cord-275041-fcdwitxy	34	7	with	with	IN
cord-275041-fcdwitxy	34	8	HCQ	HCQ	NNP
cord-275041-fcdwitxy	34	9	are	be	VBP
cord-275041-fcdwitxy	34	10	required	require	VBN
cord-275041-fcdwitxy	34	11	.	.	.
cord-275041-fcdwitxy	35	1	Research	research	NN
cord-275041-fcdwitxy	35	2	policies	policy	NNS
cord-275041-fcdwitxy	35	3	are	be	VBP
cord-275041-fcdwitxy	35	4	currently	currently	RB
cord-275041-fcdwitxy	35	5	shifting	shift	VBG
cord-275041-fcdwitxy	35	6	towards	towards	IN
cord-275041-fcdwitxy	35	7	the	the	DT
cord-275041-fcdwitxy	35	8	investigation	investigation	NN
cord-275041-fcdwitxy	35	9	of	of	IN
cord-275041-fcdwitxy	35	10	more	more	RBR
cord-275041-fcdwitxy	35	11	expensive	expensive	JJ
cord-275041-fcdwitxy	35	12	treatments	treatment	NNS
cord-275041-fcdwitxy	35	13	[	[	-LRB-
cord-275041-fcdwitxy	35	14	15	15	CD
cord-275041-fcdwitxy	35	15	]	]	-RRB-
cord-275041-fcdwitxy	35	16	[	[	-LRB-
cord-275041-fcdwitxy	35	17	16	16	CD
cord-275041-fcdwitxy	35	18	]	]	-RRB-
cord-275041-fcdwitxy	35	19	[	[	-LRB-
cord-275041-fcdwitxy	35	20	17	17	CD
cord-275041-fcdwitxy	35	21	]	]	-RRB-
cord-275041-fcdwitxy	35	22	[	[	-LRB-
cord-275041-fcdwitxy	35	23	18	18	CD
cord-275041-fcdwitxy	35	24	]	]	-RRB-
cord-275041-fcdwitxy	35	25	.	.	.
cord-275041-fcdwitxy	36	1	Studies	study	NNS
cord-275041-fcdwitxy	36	2	on	on	IN
cord-275041-fcdwitxy	36	3	HCQ	HCQ	NNP
cord-275041-fcdwitxy	36	4	could	could	MD
cord-275041-fcdwitxy	36	5	inform	inform	VB
cord-275041-fcdwitxy	36	6	evidence	evidence	NN
cord-275041-fcdwitxy	36	7	-	-	HYPH
cord-275041-fcdwitxy	36	8	based	base	VBN
cord-275041-fcdwitxy	36	9	and	and	CC
cord-275041-fcdwitxy	36	10	affordable	affordable	JJ
cord-275041-fcdwitxy	36	11	management	management	NN
cord-275041-fcdwitxy	36	12	for	for	IN
cord-275041-fcdwitxy	36	13	COVID-19	COVID-19	NNP
cord-275041-fcdwitxy	36	14	,	,	,
cord-275041-fcdwitxy	36	15	which	which	WDT
cord-275041-fcdwitxy	36	16	may	may	MD
cord-275041-fcdwitxy	36	17	be	be	VB
cord-275041-fcdwitxy	36	18	particularly	particularly	RB
cord-275041-fcdwitxy	36	19	relevant	relevant	JJ
cord-275041-fcdwitxy	36	20	when	when	WRB
cord-275041-fcdwitxy	36	21	the	the	DT
cord-275041-fcdwitxy	36	22	world	world	NN
cord-275041-fcdwitxy	36	23	is	be	VBZ
cord-275041-fcdwitxy	36	24	facing	face	VBG
cord-275041-fcdwitxy	36	25	an	an	DT
cord-275041-fcdwitxy	36	26	economic	economic	JJ
cord-275041-fcdwitxy	36	27	crisis	crisis	NN
cord-275041-fcdwitxy	36	28	,	,	,
cord-275041-fcdwitxy	36	29	more	more	RBR
cord-275041-fcdwitxy	36	30	so	so	RB
cord-275041-fcdwitxy	36	31	in	in	IN
cord-275041-fcdwitxy	36	32	areas	area	NNS
cord-275041-fcdwitxy	36	33	where	where	WRB
cord-275041-fcdwitxy	36	34	health	health	NN
cord-275041-fcdwitxy	36	35	care	care	NN
cord-275041-fcdwitxy	36	36	is	be	VBZ
cord-275041-fcdwitxy	36	37	based	base	VBN
cord-275041-fcdwitxy	36	38	on	on	IN
cord-275041-fcdwitxy	36	39	limited	limited	JJ
cord-275041-fcdwitxy	36	40	resources	resource	NNS
cord-275041-fcdwitxy	36	41	.	.	.
cord-275041-fcdwitxy	37	1	This	this	DT
cord-275041-fcdwitxy	37	2	study	study	NN
cord-275041-fcdwitxy	37	3	investigates	investigate	VBZ
cord-275041-fcdwitxy	37	4	the	the	DT
cord-275041-fcdwitxy	37	5	association	association	NN
cord-275041-fcdwitxy	37	6	between	between	IN
cord-275041-fcdwitxy	37	7	treatment	treatment	NN
cord-275041-fcdwitxy	37	8	with	with	IN
cord-275041-fcdwitxy	37	9	HCQ	hcq	NN
cord-275041-fcdwitxy	37	10	and	and	CC
cord-275041-fcdwitxy	37	11	mortality	mortality	NN
cord-275041-fcdwitxy	37	12	,	,	,
cord-275041-fcdwitxy	37	13	in	in	IN
cord-275041-fcdwitxy	37	14	hospitalized	hospitalize	VBN
cord-275041-fcdwitxy	37	15	patients	patient	NNS
cord-275041-fcdwitxy	37	16	with	with	IN
cord-275041-fcdwitxy	37	17	COVID-19	COVID-19	NNP
cord-275041-fcdwitxy	37	18	.	.	.
cord-275041-fcdwitxy	38	1	The	the	DT
cord-275041-fcdwitxy	38	2	clinical	clinical	JJ
cord-275041-fcdwitxy	38	3	records	record	NNS
cord-275041-fcdwitxy	38	4	up	up	IN
cord-275041-fcdwitxy	38	5	to	to	IN
cord-275041-fcdwitxy	38	6	the	the	DT
cord-275041-fcdwitxy	38	7	24th	24th	NN
cord-275041-fcdwitxy	38	8	of	of	IN
cord-275041-fcdwitxy	38	9	April	April	NNP
cord-275041-fcdwitxy	38	10	2020	2020	CD
cord-275041-fcdwitxy	38	11	,	,	,
cord-275041-fcdwitxy	38	12	of	of	IN
cord-275041-fcdwitxy	38	13	all	all	PDT
cord-275041-fcdwitxy	38	14	the	the	DT
cord-275041-fcdwitxy	38	15	patients	patient	NNS
cord-275041-fcdwitxy	38	16	with	with	IN
cord-275041-fcdwitxy	38	17	COVID-19	COVID-19	NNP
cord-275041-fcdwitxy	38	18	(	(	-LRB-
cord-275041-fcdwitxy	38	19	n	n	NN
cord-275041-fcdwitxy	38	20	=	=	SYM
cord-275041-fcdwitxy	38	21	2075	2075	CD
cord-275041-fcdwitxy	38	22	)	)	-RRB-
cord-275041-fcdwitxy	38	23	,	,	,
cord-275041-fcdwitxy	38	24	admitted	admit	VBN
cord-275041-fcdwitxy	38	25	in	in	IN
cord-275041-fcdwitxy	38	26	all	all	DT
cord-275041-fcdwitxy	38	27	17	17	CD
cord-275041-fcdwitxy	38	28	Spanish	spanish	JJ
cord-275041-fcdwitxy	38	29	hospitals	hospital	NNS
cord-275041-fcdwitxy	38	30	,	,	,
cord-275041-fcdwitxy	38	31	of	of	IN
cord-275041-fcdwitxy	38	32	the	the	DT
cord-275041-fcdwitxy	38	33	private	private	JJ
cord-275041-fcdwitxy	38	34	healthcare	healthcare	NN
cord-275041-fcdwitxy	38	35	provider	provider	NN
cord-275041-fcdwitxy	38	36	HM	HM	NNP
cord-275041-fcdwitxy	38	37	Hospitales	Hospitales	NNP
cord-275041-fcdwitxy	38	38	,	,	,
cord-275041-fcdwitxy	38	39	were	be	VBD
cord-275041-fcdwitxy	38	40	reviewed	review	VBN
cord-275041-fcdwitxy	38	41	.	.	.
cord-275041-fcdwitxy	39	1	These	these	DT
cord-275041-fcdwitxy	39	2	hospitals	hospital	NNS
cord-275041-fcdwitxy	39	3	are	be	VBP
cord-275041-fcdwitxy	39	4	based	base	VBN
cord-275041-fcdwitxy	39	5	in	in	IN
cord-275041-fcdwitxy	39	6	the	the	DT
cord-275041-fcdwitxy	39	7	provinces	province	NNS
cord-275041-fcdwitxy	39	8	of	of	IN
cord-275041-fcdwitxy	39	9	Barcelona	Barcelona	NNP
cord-275041-fcdwitxy	39	10	,	,	,
cord-275041-fcdwitxy	39	11	Coruña	Coruña	NNP
cord-275041-fcdwitxy	39	12	,	,	,
cord-275041-fcdwitxy	39	13	León	León	NNP
cord-275041-fcdwitxy	39	14	,	,	,
cord-275041-fcdwitxy	39	15	Madrid	Madrid	NNP
cord-275041-fcdwitxy	39	16	,	,	,
cord-275041-fcdwitxy	39	17	Pontevedra	Pontevedra	NNP
cord-275041-fcdwitxy	39	18	,	,	,
cord-275041-fcdwitxy	39	19	and	and	CC
cord-275041-fcdwitxy	39	20	Toledo	Toledo	NNP
cord-275041-fcdwitxy	39	21	[	[	-LRB-
cord-275041-fcdwitxy	39	22	19	19	CD
cord-275041-fcdwitxy	39	23	]	]	-RRB-
cord-275041-fcdwitxy	39	24	.	.	.
cord-275041-fcdwitxy	40	1	Patients	patient	NNS
cord-275041-fcdwitxy	40	2	had	have	VBD
cord-275041-fcdwitxy	40	3	been	be	VBN
cord-275041-fcdwitxy	40	4	diagnosed	diagnose	VBN
cord-275041-fcdwitxy	40	5	with	with	IN
cord-275041-fcdwitxy	40	6	polymerase	polymerase	NN
cord-275041-fcdwitxy	40	7	chain	chain	NN
cord-275041-fcdwitxy	40	8	reaction	reaction	NN
cord-275041-fcdwitxy	40	9	test	test	NN
cord-275041-fcdwitxy	40	10	of	of	IN
cord-275041-fcdwitxy	40	11	respiratory	respiratory	JJ
cord-275041-fcdwitxy	40	12	samples	sample	NNS
cord-275041-fcdwitxy	40	13	for	for	IN
cord-275041-fcdwitxy	40	14	SARS	SARS	NNP
cord-275041-fcdwitxy	40	15	-	-	HYPH
cord-275041-fcdwitxy	40	16	CoV-2	CoV-2	NNP
cord-275041-fcdwitxy	40	17	,	,	,
cord-275041-fcdwitxy	40	18	between	between	IN
cord-275041-fcdwitxy	40	19	the	the	DT
cord-275041-fcdwitxy	40	20	1st	1st	NN
cord-275041-fcdwitxy	40	21	of	of	IN
cord-275041-fcdwitxy	40	22	March	March	NNP
cord-275041-fcdwitxy	40	23	and	and	CC
cord-275041-fcdwitxy	40	24	the	the	DT
cord-275041-fcdwitxy	40	25	20th	20th	NN
cord-275041-fcdwitxy	40	26	of	of	IN
cord-275041-fcdwitxy	40	27	April	April	NNP
cord-275041-fcdwitxy	40	28	2020	2020	CD
cord-275041-fcdwitxy	40	29	.	.	.
cord-275041-fcdwitxy	41	1	Seven	seven	CD
cord-275041-fcdwitxy	41	2	patients	patient	NNS
cord-275041-fcdwitxy	41	3	had	have	VBD
cord-275041-fcdwitxy	41	4	been	be	VBN
cord-275041-fcdwitxy	41	5	admitted	admit	VBN
cord-275041-fcdwitxy	41	6	before	before	IN
cord-275041-fcdwitxy	41	7	the	the	DT
cord-275041-fcdwitxy	41	8	1st	1st	NN
cord-275041-fcdwitxy	41	9	of	of	IN
cord-275041-fcdwitxy	41	10	March	March	NNP
cord-275041-fcdwitxy	41	11	2020	2020	CD
cord-275041-fcdwitxy	41	12	.	.	.
cord-275041-fcdwitxy	42	1	Data	datum	NNS
cord-275041-fcdwitxy	42	2	on	on	IN
cord-275041-fcdwitxy	42	3	age	age	NN
cord-275041-fcdwitxy	42	4	and	and	CC
cord-275041-fcdwitxy	42	5	gender	gender	NN
cord-275041-fcdwitxy	42	6	,	,	,
cord-275041-fcdwitxy	42	7	together	together	RB
cord-275041-fcdwitxy	42	8	with	with	IN
cord-275041-fcdwitxy	42	9	temperature	temperature	NN
cord-275041-fcdwitxy	42	10	and	and	CC
cord-275041-fcdwitxy	42	11	saturation	saturation	NN
cord-275041-fcdwitxy	42	12	of	of	IN
cord-275041-fcdwitxy	42	13	oxygen	oxygen	NN
cord-275041-fcdwitxy	42	14	at	at	IN
cord-275041-fcdwitxy	42	15	the	the	DT
cord-275041-fcdwitxy	42	16	time	time	NN
cord-275041-fcdwitxy	42	17	of	of	IN
cord-275041-fcdwitxy	42	18	admission	admission	NN
cord-275041-fcdwitxy	42	19	,	,	,
cord-275041-fcdwitxy	42	20	were	be	VBD
cord-275041-fcdwitxy	42	21	collected	collect	VBN
cord-275041-fcdwitxy	42	22	.	.	.
cord-275041-fcdwitxy	43	1	Data	datum	NNS
cord-275041-fcdwitxy	43	2	on	on	IN
cord-275041-fcdwitxy	43	3	treatments	treatment	NNS
cord-275041-fcdwitxy	43	4	at	at	IN
cord-275041-fcdwitxy	43	5	any	any	DT
cord-275041-fcdwitxy	43	6	time	time	NN
cord-275041-fcdwitxy	43	7	during	during	IN
cord-275041-fcdwitxy	43	8	admission	admission	NN
cord-275041-fcdwitxy	43	9	with	with	IN
cord-275041-fcdwitxy	43	10	HCQ	HCQ	NNP
cord-275041-fcdwitxy	43	11	were	be	VBD
cord-275041-fcdwitxy	43	12	collected	collect	VBN
cord-275041-fcdwitxy	43	13	.	.	.
cord-275041-fcdwitxy	44	1	Once	once	IN
cord-275041-fcdwitxy	44	2	it	-PRON-	PRP
cord-275041-fcdwitxy	44	3	was	be	VBD
cord-275041-fcdwitxy	44	4	approved	approve	VBN
cord-275041-fcdwitxy	44	5	for	for	IN
cord-275041-fcdwitxy	44	6	clinical	clinical	JJ
cord-275041-fcdwitxy	44	7	use	use	NN
cord-275041-fcdwitxy	44	8	in	in	IN
cord-275041-fcdwitxy	44	9	COVID-19	COVID-19	NNP
cord-275041-fcdwitxy	44	10	patients	patient	NNS
cord-275041-fcdwitxy	44	11	,	,	,
cord-275041-fcdwitxy	44	12	HCQ	HCQ	NNP
cord-275041-fcdwitxy	44	13	was	be	VBD
cord-275041-fcdwitxy	44	14	started	start	VBN
cord-275041-fcdwitxy	44	15	immediately	immediately	RB
cord-275041-fcdwitxy	44	16	after	after	IN
cord-275041-fcdwitxy	44	17	admission	admission	NN
cord-275041-fcdwitxy	44	18	,	,	,
cord-275041-fcdwitxy	44	19	and	and	CC
cord-275041-fcdwitxy	44	20	it	-PRON-	PRP
cord-275041-fcdwitxy	44	21	was	be	VBD
cord-275041-fcdwitxy	44	22	stopped	stop	VBN
cord-275041-fcdwitxy	44	23	if	if	IN
cord-275041-fcdwitxy	44	24	any	any	DT
cord-275041-fcdwitxy	44	25	abnormalities	abnormality	NNS
cord-275041-fcdwitxy	44	26	were	be	VBD
cord-275041-fcdwitxy	44	27	identified	identify	VBN
cord-275041-fcdwitxy	44	28	in	in	IN
cord-275041-fcdwitxy	44	29	the	the	DT
cord-275041-fcdwitxy	44	30	ECGs	ecg	NNS
cord-275041-fcdwitxy	44	31	that	that	WDT
cord-275041-fcdwitxy	44	32	were	be	VBD
cord-275041-fcdwitxy	44	33	done	do	VBN
cord-275041-fcdwitxy	44	34	on	on	IN
cord-275041-fcdwitxy	44	35	a	a	DT
cord-275041-fcdwitxy	44	36	daily	daily	JJ
cord-275041-fcdwitxy	44	37	basis	basis	NN
cord-275041-fcdwitxy	44	38	to	to	IN
cord-275041-fcdwitxy	44	39	patients	patient	NNS
cord-275041-fcdwitxy	44	40	who	who	WP
cord-275041-fcdwitxy	44	41	were	be	VBD
cord-275041-fcdwitxy	44	42	taking	take	VBG
cord-275041-fcdwitxy	44	43	it	-PRON-	PRP
cord-275041-fcdwitxy	44	44	.	.	.
cord-275041-fcdwitxy	45	1	HCQ	HCQ	NNP
cord-275041-fcdwitxy	45	2	was	be	VBD
cord-275041-fcdwitxy	45	3	dosed	dose	VBN
cord-275041-fcdwitxy	45	4	as	as	IN
cord-275041-fcdwitxy	45	5	400	400	CD
cord-275041-fcdwitxy	45	6	mg	mg	PRP
cord-275041-fcdwitxy	45	7	twice	twice	RB
cord-275041-fcdwitxy	45	8	daily	daily	RB
cord-275041-fcdwitxy	45	9	the	the	DT
cord-275041-fcdwitxy	45	10	first	first	JJ
cord-275041-fcdwitxy	45	11	day	day	NN
cord-275041-fcdwitxy	45	12	,	,	,
cord-275041-fcdwitxy	45	13	followed	follow	VBN
cord-275041-fcdwitxy	45	14	by	by	IN
cord-275041-fcdwitxy	45	15	200	200	CD
cord-275041-fcdwitxy	45	16	mg	mg	NNS
cord-275041-fcdwitxy	45	17	twice	twice	RB
cord-275041-fcdwitxy	45	18	daily	daily	RB
cord-275041-fcdwitxy	45	19	for	for	IN
cord-275041-fcdwitxy	45	20	4	4	CD
cord-275041-fcdwitxy	45	21	-	-	SYM
cord-275041-fcdwitxy	45	22	6	6	CD
cord-275041-fcdwitxy	45	23	days	day	NNS
cord-275041-fcdwitxy	45	24	.	.	.
cord-275041-fcdwitxy	46	1	Data	datum	NNS
cord-275041-fcdwitxy	46	2	on	on	IN
cord-275041-fcdwitxy	46	3	treatments	treatment	NNS
cord-275041-fcdwitxy	46	4	with	with	IN
cord-275041-fcdwitxy	46	5	azithromycin	azithromycin	NNP
cord-275041-fcdwitxy	46	6	,	,	,
cord-275041-fcdwitxy	46	7	steroids	steroid	NNS
cord-275041-fcdwitxy	46	8	,	,	,
cord-275041-fcdwitxy	46	9	heparin	heparin	NN
cord-275041-fcdwitxy	46	10	,	,	,
cord-275041-fcdwitxy	46	11	tocilizumab	tocilizumab	NNP
cord-275041-fcdwitxy	46	12	,	,	,
cord-275041-fcdwitxy	46	13	a	a	DT
cord-275041-fcdwitxy	46	14	combination	combination	NN
cord-275041-fcdwitxy	46	15	of	of	IN
cord-275041-fcdwitxy	46	16	lopinavir	lopinavir	NNS
cord-275041-fcdwitxy	46	17	with	with	IN
cord-275041-fcdwitxy	46	18	ritonavir	ritonavir	NNP
cord-275041-fcdwitxy	46	19	,	,	,
cord-275041-fcdwitxy	46	20	and	and	CC
cord-275041-fcdwitxy	46	21	oseltamivir	oseltamivir	NNP
cord-275041-fcdwitxy	46	22	,	,	,
cord-275041-fcdwitxy	46	23	were	be	VBD
cord-275041-fcdwitxy	46	24	collected	collect	VBN
cord-275041-fcdwitxy	46	25	,	,	,
cord-275041-fcdwitxy	46	26	as	as	RB
cord-275041-fcdwitxy	46	27	well	well	RB
cord-275041-fcdwitxy	46	28	.	.	.
cord-275041-fcdwitxy	47	1	The	the	DT
cord-275041-fcdwitxy	47	2	limited	limited	JJ
cord-275041-fcdwitxy	47	3	evidence	evidence	NN
cord-275041-fcdwitxy	47	4	on	on	IN
cord-275041-fcdwitxy	47	5	which	which	WDT
cord-275041-fcdwitxy	47	6	these	these	DT
cord-275041-fcdwitxy	47	7	treatments	treatment	NNS
cord-275041-fcdwitxy	47	8	were	be	VBD
cord-275041-fcdwitxy	47	9	based	base	VBN
cord-275041-fcdwitxy	47	10	,	,	,
cord-275041-fcdwitxy	47	11	and	and	CC
cord-275041-fcdwitxy	47	12	the	the	DT
cord-275041-fcdwitxy	47	13	rapidly	rapidly	RB
cord-275041-fcdwitxy	47	14	evolving	evolve	VBG
cord-275041-fcdwitxy	47	15	clinical	clinical	JJ
cord-275041-fcdwitxy	47	16	protocols	protocol	NNS
cord-275041-fcdwitxy	47	17	,	,	,
cord-275041-fcdwitxy	47	18	resulted	result	VBD
cord-275041-fcdwitxy	47	19	in	in	IN
cord-275041-fcdwitxy	47	20	these	these	DT
cord-275041-fcdwitxy	47	21	drugs	drug	NNS
cord-275041-fcdwitxy	47	22	being	be	VBG
cord-275041-fcdwitxy	47	23	given	give	VBN
cord-275041-fcdwitxy	47	24	in	in	IN
cord-275041-fcdwitxy	47	25	many	many	JJ
cord-275041-fcdwitxy	47	26	different	different	JJ
cord-275041-fcdwitxy	47	27	specific	specific	JJ
cord-275041-fcdwitxy	47	28	preparations	preparation	NNS
cord-275041-fcdwitxy	47	29	,	,	,
cord-275041-fcdwitxy	47	30	doses	dose	NNS
cord-275041-fcdwitxy	47	31	,	,	,
cord-275041-fcdwitxy	47	32	and	and	CC
cord-275041-fcdwitxy	47	33	frequency	frequency	NN
cord-275041-fcdwitxy	47	34	.	.	.
cord-275041-fcdwitxy	48	1	No	no	DT
cord-275041-fcdwitxy	48	2	information	information	NN
cord-275041-fcdwitxy	48	3	on	on	IN
cord-275041-fcdwitxy	48	4	specific	specific	JJ
cord-275041-fcdwitxy	48	5	preparations	preparation	NNS
cord-275041-fcdwitxy	48	6	of	of	IN
cord-275041-fcdwitxy	48	7	these	these	DT
cord-275041-fcdwitxy	48	8	drugs	drug	NNS
cord-275041-fcdwitxy	48	9	,	,	,
cord-275041-fcdwitxy	48	10	dosage	dosage	NN
cord-275041-fcdwitxy	48	11	,	,	,
cord-275041-fcdwitxy	48	12	duration	duration	NN
cord-275041-fcdwitxy	48	13	of	of	IN
cord-275041-fcdwitxy	48	14	treatment	treatment	NN
cord-275041-fcdwitxy	48	15	,	,	,
cord-275041-fcdwitxy	48	16	or	or	CC
cord-275041-fcdwitxy	48	17	route	route	NN
cord-275041-fcdwitxy	48	18	of	of	IN
cord-275041-fcdwitxy	48	19	administration	administration	NN
cord-275041-fcdwitxy	48	20	,	,	,
cord-275041-fcdwitxy	48	21	were	be	VBD
cord-275041-fcdwitxy	48	22	collected	collect	VBN
cord-275041-fcdwitxy	48	23	.	.	.
cord-275041-fcdwitxy	49	1	Finally	finally	RB
cord-275041-fcdwitxy	49	2	,	,	,
cord-275041-fcdwitxy	49	3	data	datum	NNS
cord-275041-fcdwitxy	49	4	on	on	IN
cord-275041-fcdwitxy	49	5	death	death	NN
cord-275041-fcdwitxy	49	6	were	be	VBD
cord-275041-fcdwitxy	49	7	recorded	record	VBN
cord-275041-fcdwitxy	49	8	.	.	.
cord-275041-fcdwitxy	50	1	The	the	DT
cord-275041-fcdwitxy	50	2	age	age	NN
cord-275041-fcdwitxy	50	3	of	of	IN
cord-275041-fcdwitxy	50	4	patients	patient	NNS
cord-275041-fcdwitxy	50	5	treated	treat	VBN
cord-275041-fcdwitxy	50	6	and	and	CC
cord-275041-fcdwitxy	50	7	not	not	RB
cord-275041-fcdwitxy	50	8	treated	treat	VBN
cord-275041-fcdwitxy	50	9	with	with	IN
cord-275041-fcdwitxy	50	10	HCQ	HCQ	NNP
cord-275041-fcdwitxy	50	11	was	be	VBD
cord-275041-fcdwitxy	50	12	compared	compare	VBN
cord-275041-fcdwitxy	50	13	with	with	IN
cord-275041-fcdwitxy	50	14	t	t	NN
cord-275041-fcdwitxy	50	15	tests	test	NNS
cord-275041-fcdwitxy	50	16	.	.	.
cord-275041-fcdwitxy	51	1	The	the	DT
cord-275041-fcdwitxy	51	2	proportion	proportion	NN
cord-275041-fcdwitxy	51	3	of	of	IN
cord-275041-fcdwitxy	51	4	men	man	NNS
cord-275041-fcdwitxy	51	5	and	and	CC
cord-275041-fcdwitxy	51	6	women	woman	NNS
cord-275041-fcdwitxy	51	7	for	for	IN
cord-275041-fcdwitxy	51	8	those	those	DT
cord-275041-fcdwitxy	51	9	treated	treat	VBN
cord-275041-fcdwitxy	51	10	and	and	CC
cord-275041-fcdwitxy	51	11	not	not	RB
cord-275041-fcdwitxy	51	12	treated	treat	VBN
cord-275041-fcdwitxy	51	13	with	with	IN
cord-275041-fcdwitxy	51	14	HCQ	HCQ	NNP
cord-275041-fcdwitxy	51	15	was	be	VBD
cord-275041-fcdwitxy	51	16	compared	compare	VBN
cord-275041-fcdwitxy	51	17	with	with	IN
cord-275041-fcdwitxy	51	18	Chi	Chi	NNP
cord-275041-fcdwitxy	51	19	-	-	HYPH
cord-275041-fcdwitxy	51	20	squared	square	VBN
cord-275041-fcdwitxy	51	21	tests	test	NNS
cord-275041-fcdwitxy	51	22	.	.	.
cord-275041-fcdwitxy	52	1	The	the	DT
cord-275041-fcdwitxy	52	2	association	association	NN
cord-275041-fcdwitxy	52	3	between	between	IN
cord-275041-fcdwitxy	52	4	treatment	treatment	NN
cord-275041-fcdwitxy	52	5	with	with	IN
cord-275041-fcdwitxy	52	6	HCQ	hcq	NN
cord-275041-fcdwitxy	52	7	and	and	CC
cord-275041-fcdwitxy	52	8	mortality	mortality	NN
cord-275041-fcdwitxy	52	9	was	be	VBD
cord-275041-fcdwitxy	52	10	examined	examine	VBN
cord-275041-fcdwitxy	52	11	with	with	IN
cord-275041-fcdwitxy	52	12	four	four	CD
cord-275041-fcdwitxy	52	13	different	different	JJ
cord-275041-fcdwitxy	52	14	logistic	logistic	JJ
cord-275041-fcdwitxy	52	15	regression	regression	NN
cord-275041-fcdwitxy	52	16	models	model	NNS
cord-275041-fcdwitxy	52	17	:	:	:
cord-275041-fcdwitxy	52	18	model	model	VB
cord-275041-fcdwitxy	52	19	one	one	CD
cord-275041-fcdwitxy	52	20	was	be	VBD
cord-275041-fcdwitxy	52	21	adjusted	adjust	VBN
cord-275041-fcdwitxy	52	22	for	for	IN
cord-275041-fcdwitxy	52	23	age	age	NN
cord-275041-fcdwitxy	52	24	and	and	CC
cord-275041-fcdwitxy	52	25	gender	gender	NN
cord-275041-fcdwitxy	52	26	;	;	:
cord-275041-fcdwitxy	52	27	model	model	NN
cord-275041-fcdwitxy	52	28	two	two	CD
cord-275041-fcdwitxy	52	29	included	include	VBN
cord-275041-fcdwitxy	52	30	age	age	NN
cord-275041-fcdwitxy	52	31	and	and	CC
cord-275041-fcdwitxy	52	32	gender	gender	NN
cord-275041-fcdwitxy	52	33	,	,	,
cord-275041-fcdwitxy	52	34	together	together	RB
cord-275041-fcdwitxy	52	35	with	with	IN
cord-275041-fcdwitxy	52	36	temperature	temperature	NN
cord-275041-fcdwitxy	52	37	>	>	XX
cord-275041-fcdwitxy	52	38	37	37	CD
cord-275041-fcdwitxy	52	39	°	°	NN
cord-275041-fcdwitxy	52	40	C	c	NN
cord-275041-fcdwitxy	52	41	,	,	,
cord-275041-fcdwitxy	52	42	and	and	CC
cord-275041-fcdwitxy	52	43	saturation	saturation	NN
cord-275041-fcdwitxy	52	44	of	of	IN
cord-275041-fcdwitxy	52	45	oxygen	oxygen	NN
cord-275041-fcdwitxy	52	46	<	<	XX
cord-275041-fcdwitxy	52	47	90	90	CD
cord-275041-fcdwitxy	52	48	%	%	NN
cord-275041-fcdwitxy	52	49	on	on	IN
cord-275041-fcdwitxy	52	50	admission	admission	NN
cord-275041-fcdwitxy	52	51	,	,	,
cord-275041-fcdwitxy	52	52	which	which	WDT
cord-275041-fcdwitxy	52	53	were	be	VBD
cord-275041-fcdwitxy	52	54	both	both	DT
cord-275041-fcdwitxy	52	55	associated	associate	VBN
cord-275041-fcdwitxy	52	56	with	with	IN
cord-275041-fcdwitxy	52	57	mortality	mortality	NN
cord-275041-fcdwitxy	52	58	in	in	IN
cord-275041-fcdwitxy	52	59	an	an	DT
cord-275041-fcdwitxy	52	60	exploratory	exploratory	JJ
cord-275041-fcdwitxy	52	61	analysis	analysis	NN
cord-275041-fcdwitxy	52	62	;	;	:
cord-275041-fcdwitxy	52	63	model	model	NNP
cord-275041-fcdwitxy	52	64	three	three	CD
cord-275041-fcdwitxy	52	65	had	have	VBD
cord-275041-fcdwitxy	52	66	all	all	PDT
cord-275041-fcdwitxy	52	67	the	the	DT
cord-275041-fcdwitxy	52	68	variables	variable	NNS
cord-275041-fcdwitxy	52	69	previously	previously	RB
cord-275041-fcdwitxy	52	70	mentioned	mention	VBN
cord-275041-fcdwitxy	52	71	together	together	RB
cord-275041-fcdwitxy	52	72	with	with	IN
cord-275041-fcdwitxy	52	73	treatment	treatment	NN
cord-275041-fcdwitxy	52	74	with	with	IN
cord-275041-fcdwitxy	52	75	azithromycin	azithromycin	NNP
cord-275041-fcdwitxy	52	76	,	,	,
cord-275041-fcdwitxy	52	77	steroids	steroid	NNS
cord-275041-fcdwitxy	52	78	,	,	,
cord-275041-fcdwitxy	52	79	heparin	heparin	NN
cord-275041-fcdwitxy	52	80	,	,	,
cord-275041-fcdwitxy	52	81	tocilizumab	tocilizumab	NNP
cord-275041-fcdwitxy	52	82	,	,	,
cord-275041-fcdwitxy	52	83	a	a	DT
cord-275041-fcdwitxy	52	84	combination	combination	NN
cord-275041-fcdwitxy	52	85	of	of	IN
cord-275041-fcdwitxy	52	86	lopinavir	lopinavir	NNS
cord-275041-fcdwitxy	52	87	with	with	IN
cord-275041-fcdwitxy	52	88	ritonavir	ritonavir	NNP
cord-275041-fcdwitxy	52	89	,	,	,
cord-275041-fcdwitxy	52	90	and	and	CC
cord-275041-fcdwitxy	52	91	oseltamivir	oseltamivir	NN
cord-275041-fcdwitxy	52	92	;	;	:
cord-275041-fcdwitxy	52	93	finally	finally	RB
cord-275041-fcdwitxy	52	94	,	,	,
cord-275041-fcdwitxy	52	95	to	to	TO
cord-275041-fcdwitxy	52	96	account	account	VB
cord-275041-fcdwitxy	52	97	for	for	IN
cord-275041-fcdwitxy	52	98	the	the	DT
cord-275041-fcdwitxy	52	99	change	change	NN
cord-275041-fcdwitxy	52	100	in	in	IN
cord-275041-fcdwitxy	52	101	clinical	clinical	JJ
cord-275041-fcdwitxy	52	102	management	management	NN
cord-275041-fcdwitxy	52	103	during	during	IN
cord-275041-fcdwitxy	52	104	the	the	DT
cord-275041-fcdwitxy	52	105	study	study	NN
cord-275041-fcdwitxy	52	106	period	period	NN
cord-275041-fcdwitxy	52	107	,	,	,
cord-275041-fcdwitxy	52	108	model	model	NN
cord-275041-fcdwitxy	52	109	four	four	CD
cord-275041-fcdwitxy	52	110	was	be	VBD
cord-275041-fcdwitxy	52	111	adjusted	adjust	VBN
cord-275041-fcdwitxy	52	112	for	for	IN
cord-275041-fcdwitxy	52	113	all	all	PDT
cord-275041-fcdwitxy	52	114	the	the	DT
cord-275041-fcdwitxy	52	115	previously	previously	RB
cord-275041-fcdwitxy	52	116	mentioned	mention	VBN
cord-275041-fcdwitxy	52	117	demographic	demographic	JJ
cord-275041-fcdwitxy	52	118	,	,	,
cord-275041-fcdwitxy	52	119	clinical	clinical	JJ
cord-275041-fcdwitxy	52	120	severity	severity	NN
cord-275041-fcdwitxy	52	121	measures	measure	NNS
cord-275041-fcdwitxy	52	122	,	,	,
cord-275041-fcdwitxy	52	123	and	and	CC
cord-275041-fcdwitxy	52	124	drugs	drug	NNS
cord-275041-fcdwitxy	52	125	,	,	,
cord-275041-fcdwitxy	52	126	together	together	RB
cord-275041-fcdwitxy	52	127	with	with	IN
cord-275041-fcdwitxy	52	128	a	a	DT
cord-275041-fcdwitxy	52	129	categorical	categorical	JJ
cord-275041-fcdwitxy	52	130	variable	variable	NN
cord-275041-fcdwitxy	52	131	for	for	IN
cord-275041-fcdwitxy	52	132	date	date	NN
cord-275041-fcdwitxy	52	133	of	of	IN
cord-275041-fcdwitxy	52	134	admission	admission	NN
cord-275041-fcdwitxy	52	135	(	(	-LRB-
cord-275041-fcdwitxy	52	136	before	before	IN
cord-275041-fcdwitxy	52	137	the	the	DT
cord-275041-fcdwitxy	52	138	10th	10th	NN
cord-275041-fcdwitxy	52	139	of	of	IN
cord-275041-fcdwitxy	52	140	March	March	NNP
cord-275041-fcdwitxy	52	141	,	,	,
cord-275041-fcdwitxy	52	142	11	11	CD
cord-275041-fcdwitxy	52	143	-	-	HYPH
cord-275041-fcdwitxy	52	144	20th	20th	NN
cord-275041-fcdwitxy	52	145	of	of	IN
cord-275041-fcdwitxy	52	146	March	March	NNP
cord-275041-fcdwitxy	52	147	,	,	,
cord-275041-fcdwitxy	52	148	20	20	CD
cord-275041-fcdwitxy	52	149	-	-	HYPH
cord-275041-fcdwitxy	52	150	31st	31st	NN
cord-275041-fcdwitxy	52	151	March	March	NNP
cord-275041-fcdwitxy	52	152	,	,	,
cord-275041-fcdwitxy	52	153	1st-10th	1st-10th	NNP
cord-275041-fcdwitxy	52	154	of	of	IN
cord-275041-fcdwitxy	52	155	April	April	NNP
cord-275041-fcdwitxy	52	156	,	,	,
cord-275041-fcdwitxy	52	157	and	and	CC
cord-275041-fcdwitxy	52	158	11	11	CD
cord-275041-fcdwitxy	52	159	-	-	HYPH
cord-275041-fcdwitxy	52	160	20th	20th	NN
cord-275041-fcdwitxy	52	161	of	of	IN
cord-275041-fcdwitxy	52	162	April	April	NNP
cord-275041-fcdwitxy	52	163	)	)	-RRB-
cord-275041-fcdwitxy	52	164	.	.	.
cord-275041-fcdwitxy	53	1	All	all	DT
cord-275041-fcdwitxy	53	2	covariates	covariate	NNS
cord-275041-fcdwitxy	53	3	included	include	VBN
cord-275041-fcdwitxy	53	4	in	in	IN
cord-275041-fcdwitxy	53	5	the	the	DT
cord-275041-fcdwitxy	53	6	four	four	CD
cord-275041-fcdwitxy	53	7	models	model	NNS
cord-275041-fcdwitxy	53	8	were	be	VBD
cord-275041-fcdwitxy	53	9	considered	consider	VBN
cord-275041-fcdwitxy	53	10	potential	potential	JJ
cord-275041-fcdwitxy	53	11	confounders	confounder	NNS
cord-275041-fcdwitxy	53	12	.	.	.
cord-275041-fcdwitxy	54	1	No	no	DT
cord-275041-fcdwitxy	54	2	further	further	JJ
cord-275041-fcdwitxy	54	3	variables	variable	NNS
cord-275041-fcdwitxy	54	4	were	be	VBD
cord-275041-fcdwitxy	54	5	included	include	VBN
cord-275041-fcdwitxy	54	6	to	to	TO
cord-275041-fcdwitxy	54	7	avoid	avoid	VB
cord-275041-fcdwitxy	54	8	the	the	DT
cord-275041-fcdwitxy	54	9	complex	complex	JJ
cord-275041-fcdwitxy	54	10	interpretation	interpretation	NN
cord-275041-fcdwitxy	54	11	of	of	IN
cord-275041-fcdwitxy	54	12	results	result	NNS
cord-275041-fcdwitxy	54	13	and	and	CC
cord-275041-fcdwitxy	54	14	collinearity	collinearity	NN
cord-275041-fcdwitxy	54	15	.	.	.
cord-275041-fcdwitxy	55	1	The	the	DT
cord-275041-fcdwitxy	55	2	software	software	NN
cord-275041-fcdwitxy	55	3	Stata	Stata	NNP
cord-275041-fcdwitxy	55	4	14.0	14.0	CD
cord-275041-fcdwitxy	55	5	was	be	VBD
cord-275041-fcdwitxy	55	6	used	use	VBN
cord-275041-fcdwitxy	55	7	for	for	IN
cord-275041-fcdwitxy	55	8	the	the	DT
cord-275041-fcdwitxy	55	9	analysis	analysis	NN
cord-275041-fcdwitxy	55	10	[	[	-LRB-
cord-275041-fcdwitxy	55	11	20	20	CD
cord-275041-fcdwitxy	55	12	]	]	-RRB-
cord-275041-fcdwitxy	55	13	.	.	.
cord-275041-fcdwitxy	56	1	Missing	miss	VBG
cord-275041-fcdwitxy	56	2	data	datum	NNS
cord-275041-fcdwitxy	56	3	were	be	VBD
cord-275041-fcdwitxy	56	4	treated	treat	VBN
cord-275041-fcdwitxy	56	5	as	as	IN
cord-275041-fcdwitxy	56	6	a	a	DT
cord-275041-fcdwitxy	56	7	separate	separate	JJ
cord-275041-fcdwitxy	56	8	category	category	NN
cord-275041-fcdwitxy	56	9	for	for	IN
cord-275041-fcdwitxy	56	10	temperature	temperature	NN
cord-275041-fcdwitxy	56	11	and	and	CC
cord-275041-fcdwitxy	56	12	oxygen	oxygen	NN
cord-275041-fcdwitxy	56	13	saturation	saturation	NN
cord-275041-fcdwitxy	56	14	.	.	.
cord-275041-fcdwitxy	57	1	Sensitivity	sensitivity	NN
cord-275041-fcdwitxy	57	2	analyses	analysis	NNS
cord-275041-fcdwitxy	57	3	were	be	VBD
cord-275041-fcdwitxy	57	4	made	make	VBN
cord-275041-fcdwitxy	57	5	to	to	TO
cord-275041-fcdwitxy	57	6	compare	compare	VB
cord-275041-fcdwitxy	57	7	estimates	estimate	NNS
cord-275041-fcdwitxy	57	8	based	base	VBN
cord-275041-fcdwitxy	57	9	on	on	IN
cord-275041-fcdwitxy	57	10	using	use	VBG
cord-275041-fcdwitxy	57	11	missing	miss	VBG
cord-275041-fcdwitxy	57	12	data	datum	NNS
cord-275041-fcdwitxy	57	13	as	as	IN
cord-275041-fcdwitxy	57	14	categories	category	NNS
cord-275041-fcdwitxy	57	15	with	with	IN
cord-275041-fcdwitxy	57	16	,	,	,
cord-275041-fcdwitxy	57	17	(	(	-LRB-
cord-275041-fcdwitxy	57	18	1	1	CD
cord-275041-fcdwitxy	57	19	)	)	-RRB-
cord-275041-fcdwitxy	57	20	estimates	estimate	NNS
cord-275041-fcdwitxy	57	21	based	base	VBN
cord-275041-fcdwitxy	57	22	on	on	IN
cord-275041-fcdwitxy	57	23	complete	complete	JJ
cord-275041-fcdwitxy	57	24	data	datum	NNS
cord-275041-fcdwitxy	57	25	dropping	drop	VBG
cord-275041-fcdwitxy	57	26	variables	variable	NNS
cord-275041-fcdwitxy	57	27	with	with	IN
cord-275041-fcdwitxy	57	28	missing	miss	VBG
cord-275041-fcdwitxy	57	29	observations	observation	NNS
cord-275041-fcdwitxy	57	30	,	,	,
cord-275041-fcdwitxy	57	31	and	and	CC
cord-275041-fcdwitxy	57	32	(	(	-LRB-
cord-275041-fcdwitxy	57	33	2	2	LS
cord-275041-fcdwitxy	57	34	)	)	-RRB-
cord-275041-fcdwitxy	57	35	complete	complete	JJ
cord-275041-fcdwitxy	57	36	case	case	NN
cord-275041-fcdwitxy	57	37	analysis	analysis	NN
cord-275041-fcdwitxy	57	38	;	;	:
cord-275041-fcdwitxy	57	39	dropping	drop	VBG
cord-275041-fcdwitxy	57	40	cases	case	NNS
cord-275041-fcdwitxy	57	41	with	with	IN
cord-275041-fcdwitxy	57	42	missing	miss	VBG
cord-275041-fcdwitxy	57	43	data	datum	NNS
cord-275041-fcdwitxy	57	44	.	.	.
cord-275041-fcdwitxy	58	1	Among	among	IN
cord-275041-fcdwitxy	58	2	the	the	DT
cord-275041-fcdwitxy	58	3	2075	2075	CD
cord-275041-fcdwitxy	58	4	patients	patient	NNS
cord-275041-fcdwitxy	58	5	whose	whose	WP$
cord-275041-fcdwitxy	58	6	records	record	NNS
cord-275041-fcdwitxy	58	7	were	be	VBD
cord-275041-fcdwitxy	58	8	reviewed	review	VBN
cord-275041-fcdwitxy	58	9	,	,	,
cord-275041-fcdwitxy	58	10	1256	1256	CD
cord-275041-fcdwitxy	58	11	were	be	VBD
cord-275041-fcdwitxy	58	12	men	man	NNS
cord-275041-fcdwitxy	58	13	,	,	,
cord-275041-fcdwitxy	58	14	819	819	CD
cord-275041-fcdwitxy	58	15	were	be	VBD
cord-275041-fcdwitxy	58	16	women	woman	NNS
cord-275041-fcdwitxy	58	17	,	,	,
cord-275041-fcdwitxy	58	18	and	and	CC
cord-275041-fcdwitxy	58	19	the	the	DT
cord-275041-fcdwitxy	58	20	mean	mean	JJ
cord-275041-fcdwitxy	58	21	age	age	NN
cord-275041-fcdwitxy	58	22	was	be	VBD
cord-275041-fcdwitxy	58	23	67.57	67.57	CD
cord-275041-fcdwitxy	58	24	.	.	.
cord-275041-fcdwitxy	59	1	At	at	IN
cord-275041-fcdwitxy	59	2	the	the	DT
cord-275041-fcdwitxy	59	3	time	time	NN
cord-275041-fcdwitxy	59	4	of	of	IN
cord-275041-fcdwitxy	59	5	collecting	collect	VBG
cord-275041-fcdwitxy	59	6	the	the	DT
cord-275041-fcdwitxy	59	7	data	datum	NNS
cord-275041-fcdwitxy	59	8	,	,	,
cord-275041-fcdwitxy	59	9	301	301	CD
cord-275041-fcdwitxy	59	10	had	have	VBD
cord-275041-fcdwitxy	59	11	died	die	VBN
cord-275041-fcdwitxy	59	12	,	,	,
cord-275041-fcdwitxy	59	13	1449	1449	CD
cord-275041-fcdwitxy	59	14	patients	patient	NNS
cord-275041-fcdwitxy	59	15	had	have	VBD
cord-275041-fcdwitxy	59	16	been	be	VBN
cord-275041-fcdwitxy	59	17	discharged	discharge	VBN
cord-275041-fcdwitxy	59	18	home	home	RB
cord-275041-fcdwitxy	59	19	from	from	IN
cord-275041-fcdwitxy	59	20	hospitals	hospital	NNS
cord-275041-fcdwitxy	59	21	,	,	,
cord-275041-fcdwitxy	59	22	240	240	CD
cord-275041-fcdwitxy	59	23	were	be	VBD
cord-275041-fcdwitxy	59	24	still	still	RB
cord-275041-fcdwitxy	59	25	admitted	admit	VBN
cord-275041-fcdwitxy	59	26	,	,	,
cord-275041-fcdwitxy	59	27	and	and	CC
cord-275041-fcdwitxy	59	28	85	85	CD
cord-275041-fcdwitxy	59	29	had	have	VBD
cord-275041-fcdwitxy	59	30	been	be	VBN
cord-275041-fcdwitxy	59	31	transferred	transfer	VBN
cord-275041-fcdwitxy	59	32	to	to	IN
cord-275041-fcdwitxy	59	33	hospitals	hospital	NNS
cord-275041-fcdwitxy	59	34	not	not	RB
cord-275041-fcdwitxy	59	35	included	include	VBN
cord-275041-fcdwitxy	59	36	in	in	IN
cord-275041-fcdwitxy	59	37	the	the	DT
cord-275041-fcdwitxy	59	38	study	study	NN
cord-275041-fcdwitxy	59	39	.	.	.
cord-275041-fcdwitxy	60	1	Median	median	JJ
cord-275041-fcdwitxy	60	2	(	(	-LRB-
cord-275041-fcdwitxy	60	3	IQR	IQR	NNP
cord-275041-fcdwitxy	60	4	)	)	-RRB-
cord-275041-fcdwitxy	60	5	follow	follow	VB
cord-275041-fcdwitxy	60	6	-	-	HYPH
cord-275041-fcdwitxy	60	7	up	up	RP
cord-275041-fcdwitxy	60	8	time	time	NN
cord-275041-fcdwitxy	60	9	was	be	VBD
cord-275041-fcdwitxy	60	10	8	8	CD
cord-275041-fcdwitxy	60	11	(	(	-LRB-
cord-275041-fcdwitxy	60	12	5	5	CD
cord-275041-fcdwitxy	60	13	-	-	SYM
cord-275041-fcdwitxy	60	14	12	12	CD
cord-275041-fcdwitxy	60	15	)	)	-RRB-
cord-275041-fcdwitxy	60	16	days	day	NNS
cord-275041-fcdwitxy	60	17	.	.	.
cord-275041-fcdwitxy	61	1	Data	datum	NNS
cord-275041-fcdwitxy	61	2	on	on	IN
cord-275041-fcdwitxy	61	3	treatment	treatment	NN
cord-275041-fcdwitxy	61	4	with	with	IN
cord-275041-fcdwitxy	61	5	HCQ	HCQ	NNP
cord-275041-fcdwitxy	61	6	were	be	VBD
cord-275041-fcdwitxy	61	7	available	available	JJ
cord-275041-fcdwitxy	61	8	for	for	IN
cord-275041-fcdwitxy	61	9	2019	2019	CD
cord-275041-fcdwitxy	61	10	patients	patient	NNS
cord-275041-fcdwitxy	61	11	.	.	.
cord-275041-fcdwitxy	62	1	There	there	EX
cord-275041-fcdwitxy	62	2	was	be	VBD
cord-275041-fcdwitxy	62	3	a	a	DT
cord-275041-fcdwitxy	62	4	younger	young	JJR
cord-275041-fcdwitxy	62	5	age	age	NN
cord-275041-fcdwitxy	62	6	(	(	-LRB-
cord-275041-fcdwitxy	62	7	p	p	NN
cord-275041-fcdwitxy	62	8	<	<	XX
cord-275041-fcdwitxy	62	9	0.001	0.001	CD
cord-275041-fcdwitxy	62	10	)	)	-RRB-
cord-275041-fcdwitxy	62	11	,	,	,
cord-275041-fcdwitxy	62	12	and	and	CC
cord-275041-fcdwitxy	62	13	a	a	DT
cord-275041-fcdwitxy	62	14	higher	high	JJR
cord-275041-fcdwitxy	62	15	proportion	proportion	NN
cord-275041-fcdwitxy	62	16	of	of	IN
cord-275041-fcdwitxy	62	17	men	man	NNS
cord-275041-fcdwitxy	62	18	(	(	-LRB-
cord-275041-fcdwitxy	62	19	p	p	NN
cord-275041-fcdwitxy	62	20	=	=	SYM
cord-275041-fcdwitxy	62	21	0.017	0.017	CD
cord-275041-fcdwitxy	62	22	)	)	-RRB-
cord-275041-fcdwitxy	62	23	for	for	IN
cord-275041-fcdwitxy	62	24	those	those	DT
cord-275041-fcdwitxy	62	25	who	who	WP
cord-275041-fcdwitxy	62	26	received	receive	VBD
cord-275041-fcdwitxy	62	27	HCQ	HCQ	NNP
cord-275041-fcdwitxy	62	28	.	.	.
cord-275041-fcdwitxy	63	1	Among	among	IN
cord-275041-fcdwitxy	63	2	the	the	DT
cord-275041-fcdwitxy	63	3	1857	1857	CD
cord-275041-fcdwitxy	63	4	patients	patient	NNS
cord-275041-fcdwitxy	63	5	who	who	WP
cord-275041-fcdwitxy	63	6	had	have	VBD
cord-275041-fcdwitxy	63	7	been	be	VBN
cord-275041-fcdwitxy	63	8	treated	treat	VBN
cord-275041-fcdwitxy	63	9	with	with	IN
cord-275041-fcdwitxy	63	10	HCQ	HCQ	NNP
cord-275041-fcdwitxy	63	11	,	,	,
cord-275041-fcdwitxy	63	12	237	237	CD
cord-275041-fcdwitxy	63	13	had	have	VBD
cord-275041-fcdwitxy	63	14	died	die	VBN
cord-275041-fcdwitxy	63	15	.	.	.
cord-275041-fcdwitxy	64	1	(	(	-LRB-
cord-275041-fcdwitxy	64	2	Table	table	NN
cord-275041-fcdwitxy	64	3	1	1	CD
cord-275041-fcdwitxy	64	4	)	)	-RRB-
cord-275041-fcdwitxy	64	5	.	.	.
cord-275041-fcdwitxy	65	1	HCQ	HCQ	NNP
cord-275041-fcdwitxy	65	2	was	be	VBD
cord-275041-fcdwitxy	65	3	associated	associate	VBN
cord-275041-fcdwitxy	65	4	with	with	IN
cord-275041-fcdwitxy	65	5	lower	low	JJR
cord-275041-fcdwitxy	65	6	mortality	mortality	NN
cord-275041-fcdwitxy	65	7	when	when	WRB
cord-275041-fcdwitxy	65	8	the	the	DT
cord-275041-fcdwitxy	65	9	model	model	NN
cord-275041-fcdwitxy	65	10	was	be	VBD
cord-275041-fcdwitxy	65	11	adjusted	adjust	VBN
cord-275041-fcdwitxy	65	12	for	for	IN
cord-275041-fcdwitxy	65	13	age	age	NN
cord-275041-fcdwitxy	65	14	and	and	CC
cord-275041-fcdwitxy	65	15	gender	gender	NN
cord-275041-fcdwitxy	65	16	with	with	IN
cord-275041-fcdwitxy	65	17	OR	or	NN
cord-275041-fcdwitxy	65	18	:	:	:
cord-275041-fcdwitxy	65	19	0.44	0.44	CD
cord-275041-fcdwitxy	65	20	(	(	-LRB-
cord-275041-fcdwitxy	65	21	0.29	0.29	CD
cord-275041-fcdwitxy	65	22	-	-	SYM
cord-275041-fcdwitxy	65	23	0.67	0.67	CD
cord-275041-fcdwitxy	65	24	)	)	-RRB-
cord-275041-fcdwitxy	66	1	,	,	,
cord-275041-fcdwitxy	66	2	p	p	NN
cord-275041-fcdwitxy	66	3	value	value	NN
cord-275041-fcdwitxy	66	4	<	<	XX
cord-275041-fcdwitxy	66	5	0.001	0.001	CD
cord-275041-fcdwitxy	66	6	.	.	.
cord-275041-fcdwitxy	67	1	When	when	WRB
cord-275041-fcdwitxy	67	2	the	the	DT
cord-275041-fcdwitxy	67	3	model	model	NN
cord-275041-fcdwitxy	67	4	was	be	VBD
cord-275041-fcdwitxy	67	5	adjusted	adjust	VBN
cord-275041-fcdwitxy	67	6	for	for	IN
cord-275041-fcdwitxy	67	7	age	age	NN
cord-275041-fcdwitxy	67	8	,	,	,
cord-275041-fcdwitxy	67	9	gender	gender	NN
cord-275041-fcdwitxy	67	10	,	,	,
cord-275041-fcdwitxy	67	11	together	together	RB
cord-275041-fcdwitxy	67	12	with	with	IN
cord-275041-fcdwitxy	67	13	temperature	temperature	NN
cord-275041-fcdwitxy	67	14	>	>	XX
cord-275041-fcdwitxy	67	15	37	37	CD
cord-275041-fcdwitxy	67	16	°	°	NN
cord-275041-fcdwitxy	67	17	C	c	NN
cord-275041-fcdwitxy	67	18	and	and	CC
cord-275041-fcdwitxy	67	19	saturation	saturation	NN
cord-275041-fcdwitxy	67	20	of	of	IN
cord-275041-fcdwitxy	67	21	oxygen	oxygen	NN
cord-275041-fcdwitxy	67	22	<	<	XX
cord-275041-fcdwitxy	67	23	90	90	CD
cord-275041-fcdwitxy	67	24	%	%	NN
cord-275041-fcdwitxy	67	25	on	on	IN
cord-275041-fcdwitxy	67	26	admission	admission	NN
cord-275041-fcdwitxy	67	27	,	,	,
cord-275041-fcdwitxy	67	28	and	and	CC
cord-275041-fcdwitxy	67	29	also	also	RB
cord-275041-fcdwitxy	67	30	when	when	WRB
cord-275041-fcdwitxy	67	31	the	the	DT
cord-275041-fcdwitxy	67	32	model	model	NN
cord-275041-fcdwitxy	67	33	included	include	VBD
cord-275041-fcdwitxy	67	34	all	all	PDT
cord-275041-fcdwitxy	67	35	the	the	DT
cord-275041-fcdwitxy	67	36	previous	previous	JJ
cord-275041-fcdwitxy	67	37	variables	variable	NNS
cord-275041-fcdwitxy	67	38	plus	plus	CC
cord-275041-fcdwitxy	67	39	treatment	treatment	NN
cord-275041-fcdwitxy	67	40	with	with	IN
cord-275041-fcdwitxy	67	41	all	all	DT
cord-275041-fcdwitxy	67	42	drugs	drug	NNS
cord-275041-fcdwitxy	67	43	,	,	,
cord-275041-fcdwitxy	67	44	the	the	DT
cord-275041-fcdwitxy	67	45	association	association	NN
cord-275041-fcdwitxy	67	46	between	between	IN
cord-275041-fcdwitxy	67	47	use	use	NN
cord-275041-fcdwitxy	67	48	of	of	IN
cord-275041-fcdwitxy	67	49	HCQ	hcq	NN
cord-275041-fcdwitxy	67	50	and	and	CC
cord-275041-fcdwitxy	67	51	lower	low	JJR
cord-275041-fcdwitxy	67	52	mortality	mortality	NN
cord-275041-fcdwitxy	67	53	remained	remain	VBD
cord-275041-fcdwitxy	67	54	significant	significant	JJ
cord-275041-fcdwitxy	67	55	.	.	.
cord-275041-fcdwitxy	68	1	The	the	DT
cord-275041-fcdwitxy	68	2	analysis	analysis	NN
cord-275041-fcdwitxy	68	3	of	of	IN
cord-275041-fcdwitxy	68	4	interaction	interaction	NN
cord-275041-fcdwitxy	68	5	suggested	suggest	VBD
cord-275041-fcdwitxy	68	6	that	that	IN
cord-275041-fcdwitxy	68	7	HCQ	HCQ	NNP
cord-275041-fcdwitxy	68	8	was	be	VBD
cord-275041-fcdwitxy	68	9	associated	associate	VBN
cord-275041-fcdwitxy	68	10	with	with	IN
cord-275041-fcdwitxy	68	11	lower	low	JJR
cord-275041-fcdwitxy	68	12	mortality	mortality	NN
cord-275041-fcdwitxy	68	13	,	,	,
cord-275041-fcdwitxy	68	14	and	and	CC
cord-275041-fcdwitxy	68	15	there	there	EX
cord-275041-fcdwitxy	68	16	was	be	VBD
cord-275041-fcdwitxy	68	17	no	no	DT
cord-275041-fcdwitxy	68	18	difference	difference	NN
cord-275041-fcdwitxy	68	19	for	for	IN
cord-275041-fcdwitxy	68	20	those	those	DT
cord-275041-fcdwitxy	68	21	taking	take	VBG
cord-275041-fcdwitxy	68	22	(	(	-LRB-
cord-275041-fcdwitxy	68	23	n	n	NN
cord-275041-fcdwitxy	68	24	=	=	SYM
cord-275041-fcdwitxy	68	25	1187	1187	CD
cord-275041-fcdwitxy	68	26	)	)	-RRB-
cord-275041-fcdwitxy	68	27	,	,	,
cord-275041-fcdwitxy	68	28	or	or	CC
cord-275041-fcdwitxy	68	29	not	not	RB
cord-275041-fcdwitxy	68	30	(	(	-LRB-
cord-275041-fcdwitxy	68	31	n	n	NN
cord-275041-fcdwitxy	68	32	=	=	SYM
cord-275041-fcdwitxy	68	33	670	670	CD
cord-275041-fcdwitxy	68	34	)	)	-RRB-
cord-275041-fcdwitxy	68	35	,	,	,
cord-275041-fcdwitxy	68	36	azithromycin	azithromycin	NNP
cord-275041-fcdwitxy	68	37	,	,	,
cord-275041-fcdwitxy	68	38	as	as	RB
cord-275041-fcdwitxy	68	39	well	well	RB
cord-275041-fcdwitxy	68	40	.	.	.
cord-275041-fcdwitxy	69	1	In	in	IN
cord-275041-fcdwitxy	69	2	the	the	DT
cord-275041-fcdwitxy	69	3	final	final	JJ
cord-275041-fcdwitxy	69	4	model	model	NN
cord-275041-fcdwitxy	69	5	where	where	WRB
cord-275041-fcdwitxy	69	6	all	all	PDT
cord-275041-fcdwitxy	69	7	the	the	DT
cord-275041-fcdwitxy	69	8	previous	previous	JJ
cord-275041-fcdwitxy	69	9	demographic	demographic	JJ
cord-275041-fcdwitxy	69	10	,	,	,
cord-275041-fcdwitxy	69	11	clinical	clinical	JJ
cord-275041-fcdwitxy	69	12	variables	variable	NNS
cord-275041-fcdwitxy	69	13	,	,	,
cord-275041-fcdwitxy	69	14	and	and	CC
cord-275041-fcdwitxy	69	15	drugs	drug	NNS
cord-275041-fcdwitxy	69	16	were	be	VBD
cord-275041-fcdwitxy	69	17	introduced	introduce	VBN
cord-275041-fcdwitxy	69	18	,	,	,
cord-275041-fcdwitxy	69	19	together	together	RB
cord-275041-fcdwitxy	69	20	with	with	IN
cord-275041-fcdwitxy	69	21	time	time	NN
cord-275041-fcdwitxy	69	22	of	of	IN
cord-275041-fcdwitxy	69	23	admission	admission	NN
cord-275041-fcdwitxy	69	24	,	,	,
cord-275041-fcdwitxy	69	25	the	the	DT
cord-275041-fcdwitxy	69	26	association	association	NN
cord-275041-fcdwitxy	69	27	between	between	IN
cord-275041-fcdwitxy	69	28	treatment	treatment	NN
cord-275041-fcdwitxy	69	29	with	with	IN
cord-275041-fcdwitxy	69	30	HCQ	hcq	NN
cord-275041-fcdwitxy	69	31	and	and	CC
cord-275041-fcdwitxy	69	32	lower	low	JJR
cord-275041-fcdwitxy	69	33	mortality	mortality	NN
cord-275041-fcdwitxy	69	34	was	be	VBD
cord-275041-fcdwitxy	69	35	also	also	RB
cord-275041-fcdwitxy	69	36	significant	significant	JJ
cord-275041-fcdwitxy	69	37	.	.	.
cord-275041-fcdwitxy	70	1	(	(	-LRB-
cord-275041-fcdwitxy	70	2	Table	table	NN
cord-275041-fcdwitxy	70	3	2	2	CD
cord-275041-fcdwitxy	70	4	)	)	-RRB-
cord-275041-fcdwitxy	70	5	.	.	.
cord-275041-fcdwitxy	71	1	Treatment	treatment	NN
cord-275041-fcdwitxy	71	2	with	with	IN
cord-275041-fcdwitxy	71	3	HCQ	HCQ	NNP
cord-275041-fcdwitxy	71	4	was	be	VBD
cord-275041-fcdwitxy	71	5	associated	associate	VBN
cord-275041-fcdwitxy	71	6	with	with	IN
cord-275041-fcdwitxy	71	7	lower	low	JJR
cord-275041-fcdwitxy	71	8	mortality	mortality	NN
cord-275041-fcdwitxy	71	9	in	in	IN
cord-275041-fcdwitxy	71	10	patients	patient	NNS
cord-275041-fcdwitxy	71	11	admitted	admit	VBN
cord-275041-fcdwitxy	71	12	with	with	IN
cord-275041-fcdwitxy	71	13	COVID-19	COVID-19	NNP
cord-275041-fcdwitxy	71	14	.	.	.
cord-275041-fcdwitxy	72	1	This	this	DT
cord-275041-fcdwitxy	72	2	study	study	NN
cord-275041-fcdwitxy	72	3	has	have	VBZ
cord-275041-fcdwitxy	72	4	strengths	strength	NNS
cord-275041-fcdwitxy	72	5	and	and	CC
cord-275041-fcdwitxy	72	6	limitations	limitation	NNS
cord-275041-fcdwitxy	72	7	.	.	.
cord-275041-fcdwitxy	73	1	Patients	patient	NNS
cord-275041-fcdwitxy	73	2	were	be	VBD
cord-275041-fcdwitxy	73	3	not	not	RB
cord-275041-fcdwitxy	73	4	randomized	randomized	JJ
cord-275041-fcdwitxy	73	5	and	and	CC
cord-275041-fcdwitxy	73	6	the	the	DT
cord-275041-fcdwitxy	73	7	differences	difference	NNS
cord-275041-fcdwitxy	73	8	in	in	IN
cord-275041-fcdwitxy	73	9	mortality	mortality	NN
cord-275041-fcdwitxy	73	10	may	may	MD
cord-275041-fcdwitxy	73	11	be	be	VB
cord-275041-fcdwitxy	73	12	explained	explain	VBN
cord-275041-fcdwitxy	73	13	by	by	IN
cord-275041-fcdwitxy	73	14	factors	factor	NNS
cord-275041-fcdwitxy	73	15	other	other	JJ
cord-275041-fcdwitxy	73	16	than	than	IN
cord-275041-fcdwitxy	73	17	the	the	DT
cord-275041-fcdwitxy	73	18	use	use	NN
cord-275041-fcdwitxy	73	19	of	of	IN
cord-275041-fcdwitxy	73	20	HCQ	HCQ	NNP
cord-275041-fcdwitxy	73	21	.	.	.
cord-275041-fcdwitxy	74	1	In	in	IN
cord-275041-fcdwitxy	74	2	an	an	DT
cord-275041-fcdwitxy	74	3	effort	effort	NN
cord-275041-fcdwitxy	74	4	to	to	TO
cord-275041-fcdwitxy	74	5	control	control	VB
cord-275041-fcdwitxy	74	6	for	for	IN
cord-275041-fcdwitxy	74	7	the	the	DT
cord-275041-fcdwitxy	74	8	severity	severity	NN
cord-275041-fcdwitxy	74	9	of	of	IN
cord-275041-fcdwitxy	74	10	disease	disease	NN
cord-275041-fcdwitxy	74	11	,	,	,
cord-275041-fcdwitxy	74	12	available	available	JJ
cord-275041-fcdwitxy	74	13	markers	marker	NNS
cord-275041-fcdwitxy	74	14	were	be	VBD
cord-275041-fcdwitxy	74	15	considered	consider	VBN
cord-275041-fcdwitxy	74	16	,	,	,
cord-275041-fcdwitxy	74	17	and	and	CC
cord-275041-fcdwitxy	74	18	adjusted	adjust	VBN
cord-275041-fcdwitxy	74	19	for	for	IN
cord-275041-fcdwitxy	74	20	,	,	,
cord-275041-fcdwitxy	74	21	in	in	IN
cord-275041-fcdwitxy	74	22	all	all	PDT
cord-275041-fcdwitxy	74	23	the	the	DT
cord-275041-fcdwitxy	74	24	models	model	NNS
cord-275041-fcdwitxy	74	25	.	.	.
cord-275041-fcdwitxy	75	1	The	the	DT
cord-275041-fcdwitxy	75	2	observation	observation	NN
cord-275041-fcdwitxy	75	3	of	of	IN
cord-275041-fcdwitxy	75	4	a	a	DT
cord-275041-fcdwitxy	75	5	large	large	JJ
cord-275041-fcdwitxy	75	6	number	number	NN
cord-275041-fcdwitxy	75	7	of	of	IN
cord-275041-fcdwitxy	75	8	unselected	unselected	JJ
cord-275041-fcdwitxy	75	9	patients	patient	NNS
cord-275041-fcdwitxy	75	10	admitted	admit	VBN
cord-275041-fcdwitxy	75	11	in	in	IN
cord-275041-fcdwitxy	75	12	17	17	CD
cord-275041-fcdwitxy	75	13	hospitals	hospital	NNS
cord-275041-fcdwitxy	75	14	,	,	,
cord-275041-fcdwitxy	75	15	and	and	CC
cord-275041-fcdwitxy	75	16	the	the	DT
cord-275041-fcdwitxy	75	17	analyses	analysis	NNS
cord-275041-fcdwitxy	75	18	run	run	VBP
cord-275041-fcdwitxy	75	19	with	with	IN
cord-275041-fcdwitxy	75	20	some	some	DT
cord-275041-fcdwitxy	75	21	variations	variation	NNS
cord-275041-fcdwitxy	75	22	to	to	TO
cord-275041-fcdwitxy	75	23	test	test	VB
cord-275041-fcdwitxy	75	24	the	the	DT
cord-275041-fcdwitxy	75	25	consistency	consistency	NN
cord-275041-fcdwitxy	75	26	of	of	IN
cord-275041-fcdwitxy	75	27	the	the	DT
cord-275041-fcdwitxy	75	28	results	result	NNS
cord-275041-fcdwitxy	75	29	are	be	VBP
cord-275041-fcdwitxy	75	30	also	also	RB
cord-275041-fcdwitxy	75	31	strengths	strength	NNS
cord-275041-fcdwitxy	75	32	of	of	IN
cord-275041-fcdwitxy	75	33	this	this	DT
cord-275041-fcdwitxy	75	34	study	study	NN
cord-275041-fcdwitxy	75	35	.	.	.
cord-275041-fcdwitxy	76	1	However	however	RB
cord-275041-fcdwitxy	76	2	,	,	,
cord-275041-fcdwitxy	76	3	residual	residual	JJ
cord-275041-fcdwitxy	76	4	confounding	confounding	NN
cord-275041-fcdwitxy	76	5	is	be	VBZ
cord-275041-fcdwitxy	76	6	always	always	RB
cord-275041-fcdwitxy	76	7	present	present	JJ
cord-275041-fcdwitxy	76	8	in	in	IN
cord-275041-fcdwitxy	76	9	all	all	DT
cord-275041-fcdwitxy	76	10	observational	observational	JJ
cord-275041-fcdwitxy	76	11	research	research	NN
cord-275041-fcdwitxy	76	12	.	.	.
cord-275041-fcdwitxy	77	1	The	the	DT
cord-275041-fcdwitxy	77	2	association	association	NN
cord-275041-fcdwitxy	77	3	,	,	,
cord-275041-fcdwitxy	77	4	that	that	WDT
cord-275041-fcdwitxy	77	5	was	be	VBD
cord-275041-fcdwitxy	77	6	consistent	consistent	JJ
cord-275041-fcdwitxy	77	7	across	across	IN
cord-275041-fcdwitxy	77	8	a	a	DT
cord-275041-fcdwitxy	77	9	set	set	NN
cord-275041-fcdwitxy	77	10	of	of	IN
cord-275041-fcdwitxy	77	11	models	model	NNS
cord-275041-fcdwitxy	77	12	that	that	WDT
cord-275041-fcdwitxy	77	13	adjusted	adjust	VBD
cord-275041-fcdwitxy	77	14	for	for	IN
cord-275041-fcdwitxy	77	15	different	different	JJ
cord-275041-fcdwitxy	77	16	potential	potential	JJ
cord-275041-fcdwitxy	77	17	confounders	confounder	NNS
cord-275041-fcdwitxy	77	18	,	,	,
cord-275041-fcdwitxy	77	19	provides	provide	VBZ
cord-275041-fcdwitxy	77	20	support	support	NN
cord-275041-fcdwitxy	77	21	to	to	IN
cord-275041-fcdwitxy	77	22	an	an	DT
cord-275041-fcdwitxy	77	23	independent	independent	JJ
cord-275041-fcdwitxy	77	24	positive	positive	JJ
cord-275041-fcdwitxy	77	25	effect	effect	NN
cord-275041-fcdwitxy	77	26	of	of	IN
cord-275041-fcdwitxy	77	27	HCQ	HCQ	NNP
cord-275041-fcdwitxy	77	28	.	.	.
cord-275041-fcdwitxy	78	1	For	for	IN
cord-275041-fcdwitxy	78	2	all	all	DT
cord-275041-fcdwitxy	78	3	models	model	NNS
cord-275041-fcdwitxy	78	4	,	,	,
cord-275041-fcdwitxy	78	5	the	the	DT
cord-275041-fcdwitxy	78	6	sensitivity	sensitivity	NN
cord-275041-fcdwitxy	78	7	analyses	analysis	NNS
cord-275041-fcdwitxy	78	8	described	describe	VBN
cord-275041-fcdwitxy	78	9	in	in	IN
cord-275041-fcdwitxy	78	10	methods	method	NNS
cord-275041-fcdwitxy	78	11	were	be	VBD
cord-275041-fcdwitxy	78	12	used	use	VBN
cord-275041-fcdwitxy	78	13	to	to	TO
cord-275041-fcdwitxy	78	14	assess	assess	VB
cord-275041-fcdwitxy	78	15	the	the	DT
cord-275041-fcdwitxy	78	16	impact	impact	NN
cord-275041-fcdwitxy	78	17	of	of	IN
cord-275041-fcdwitxy	78	18	missing	miss	VBG
cord-275041-fcdwitxy	78	19	data	datum	NNS
cord-275041-fcdwitxy	78	20	on	on	IN
cord-275041-fcdwitxy	78	21	the	the	DT
cord-275041-fcdwitxy	78	22	two	two	CD
cord-275041-fcdwitxy	78	23	markers	marker	NNS
cord-275041-fcdwitxy	78	24	of	of	IN
cord-275041-fcdwitxy	78	25	disease	disease	NN
cord-275041-fcdwitxy	78	26	severity	severity	NN
cord-275041-fcdwitxy	78	27	,	,	,
cord-275041-fcdwitxy	78	28	and	and	CC
cord-275041-fcdwitxy	78	29	results	result	NNS
cord-275041-fcdwitxy	78	30	were	be	VBD
cord-275041-fcdwitxy	78	31	consistent	consistent	JJ
cord-275041-fcdwitxy	78	32	with	with	IN
cord-275041-fcdwitxy	78	33	those	those	DT
cord-275041-fcdwitxy	78	34	presented	present	VBN
cord-275041-fcdwitxy	78	35	.	.	.
cord-275041-fcdwitxy	79	1	HCQ	HCQ	NNP
cord-275041-fcdwitxy	79	2	has	have	VBZ
cord-275041-fcdwitxy	79	3	been	be	VBN
cord-275041-fcdwitxy	79	4	used	use	VBN
cord-275041-fcdwitxy	79	5	in	in	IN
cord-275041-fcdwitxy	79	6	all	all	DT
cord-275041-fcdwitxy	79	7	phases	phase	NNS
cord-275041-fcdwitxy	79	8	of	of	IN
cord-275041-fcdwitxy	79	9	COVID-19	COVID-19	NNP
cord-275041-fcdwitxy	79	10	since	since	IN
cord-275041-fcdwitxy	79	11	two	two	CD
cord-275041-fcdwitxy	79	12	studies	study	NNS
cord-275041-fcdwitxy	79	13	,	,	,
cord-275041-fcdwitxy	79	14	with	with	IN
cord-275041-fcdwitxy	79	15	no	no	DT
cord-275041-fcdwitxy	79	16	control	control	NN
cord-275041-fcdwitxy	79	17	arm	arm	NN
cord-275041-fcdwitxy	79	18	and	and	CC
cord-275041-fcdwitxy	79	19	small	small	JJ
cord-275041-fcdwitxy	79	20	sample	sample	NN
cord-275041-fcdwitxy	79	21	size	size	NN
cord-275041-fcdwitxy	79	22	,	,	,
cord-275041-fcdwitxy	79	23	published	publish	VBN
cord-275041-fcdwitxy	79	24	in	in	IN
cord-275041-fcdwitxy	79	25	March	March	NNP
cord-275041-fcdwitxy	79	26	2020	2020	CD
cord-275041-fcdwitxy	79	27	,	,	,
cord-275041-fcdwitxy	79	28	reported	report	VBD
cord-275041-fcdwitxy	79	29	it	-PRON-	PRP
cord-275041-fcdwitxy	79	30	to	to	TO
cord-275041-fcdwitxy	79	31	be	be	VB
cord-275041-fcdwitxy	79	32	associated	associate	VBN
cord-275041-fcdwitxy	79	33	with	with	IN
cord-275041-fcdwitxy	79	34	a	a	DT
cord-275041-fcdwitxy	79	35	reduction	reduction	NN
cord-275041-fcdwitxy	79	36	of	of	IN
cord-275041-fcdwitxy	79	37	the	the	DT
cord-275041-fcdwitxy	79	38	viral	viral	JJ
cord-275041-fcdwitxy	79	39	carriage	carriage	NN
cord-275041-fcdwitxy	79	40	and	and	CC
cord-275041-fcdwitxy	79	41	clinical	clinical	JJ
cord-275041-fcdwitxy	79	42	improvement	improvement	NN
cord-275041-fcdwitxy	79	43	[	[	-LRB-
cord-275041-fcdwitxy	79	44	9	9	CD
cord-275041-fcdwitxy	79	45	,	,	,
cord-275041-fcdwitxy	79	46	10	10	CD
cord-275041-fcdwitxy	79	47	,	,	,
cord-275041-fcdwitxy	79	48	21	21	CD
cord-275041-fcdwitxy	79	49	]	]	-RRB-
cord-275041-fcdwitxy	79	50	.	.	.
cord-275041-fcdwitxy	80	1	This	this	DT
cord-275041-fcdwitxy	80	2	has	have	VBZ
cord-275041-fcdwitxy	80	3	allowed	allow	VBN
cord-275041-fcdwitxy	80	4	for	for	IN
cord-275041-fcdwitxy	80	5	its	-PRON-	PRP$
cord-275041-fcdwitxy	80	6	effects	effect	NNS
cord-275041-fcdwitxy	80	7	to	to	TO
cord-275041-fcdwitxy	80	8	be	be	VB
cord-275041-fcdwitxy	80	9	observed	observe	VBN
cord-275041-fcdwitxy	80	10	since	since	IN
cord-275041-fcdwitxy	80	11	then	then	RB
cord-275041-fcdwitxy	80	12	in	in	IN
cord-275041-fcdwitxy	80	13	a	a	DT
cord-275041-fcdwitxy	80	14	large	large	JJ
cord-275041-fcdwitxy	80	15	number	number	NN
cord-275041-fcdwitxy	80	16	of	of	IN
cord-275041-fcdwitxy	80	17	different	different	JJ
cord-275041-fcdwitxy	80	18	patients	patient	NNS
cord-275041-fcdwitxy	80	19	in	in	IN
cord-275041-fcdwitxy	80	20	many	many	JJ
cord-275041-fcdwitxy	80	21	countries	country	NNS
cord-275041-fcdwitxy	80	22	.	.	.
cord-275041-fcdwitxy	81	1	Our	-PRON-	PRP$
cord-275041-fcdwitxy	81	2	results	result	NNS
cord-275041-fcdwitxy	81	3	,	,	,
cord-275041-fcdwitxy	81	4	showing	show	VBG
cord-275041-fcdwitxy	81	5	that	that	IN
cord-275041-fcdwitxy	81	6	HCQ	HCQ	NNP
cord-275041-fcdwitxy	81	7	is	be	VBZ
cord-275041-fcdwitxy	81	8	associated	associate	VBN
cord-275041-fcdwitxy	81	9	with	with	IN
cord-275041-fcdwitxy	81	10	positive	positive	JJ
cord-275041-fcdwitxy	81	11	outcomes	outcome	NNS
cord-275041-fcdwitxy	81	12	,	,	,
cord-275041-fcdwitxy	81	13	are	be	VBP
cord-275041-fcdwitxy	81	14	consistent	consistent	JJ
cord-275041-fcdwitxy	81	15	with	with	IN
cord-275041-fcdwitxy	81	16	the	the	DT
cord-275041-fcdwitxy	81	17	ones	one	NNS
cord-275041-fcdwitxy	81	18	first	first	RB
cord-275041-fcdwitxy	81	19	reported	report	VBN
cord-275041-fcdwitxy	81	20	in	in	IN
cord-275041-fcdwitxy	81	21	March	March	NNP
cord-275041-fcdwitxy	81	22	2020	2020	CD
cord-275041-fcdwitxy	81	23	.	.	.
cord-275041-fcdwitxy	82	1	A	a	DT
cord-275041-fcdwitxy	82	2	number	number	NN
cord-275041-fcdwitxy	82	3	of	of	IN
cord-275041-fcdwitxy	82	4	observational	observational	JJ
cord-275041-fcdwitxy	82	5	studies	study	NNS
cord-275041-fcdwitxy	82	6	later	later	RB
cord-275041-fcdwitxy	82	7	conducted	conduct	VBN
cord-275041-fcdwitxy	82	8	in	in	IN
cord-275041-fcdwitxy	82	9	China	China	NNP
cord-275041-fcdwitxy	82	10	,	,	,
cord-275041-fcdwitxy	82	11	France	France	NNP
cord-275041-fcdwitxy	82	12	,	,	,
cord-275041-fcdwitxy	82	13	Spain	Spain	NNP
cord-275041-fcdwitxy	82	14	(	(	-LRB-
cord-275041-fcdwitxy	82	15	in	in	IN
cord-275041-fcdwitxy	82	16	a	a	DT
cord-275041-fcdwitxy	82	17	hospital	hospital	NN
cord-275041-fcdwitxy	82	18	not	not	RB
cord-275041-fcdwitxy	82	19	included	include	VBN
cord-275041-fcdwitxy	82	20	in	in	IN
cord-275041-fcdwitxy	82	21	our	-PRON-	PRP$
cord-275041-fcdwitxy	82	22	project	project	NN
cord-275041-fcdwitxy	82	23	)	)	-RRB-
cord-275041-fcdwitxy	82	24	,	,	,
cord-275041-fcdwitxy	82	25	and	and	CC
cord-275041-fcdwitxy	82	26	the	the	DT
cord-275041-fcdwitxy	82	27	USA	USA	NNP
cord-275041-fcdwitxy	82	28	,	,	,
cord-275041-fcdwitxy	82	29	have	have	VBP
cord-275041-fcdwitxy	82	30	also	also	RB
cord-275041-fcdwitxy	82	31	reported	report	VBN
cord-275041-fcdwitxy	82	32	the	the	DT
cord-275041-fcdwitxy	82	33	association	association	NN
cord-275041-fcdwitxy	82	34	between	between	IN
cord-275041-fcdwitxy	82	35	HCQ	HCQ	NNP
cord-275041-fcdwitxy	82	36	and	and	CC
cord-275041-fcdwitxy	82	37	lower	low	JJR
cord-275041-fcdwitxy	82	38	mortality	mortality	NN
cord-275041-fcdwitxy	82	39	[	[	-LRB-
cord-275041-fcdwitxy	82	40	22	22	CD
cord-275041-fcdwitxy	82	41	]	]	-RRB-
cord-275041-fcdwitxy	83	1	[	[	-LRB-
cord-275041-fcdwitxy	83	2	23	23	CD
cord-275041-fcdwitxy	83	3	]	]	-RRB-
cord-275041-fcdwitxy	84	1	[	[	-LRB-
cord-275041-fcdwitxy	84	2	24	24	CD
cord-275041-fcdwitxy	84	3	]	]	-RRB-
cord-275041-fcdwitxy	84	4	[	[	-LRB-
cord-275041-fcdwitxy	84	5	25	25	CD
cord-275041-fcdwitxy	84	6	]	]	-RRB-
cord-275041-fcdwitxy	84	7	[	[	-LRB-
cord-275041-fcdwitxy	84	8	26	26	CD
cord-275041-fcdwitxy	84	9	]	]	-RRB-
cord-275041-fcdwitxy	84	10	[	[	-LRB-
cord-275041-fcdwitxy	84	11	27	27	CD
cord-275041-fcdwitxy	84	12	]	]	-RRB-
cord-275041-fcdwitxy	84	13	.	.	.
cord-275041-fcdwitxy	85	1	Three	three	CD
cord-275041-fcdwitxy	85	2	of	of	IN
cord-275041-fcdwitxy	85	3	these	these	DT
cord-275041-fcdwitxy	85	4	studies	study	NNS
cord-275041-fcdwitxy	85	5	included	include	VBN
cord-275041-fcdwitxy	85	6	over	over	IN
cord-275041-fcdwitxy	85	7	2000	2000	CD
cord-275041-fcdwitxy	85	8	participants	participant	NNS
cord-275041-fcdwitxy	85	9	[	[	-LRB-
cord-275041-fcdwitxy	85	10	23	23	CD
cord-275041-fcdwitxy	85	11	,	,	,
cord-275041-fcdwitxy	85	12	24	24	CD
cord-275041-fcdwitxy	85	13	,	,	,
cord-275041-fcdwitxy	85	14	26	26	CD
cord-275041-fcdwitxy	85	15	]	]	-RRB-
cord-275041-fcdwitxy	85	16	.	.	.
cord-275041-fcdwitxy	86	1	In	in	IN
cord-275041-fcdwitxy	86	2	one	one	CD
cord-275041-fcdwitxy	86	3	of	of	IN
cord-275041-fcdwitxy	86	4	these	these	DT
cord-275041-fcdwitxy	86	5	studies	study	NNS
cord-275041-fcdwitxy	86	6	,	,	,
cord-275041-fcdwitxy	86	7	only	only	RB
cord-275041-fcdwitxy	86	8	patients	patient	NNS
cord-275041-fcdwitxy	86	9	having	have	VBG
cord-275041-fcdwitxy	86	10	mechanical	mechanical	JJ
cord-275041-fcdwitxy	86	11	ventilation	ventilation	NN
cord-275041-fcdwitxy	86	12	were	be	VBD
cord-275041-fcdwitxy	86	13	included	include	VBN
cord-275041-fcdwitxy	86	14	[	[	-LRB-
cord-275041-fcdwitxy	86	15	22	22	CD
cord-275041-fcdwitxy	86	16	]	]	-RRB-
cord-275041-fcdwitxy	86	17	.	.	.
cord-275041-fcdwitxy	87	1	In	in	IN
cord-275041-fcdwitxy	87	2	another	another	DT
cord-275041-fcdwitxy	87	3	one	one	NN
cord-275041-fcdwitxy	87	4	,	,	,
cord-275041-fcdwitxy	87	5	HCQ	HCQ	NNP
cord-275041-fcdwitxy	87	6	was	be	VBD
cord-275041-fcdwitxy	87	7	also	also	RB
cord-275041-fcdwitxy	87	8	associated	associate	VBN
cord-275041-fcdwitxy	87	9	with	with	IN
cord-275041-fcdwitxy	87	10	lower	low	JJR
cord-275041-fcdwitxy	87	11	probability	probability	NN
cord-275041-fcdwitxy	87	12	of	of	IN
cord-275041-fcdwitxy	87	13	admission	admission	NN
cord-275041-fcdwitxy	87	14	to	to	IN
cord-275041-fcdwitxy	87	15	intensive	intensive	JJ
cord-275041-fcdwitxy	87	16	care	care	NN
cord-275041-fcdwitxy	87	17	,	,	,
cord-275041-fcdwitxy	87	18	shorter	short	JJR
cord-275041-fcdwitxy	87	19	hospital	hospital	NN
cord-275041-fcdwitxy	87	20	admissions	admission	NNS
cord-275041-fcdwitxy	87	21	,	,	,
cord-275041-fcdwitxy	87	22	and	and	CC
cord-275041-fcdwitxy	87	23	shorter	short	JJR
cord-275041-fcdwitxy	87	24	duration	duration	NN
cord-275041-fcdwitxy	87	25	of	of	IN
cord-275041-fcdwitxy	87	26	viral	viral	JJ
cord-275041-fcdwitxy	87	27	shedding	shed	VBG
cord-275041-fcdwitxy	87	28	[	[	-LRB-
cord-275041-fcdwitxy	87	29	23	23	CD
cord-275041-fcdwitxy	87	30	]	]	-RRB-
cord-275041-fcdwitxy	87	31	.	.	.
cord-275041-fcdwitxy	88	1	In	in	IN
cord-275041-fcdwitxy	88	2	two	two	CD
cord-275041-fcdwitxy	88	3	of	of	IN
cord-275041-fcdwitxy	88	4	these	these	DT
cord-275041-fcdwitxy	88	5	studies	study	NNS
cord-275041-fcdwitxy	88	6	,	,	,
cord-275041-fcdwitxy	88	7	favourable	favourable	JJ
cord-275041-fcdwitxy	88	8	results	result	NNS
cord-275041-fcdwitxy	88	9	of	of	IN
cord-275041-fcdwitxy	88	10	HCQ	hcq	NN
cord-275041-fcdwitxy	88	11	combined	combine	VBN
cord-275041-fcdwitxy	88	12	with	with	IN
cord-275041-fcdwitxy	88	13	azithromycin	azithromycin	NNS
cord-275041-fcdwitxy	88	14	were	be	VBD
cord-275041-fcdwitxy	88	15	reported	report	VBN
cord-275041-fcdwitxy	88	16	[	[	-LRB-
cord-275041-fcdwitxy	88	17	23	23	CD
cord-275041-fcdwitxy	88	18	,	,	,
cord-275041-fcdwitxy	88	19	24	24	CD
cord-275041-fcdwitxy	88	20	]	]	-RRB-
cord-275041-fcdwitxy	88	21	,	,	,
cord-275041-fcdwitxy	88	22	and	and	CC
cord-275041-fcdwitxy	88	23	in	in	IN
cord-275041-fcdwitxy	88	24	another	another	DT
cord-275041-fcdwitxy	88	25	one	one	NN
cord-275041-fcdwitxy	88	26	,	,	,
cord-275041-fcdwitxy	88	27	the	the	DT
cord-275041-fcdwitxy	88	28	lower	low	JJR
cord-275041-fcdwitxy	88	29	mortality	mortality	NN
cord-275041-fcdwitxy	88	30	was	be	VBD
cord-275041-fcdwitxy	88	31	observed	observe	VBN
cord-275041-fcdwitxy	88	32	for	for	IN
cord-275041-fcdwitxy	88	33	those	those	DT
cord-275041-fcdwitxy	88	34	on	on	IN
cord-275041-fcdwitxy	88	35	HCQ	HCQ	NNP
cord-275041-fcdwitxy	88	36	in	in	IN
cord-275041-fcdwitxy	88	37	combination	combination	NN
cord-275041-fcdwitxy	88	38	with	with	IN
cord-275041-fcdwitxy	88	39	azithromycin	azithromycin	NN
cord-275041-fcdwitxy	88	40	and	and	CC
cord-275041-fcdwitxy	88	41	zinc	zinc	NN
cord-275041-fcdwitxy	88	42	[	[	-LRB-
cord-275041-fcdwitxy	88	43	27	27	CD
cord-275041-fcdwitxy	88	44	]	]	-RRB-
cord-275041-fcdwitxy	88	45	.	.	.
cord-275041-fcdwitxy	89	1	The	the	DT
cord-275041-fcdwitxy	89	2	later	later	JJ
cord-275041-fcdwitxy	89	3	study	study	NN
cord-275041-fcdwitxy	89	4	was	be	VBD
cord-275041-fcdwitxy	89	5	based	base	VBN
cord-275041-fcdwitxy	89	6	on	on	IN
cord-275041-fcdwitxy	89	7	primary	primary	JJ
cord-275041-fcdwitxy	89	8	care	care	NN
cord-275041-fcdwitxy	89	9	,	,	,
cord-275041-fcdwitxy	89	10	and	and	CC
cord-275041-fcdwitxy	89	11	reported	report	VBD
cord-275041-fcdwitxy	89	12	an	an	DT
cord-275041-fcdwitxy	89	13	association	association	NN
cord-275041-fcdwitxy	89	14	between	between	IN
cord-275041-fcdwitxy	89	15	treatment	treatment	NN
cord-275041-fcdwitxy	89	16	and	and	CC
cord-275041-fcdwitxy	89	17	lower	low	JJR
cord-275041-fcdwitxy	89	18	rates	rate	NNS
cord-275041-fcdwitxy	89	19	of	of	IN
cord-275041-fcdwitxy	89	20	hospital	hospital	NN
cord-275041-fcdwitxy	89	21	admissions	admission	NNS
cord-275041-fcdwitxy	89	22	,	,	,
cord-275041-fcdwitxy	89	23	as	as	RB
cord-275041-fcdwitxy	89	24	well	well	RB
cord-275041-fcdwitxy	89	25	.	.	.
cord-275041-fcdwitxy	90	1	Another	another	DT
cord-275041-fcdwitxy	90	2	observational	observational	JJ
cord-275041-fcdwitxy	90	3	study	study	NN
cord-275041-fcdwitxy	90	4	conducted	conduct	VBN
cord-275041-fcdwitxy	90	5	in	in	IN
cord-275041-fcdwitxy	90	6	primary	primary	JJ
cord-275041-fcdwitxy	90	7	care	care	NN
cord-275041-fcdwitxy	90	8	,	,	,
cord-275041-fcdwitxy	90	9	were	be	VBD
cord-275041-fcdwitxy	90	10	mortality	mortality	NN
cord-275041-fcdwitxy	90	11	was	be	VBD
cord-275041-fcdwitxy	90	12	not	not	RB
cord-275041-fcdwitxy	90	13	the	the	DT
cord-275041-fcdwitxy	90	14	outcome	outcome	NN
cord-275041-fcdwitxy	90	15	,	,	,
cord-275041-fcdwitxy	90	16	showed	show	VBD
cord-275041-fcdwitxy	90	17	significantly	significantly	RB
cord-275041-fcdwitxy	90	18	shorter	short	JJR
cord-275041-fcdwitxy	90	19	time	time	NN
cord-275041-fcdwitxy	90	20	to	to	IN
cord-275041-fcdwitxy	90	21	clinical	clinical	JJ
cord-275041-fcdwitxy	90	22	recovery	recovery	NN
cord-275041-fcdwitxy	90	23	for	for	IN
cord-275041-fcdwitxy	90	24	those	those	DT
cord-275041-fcdwitxy	90	25	treated	treat	VBN
cord-275041-fcdwitxy	90	26	with	with	IN
cord-275041-fcdwitxy	90	27	HCQ	HCQ	NNP
cord-275041-fcdwitxy	90	28	or	or	CC
cord-275041-fcdwitxy	90	29	HCQ	HCQ	NNP
cord-275041-fcdwitxy	90	30	plus	plus	CC
cord-275041-fcdwitxy	90	31	azithromycin	azithromycin	NNP
cord-275041-fcdwitxy	90	32	[	[	-LRB-
cord-275041-fcdwitxy	90	33	28	28	CD
cord-275041-fcdwitxy	90	34	]	]	-RRB-
cord-275041-fcdwitxy	90	35	.	.	.
cord-275041-fcdwitxy	91	1	In	in	IN
cord-275041-fcdwitxy	91	2	our	-PRON-	PRP$
cord-275041-fcdwitxy	91	3	study	study	NN
cord-275041-fcdwitxy	91	4	,	,	,
cord-275041-fcdwitxy	91	5	the	the	DT
cord-275041-fcdwitxy	91	6	addition	addition	NN
cord-275041-fcdwitxy	91	7	of	of	IN
cord-275041-fcdwitxy	91	8	azithromycin	azithromycin	NN
cord-275041-fcdwitxy	91	9	to	to	IN
cord-275041-fcdwitxy	91	10	HCQ	HCQ	NNP
cord-275041-fcdwitxy	91	11	does	do	VBZ
cord-275041-fcdwitxy	91	12	not	not	RB
cord-275041-fcdwitxy	91	13	seem	seem	VB
cord-275041-fcdwitxy	91	14	to	to	TO
cord-275041-fcdwitxy	91	15	add	add	VB
cord-275041-fcdwitxy	91	16	any	any	DT
cord-275041-fcdwitxy	91	17	clear	clear	JJ
cord-275041-fcdwitxy	91	18	benefit	benefit	NN
cord-275041-fcdwitxy	91	19	.	.	.
cord-275041-fcdwitxy	92	1	A	a	DT
cord-275041-fcdwitxy	92	2	large	large	JJ
cord-275041-fcdwitxy	92	3	multicentre	multicentre	NNP
cord-275041-fcdwitxy	92	4	observational	observational	JJ
cord-275041-fcdwitxy	92	5	study	study	NN
cord-275041-fcdwitxy	92	6	reported	report	VBD
cord-275041-fcdwitxy	92	7	no	no	DT
cord-275041-fcdwitxy	92	8	association	association	NN
cord-275041-fcdwitxy	92	9	between	between	IN
cord-275041-fcdwitxy	92	10	HCQ	HCQ	NNP
cord-275041-fcdwitxy	92	11	,	,	,
cord-275041-fcdwitxy	92	12	or	or	CC
cord-275041-fcdwitxy	92	13	HCQ	HCQ	NNP
cord-275041-fcdwitxy	92	14	with	with	IN
cord-275041-fcdwitxy	92	15	azithromycin	azithromycin	NNP
cord-275041-fcdwitxy	92	16	,	,	,
cord-275041-fcdwitxy	92	17	and	and	CC
cord-275041-fcdwitxy	92	18	lower	low	JJR
cord-275041-fcdwitxy	92	19	mortality	mortality	NN
cord-275041-fcdwitxy	92	20	but	but	CC
cord-275041-fcdwitxy	92	21	significantly	significantly	RB
cord-275041-fcdwitxy	92	22	higher	high	JJR
cord-275041-fcdwitxy	92	23	rates	rate	NNS
cord-275041-fcdwitxy	92	24	of	of	IN
cord-275041-fcdwitxy	92	25	discharge	discharge	NN
cord-275041-fcdwitxy	92	26	home	home	NN
cord-275041-fcdwitxy	92	27	were	be	VBD
cord-275041-fcdwitxy	92	28	observed	observe	VBN
cord-275041-fcdwitxy	92	29	for	for	IN
cord-275041-fcdwitxy	92	30	patients	patient	NNS
cord-275041-fcdwitxy	92	31	treated	treat	VBN
cord-275041-fcdwitxy	92	32	by	by	IN
cord-275041-fcdwitxy	92	33	HCQ	HCQ	NNP
cord-275041-fcdwitxy	92	34	[	[	-LRB-
cord-275041-fcdwitxy	92	35	29	29	CD
cord-275041-fcdwitxy	92	36	]	]	-RRB-
cord-275041-fcdwitxy	92	37	.	.	.
cord-275041-fcdwitxy	93	1	In	in	IN
cord-275041-fcdwitxy	93	2	a	a	DT
cord-275041-fcdwitxy	93	3	recent	recent	JJ
cord-275041-fcdwitxy	93	4	meta	meta	JJ
cord-275041-fcdwitxy	93	5	-	-	HYPH
cord-275041-fcdwitxy	93	6	analysis	analysis	NN
cord-275041-fcdwitxy	93	7	,	,	,
cord-275041-fcdwitxy	93	8	studies	study	NNS
cord-275041-fcdwitxy	93	9	were	be	VBD
cord-275041-fcdwitxy	93	10	classified	classify	VBN
cord-275041-fcdwitxy	93	11	as	as	IN
cord-275041-fcdwitxy	93	12	big	big	JJ
cord-275041-fcdwitxy	93	13	data	datum	NNS
cord-275041-fcdwitxy	93	14	,	,	,
cord-275041-fcdwitxy	93	15	when	when	WRB
cord-275041-fcdwitxy	93	16	electronic	electronic	JJ
cord-275041-fcdwitxy	93	17	medical	medical	JJ
cord-275041-fcdwitxy	93	18	records	record	NNS
cord-275041-fcdwitxy	93	19	had	have	VBD
cord-275041-fcdwitxy	93	20	been	be	VBN
cord-275041-fcdwitxy	93	21	used	use	VBN
cord-275041-fcdwitxy	93	22	,	,	,
cord-275041-fcdwitxy	93	23	or	or	CC
cord-275041-fcdwitxy	93	24	clinical	clinical	JJ
cord-275041-fcdwitxy	93	25	studies	study	NNS
cord-275041-fcdwitxy	93	26	,	,	,
cord-275041-fcdwitxy	93	27	when	when	WRB
cord-275041-fcdwitxy	93	28	details	detail	NNS
cord-275041-fcdwitxy	93	29	of	of	IN
cord-275041-fcdwitxy	93	30	treatments	treatment	NNS
cord-275041-fcdwitxy	93	31	were	be	VBD
cord-275041-fcdwitxy	93	32	reported	report	VBN
cord-275041-fcdwitxy	93	33	and	and	CC
cord-275041-fcdwitxy	93	34	the	the	DT
cord-275041-fcdwitxy	93	35	study	study	NN
cord-275041-fcdwitxy	93	36	had	have	VBD
cord-275041-fcdwitxy	93	37	been	be	VBN
cord-275041-fcdwitxy	93	38	conducted	conduct	VBN
cord-275041-fcdwitxy	93	39	by	by	IN
cord-275041-fcdwitxy	93	40	the	the	DT
cord-275041-fcdwitxy	93	41	same	same	JJ
cord-275041-fcdwitxy	93	42	physicians	physician	NNS
cord-275041-fcdwitxy	93	43	who	who	WP
cord-275041-fcdwitxy	93	44	cared	care	VBD
cord-275041-fcdwitxy	93	45	for	for	IN
cord-275041-fcdwitxy	93	46	the	the	DT
cord-275041-fcdwitxy	93	47	patients	patient	NNS
cord-275041-fcdwitxy	93	48	.	.	.
cord-275041-fcdwitxy	94	1	It	-PRON-	PRP
cord-275041-fcdwitxy	94	2	reported	report	VBD
cord-275041-fcdwitxy	94	3	,	,	,
cord-275041-fcdwitxy	94	4	among	among	IN
cord-275041-fcdwitxy	94	5	clinical	clinical	JJ
cord-275041-fcdwitxy	94	6	studies	study	NNS
cord-275041-fcdwitxy	94	7	,	,	,
cord-275041-fcdwitxy	94	8	an	an	DT
cord-275041-fcdwitxy	94	9	association	association	NN
cord-275041-fcdwitxy	94	10	of	of	IN
cord-275041-fcdwitxy	94	11	chloroquine	chloroquine	NNP
cord-275041-fcdwitxy	94	12	derivates	derivate	NNS
cord-275041-fcdwitxy	94	13	with	with	IN
cord-275041-fcdwitxy	94	14	clinical	clinical	JJ
cord-275041-fcdwitxy	94	15	improvement	improvement	NN
cord-275041-fcdwitxy	94	16	,	,	,
cord-275041-fcdwitxy	94	17	lower	low	JJR
cord-275041-fcdwitxy	94	18	mortality	mortality	NN
cord-275041-fcdwitxy	94	19	,	,	,
cord-275041-fcdwitxy	94	20	and	and	CC
cord-275041-fcdwitxy	94	21	viral	viral	JJ
cord-275041-fcdwitxy	94	22	carriage	carriage	NN
cord-275041-fcdwitxy	94	23	[	[	-LRB-
cord-275041-fcdwitxy	94	24	30	30	CD
cord-275041-fcdwitxy	94	25	]	]	-RRB-
cord-275041-fcdwitxy	94	26	.	.	.
cord-275041-fcdwitxy	95	1	Finally	finally	RB
cord-275041-fcdwitxy	95	2	,	,	,
cord-275041-fcdwitxy	95	3	a	a	DT
cord-275041-fcdwitxy	95	4	small	small	JJ
cord-275041-fcdwitxy	95	5	RCT	RCT	NNP
cord-275041-fcdwitxy	95	6	reported	report	VBD
cord-275041-fcdwitxy	95	7	the	the	DT
cord-275041-fcdwitxy	95	8	association	association	NN
cord-275041-fcdwitxy	95	9	of	of	IN
cord-275041-fcdwitxy	95	10	HCQ	HCQ	NNP
cord-275041-fcdwitxy	95	11	with	with	IN
cord-275041-fcdwitxy	95	12	shorter	short	JJR
cord-275041-fcdwitxy	95	13	time	time	NN
cord-275041-fcdwitxy	95	14	both	both	DT
cord-275041-fcdwitxy	95	15	to	to	IN
cord-275041-fcdwitxy	95	16	clinical	clinical	JJ
cord-275041-fcdwitxy	95	17	recovery	recovery	NN
cord-275041-fcdwitxy	95	18	and	and	CC
cord-275041-fcdwitxy	95	19	to	to	TO
cord-275041-fcdwitxy	95	20	reach	reach	VB
cord-275041-fcdwitxy	95	21	viral	viral	JJ
cord-275041-fcdwitxy	95	22	RNA	RNA	NNP
cord-275041-fcdwitxy	95	23	negativity	negativity	NN
cord-275041-fcdwitxy	95	24	[	[	-LRB-
cord-275041-fcdwitxy	95	25	31	31	CD
cord-275041-fcdwitxy	95	26	]	]	-RRB-
cord-275041-fcdwitxy	95	27	.	.	.
cord-275041-fcdwitxy	96	1	The	the	DT
cord-275041-fcdwitxy	96	2	absence	absence	NN
cord-275041-fcdwitxy	96	3	of	of	IN
cord-275041-fcdwitxy	96	4	any	any	DT
cord-275041-fcdwitxy	96	5	positive	positive	JJ
cord-275041-fcdwitxy	96	6	effects	effect	NNS
cord-275041-fcdwitxy	96	7	of	of	IN
cord-275041-fcdwitxy	96	8	the	the	DT
cord-275041-fcdwitxy	96	9	treatment	treatment	NN
cord-275041-fcdwitxy	96	10	with	with	IN
cord-275041-fcdwitxy	96	11	HCQ	HCQ	NNP
cord-275041-fcdwitxy	96	12	has	have	VBZ
cord-275041-fcdwitxy	96	13	also	also	RB
cord-275041-fcdwitxy	96	14	been	be	VBN
cord-275041-fcdwitxy	96	15	reported	report	VBN
cord-275041-fcdwitxy	96	16	.	.	.
cord-275041-fcdwitxy	97	1	A	a	DT
cord-275041-fcdwitxy	97	2	number	number	NN
cord-275041-fcdwitxy	97	3	of	of	IN
cord-275041-fcdwitxy	97	4	observational	observational	JJ
cord-275041-fcdwitxy	97	5	studies	study	NNS
cord-275041-fcdwitxy	97	6	have	have	VBP
cord-275041-fcdwitxy	97	7	reported	report	VBN
cord-275041-fcdwitxy	97	8	that	that	IN
cord-275041-fcdwitxy	97	9	HCQ	HCQ	NNP
cord-275041-fcdwitxy	97	10	,	,	,
cord-275041-fcdwitxy	97	11	either	either	CC
cord-275041-fcdwitxy	97	12	alone	alone	RB
cord-275041-fcdwitxy	97	13	or	or	CC
cord-275041-fcdwitxy	97	14	in	in	IN
cord-275041-fcdwitxy	97	15	combination	combination	NN
cord-275041-fcdwitxy	97	16	with	with	IN
cord-275041-fcdwitxy	97	17	azithromycin	azithromycin	NNP
cord-275041-fcdwitxy	97	18	,	,	,
cord-275041-fcdwitxy	97	19	was	be	VBD
cord-275041-fcdwitxy	97	20	not	not	RB
cord-275041-fcdwitxy	97	21	associated	associate	VBN
cord-275041-fcdwitxy	97	22	with	with	IN
cord-275041-fcdwitxy	97	23	lower	low	JJR
cord-275041-fcdwitxy	97	24	mortality	mortality	NN
cord-275041-fcdwitxy	97	25	[	[	-LRB-
cord-275041-fcdwitxy	97	26	32	32	CD
cord-275041-fcdwitxy	97	27	]	]	-RRB-
cord-275041-fcdwitxy	98	1	[	[	-LRB-
cord-275041-fcdwitxy	98	2	33	33	CD
cord-275041-fcdwitxy	98	3	]	]	-RRB-
cord-275041-fcdwitxy	98	4	[	[	-LRB-
cord-275041-fcdwitxy	98	5	34	34	CD
cord-275041-fcdwitxy	98	6	]	]	-RRB-
cord-275041-fcdwitxy	98	7	[	[	-LRB-
cord-275041-fcdwitxy	98	8	35	35	CD
cord-275041-fcdwitxy	98	9	]	]	-RRB-
cord-275041-fcdwitxy	98	10	.	.	.
cord-275041-fcdwitxy	99	1	Three	three	CD
cord-275041-fcdwitxy	99	2	of	of	IN
cord-275041-fcdwitxy	99	3	these	these	DT
cord-275041-fcdwitxy	99	4	studies	study	NNS
cord-275041-fcdwitxy	99	5	included	include	VBN
cord-275041-fcdwitxy	99	6	over	over	IN
cord-275041-fcdwitxy	99	7	1000	1000	CD
cord-275041-fcdwitxy	99	8	participants	participant	NNS
cord-275041-fcdwitxy	99	9	[	[	-LRB-
cord-275041-fcdwitxy	99	10	32	32	CD
cord-275041-fcdwitxy	99	11	,	,	,
cord-275041-fcdwitxy	99	12	34	34	CD
cord-275041-fcdwitxy	99	13	,	,	,
cord-275041-fcdwitxy	99	14	35	35	CD
cord-275041-fcdwitxy	99	15	]	]	-RRB-
cord-275041-fcdwitxy	99	16	.	.	.
cord-275041-fcdwitxy	100	1	One	one	CD
cord-275041-fcdwitxy	100	2	of	of	IN
cord-275041-fcdwitxy	100	3	these	these	DT
cord-275041-fcdwitxy	100	4	studies	study	NNS
cord-275041-fcdwitxy	100	5	included	include	VBD
cord-275041-fcdwitxy	100	6	patients	patient	NNS
cord-275041-fcdwitxy	100	7	who	who	WP
cord-275041-fcdwitxy	100	8	needed	need	VBD
cord-275041-fcdwitxy	100	9	oxygen	oxygen	NN
cord-275041-fcdwitxy	100	10	[	[	-LRB-
cord-275041-fcdwitxy	100	11	33	33	CD
cord-275041-fcdwitxy	100	12	]	]	-RRB-
cord-275041-fcdwitxy	100	13	and	and	CC
cord-275041-fcdwitxy	100	14	another	another	DT
cord-275041-fcdwitxy	100	15	one	one	NN
cord-275041-fcdwitxy	100	16	used	use	VBN
cord-275041-fcdwitxy	100	17	mortality	mortality	NN
cord-275041-fcdwitxy	100	18	or	or	CC
cord-275041-fcdwitxy	100	19	need	need	VB
cord-275041-fcdwitxy	100	20	for	for	IN
cord-275041-fcdwitxy	100	21	intubation	intubation	NN
cord-275041-fcdwitxy	100	22	as	as	IN
cord-275041-fcdwitxy	100	23	an	an	DT
cord-275041-fcdwitxy	100	24	outcome	outcome	NN
cord-275041-fcdwitxy	100	25	[	[	-LRB-
cord-275041-fcdwitxy	100	26	34	34	CD
cord-275041-fcdwitxy	100	27	]	]	-RRB-
cord-275041-fcdwitxy	101	1	Two	two	CD
cord-275041-fcdwitxy	101	2	RCTs	rct	NNS
cord-275041-fcdwitxy	101	3	have	have	VBP
cord-275041-fcdwitxy	101	4	also	also	RB
cord-275041-fcdwitxy	101	5	reported	report	VBN
cord-275041-fcdwitxy	101	6	no	no	DT
cord-275041-fcdwitxy	101	7	association	association	NN
cord-275041-fcdwitxy	101	8	between	between	IN
cord-275041-fcdwitxy	101	9	HCQ	HCQ	NNP
cord-275041-fcdwitxy	101	10	and	and	CC
cord-275041-fcdwitxy	101	11	survival	survival	NN
cord-275041-fcdwitxy	101	12	[	[	-LRB-
cord-275041-fcdwitxy	101	13	36	36	CD
cord-275041-fcdwitxy	101	14	,	,	,
cord-275041-fcdwitxy	101	15	37	37	CD
cord-275041-fcdwitxy	101	16	]	]	-RRB-
cord-275041-fcdwitxy	101	17	.	.	.
cord-275041-fcdwitxy	102	1	One	one	CD
cord-275041-fcdwitxy	102	2	of	of	IN
cord-275041-fcdwitxy	102	3	them	-PRON-	PRP
cord-275041-fcdwitxy	102	4	also	also	RB
cord-275041-fcdwitxy	102	5	reported	report	VBD
cord-275041-fcdwitxy	102	6	no	no	DT
cord-275041-fcdwitxy	102	7	benefit	benefit	NN
cord-275041-fcdwitxy	102	8	in	in	IN
cord-275041-fcdwitxy	102	9	need	need	NN
cord-275041-fcdwitxy	102	10	for	for	IN
cord-275041-fcdwitxy	102	11	admissions	admission	NNS
cord-275041-fcdwitxy	102	12	or	or	CC
cord-275041-fcdwitxy	102	13	clinical	clinical	JJ
cord-275041-fcdwitxy	102	14	improvement	improvement	NN
cord-275041-fcdwitxy	102	15	[	[	-LRB-
cord-275041-fcdwitxy	102	16	37	37	CD
cord-275041-fcdwitxy	102	17	]	]	-RRB-
cord-275041-fcdwitxy	102	18	.	.	.
cord-275041-fcdwitxy	103	1	The	the	DT
cord-275041-fcdwitxy	103	2	lack	lack	NN
cord-275041-fcdwitxy	103	3	of	of	IN
cord-275041-fcdwitxy	103	4	clinical	clinical	JJ
cord-275041-fcdwitxy	103	5	improvement	improvement	NN
cord-275041-fcdwitxy	103	6	was	be	VBD
cord-275041-fcdwitxy	103	7	reported	report	VBN
cord-275041-fcdwitxy	103	8	in	in	IN
cord-275041-fcdwitxy	103	9	another	another	DT
cord-275041-fcdwitxy	103	10	trial	trial	NN
cord-275041-fcdwitxy	103	11	[	[	-LRB-
cord-275041-fcdwitxy	103	12	38	38	CD
cord-275041-fcdwitxy	103	13	]	]	-RRB-
cord-275041-fcdwitxy	103	14	.	.	.
cord-275041-fcdwitxy	104	1	Finally	finally	RB
cord-275041-fcdwitxy	104	2	,	,	,
cord-275041-fcdwitxy	104	3	two	two	CD
cord-275041-fcdwitxy	104	4	more	more	JJR
cord-275041-fcdwitxy	104	5	RCTs	rct	NNS
cord-275041-fcdwitxy	104	6	have	have	VBP
cord-275041-fcdwitxy	104	7	reported	report	VBN
cord-275041-fcdwitxy	104	8	no	no	DT
cord-275041-fcdwitxy	104	9	association	association	NN
cord-275041-fcdwitxy	104	10	between	between	IN
cord-275041-fcdwitxy	104	11	HCQ	HCQ	NNP
cord-275041-fcdwitxy	104	12	and	and	CC
cord-275041-fcdwitxy	104	13	virological	virological	JJ
cord-275041-fcdwitxy	104	14	clearance	clearance	NN
cord-275041-fcdwitxy	104	15	[	[	-LRB-
cord-275041-fcdwitxy	104	16	39	39	CD
cord-275041-fcdwitxy	104	17	]	]	-RRB-
cord-275041-fcdwitxy	104	18	or	or	CC
cord-275041-fcdwitxy	104	19	prevention	prevention	NN
cord-275041-fcdwitxy	104	20	of	of	IN
cord-275041-fcdwitxy	104	21	disease	disease	NN
cord-275041-fcdwitxy	104	22	in	in	IN
cord-275041-fcdwitxy	104	23	individuals	individual	NNS
cord-275041-fcdwitxy	104	24	exposed	expose	VBN
cord-275041-fcdwitxy	104	25	to	to	IN
cord-275041-fcdwitxy	104	26	it	-PRON-	PRP
cord-275041-fcdwitxy	104	27	[	[	-LRB-
cord-275041-fcdwitxy	104	28	40	40	CD
cord-275041-fcdwitxy	104	29	]	]	-RRB-
cord-275041-fcdwitxy	104	30	.	.	.
cord-275041-fcdwitxy	105	1	A	a	DT
cord-275041-fcdwitxy	105	2	number	number	NN
cord-275041-fcdwitxy	105	3	of	of	IN
cord-275041-fcdwitxy	105	4	factors	factor	NNS
cord-275041-fcdwitxy	105	5	could	could	MD
cord-275041-fcdwitxy	105	6	explain	explain	VB
cord-275041-fcdwitxy	105	7	the	the	DT
cord-275041-fcdwitxy	105	8	difference	difference	NN
cord-275041-fcdwitxy	105	9	between	between	IN
cord-275041-fcdwitxy	105	10	our	-PRON-	PRP$
cord-275041-fcdwitxy	105	11	results	result	NNS
cord-275041-fcdwitxy	105	12	and	and	CC
cord-275041-fcdwitxy	105	13	the	the	DT
cord-275041-fcdwitxy	105	14	ones	one	NNS
cord-275041-fcdwitxy	105	15	observed	observe	VBN
cord-275041-fcdwitxy	105	16	in	in	IN
cord-275041-fcdwitxy	105	17	these	these	DT
cord-275041-fcdwitxy	105	18	studies	study	NNS
cord-275041-fcdwitxy	105	19	[	[	-LRB-
cord-275041-fcdwitxy	105	20	32	32	CD
cord-275041-fcdwitxy	105	21	]	]	-RRB-
cord-275041-fcdwitxy	106	1	[	[	-LRB-
cord-275041-fcdwitxy	106	2	33	33	CD
cord-275041-fcdwitxy	106	3	]	]	-RRB-
cord-275041-fcdwitxy	107	1	[	[	-LRB-
cord-275041-fcdwitxy	107	2	34	34	CD
cord-275041-fcdwitxy	107	3	]	]	-RRB-
cord-275041-fcdwitxy	107	4	[	[	-LRB-
cord-275041-fcdwitxy	107	5	35	35	CD
cord-275041-fcdwitxy	107	6	]	]	-RRB-
cord-275041-fcdwitxy	107	7	[	[	-LRB-
cord-275041-fcdwitxy	107	8	36	36	CD
cord-275041-fcdwitxy	107	9	]	]	-RRB-
cord-275041-fcdwitxy	108	1	[	[	-LRB-
cord-275041-fcdwitxy	108	2	37	37	CD
cord-275041-fcdwitxy	108	3	]	]	-RRB-
cord-275041-fcdwitxy	108	4	[	[	-LRB-
cord-275041-fcdwitxy	108	5	38	38	CD
cord-275041-fcdwitxy	108	6	]	]	-RRB-
cord-275041-fcdwitxy	109	1	[	[	-LRB-
cord-275041-fcdwitxy	109	2	39	39	CD
cord-275041-fcdwitxy	109	3	]	]	-RRB-
cord-275041-fcdwitxy	110	1	[	[	-LRB-
cord-275041-fcdwitxy	110	2	40	40	CD
cord-275041-fcdwitxy	110	3	]	]	-RRB-
cord-275041-fcdwitxy	110	4	including	include	VBG
cord-275041-fcdwitxy	110	5	the	the	DT
cord-275041-fcdwitxy	110	6	following	follow	VBG
cord-275041-fcdwitxy	110	7	:	:	:
cord-275041-fcdwitxy	110	8	the	the	DT
cord-275041-fcdwitxy	110	9	clinical	clinical	JJ
cord-275041-fcdwitxy	110	10	-	-	HYPH
cord-275041-fcdwitxy	110	11	epidemiological	epidemiological	JJ
cord-275041-fcdwitxy	110	12	design	design	NN
cord-275041-fcdwitxy	110	13	of	of	IN
cord-275041-fcdwitxy	110	14	our	-PRON-	PRP$
cord-275041-fcdwitxy	110	15	work	work	NN
cord-275041-fcdwitxy	110	16	;	;	:
cord-275041-fcdwitxy	110	17	[	[	-LRB-
cord-275041-fcdwitxy	110	18	30	30	CD
cord-275041-fcdwitxy	110	19	]	]	-RRB-
cord-275041-fcdwitxy	110	20	the	the	DT
cord-275041-fcdwitxy	110	21	involvement	involvement	NN
cord-275041-fcdwitxy	110	22	of	of	IN
cord-275041-fcdwitxy	110	23	all	all	DT
cord-275041-fcdwitxy	110	24	patients	patient	NNS
cord-275041-fcdwitxy	110	25	admitted	admit	VBN
cord-275041-fcdwitxy	110	26	with	with	IN
cord-275041-fcdwitxy	110	27	COVID-19	COVID-19	NNP
cord-275041-fcdwitxy	110	28	,	,	,
cord-275041-fcdwitxy	110	29	regardless	regardless	RB
cord-275041-fcdwitxy	110	30	their	-PRON-	PRP$
cord-275041-fcdwitxy	110	31	past	past	JJ
cord-275041-fcdwitxy	110	32	medical	medical	JJ
cord-275041-fcdwitxy	110	33	history	history	NN
cord-275041-fcdwitxy	110	34	,	,	,
cord-275041-fcdwitxy	110	35	the	the	DT
cord-275041-fcdwitxy	110	36	time	time	NN
cord-275041-fcdwitxy	110	37	between	between	IN
cord-275041-fcdwitxy	110	38	onset	onset	NN
cord-275041-fcdwitxy	110	39	of	of	IN
cord-275041-fcdwitxy	110	40	symptoms	symptom	NNS
cord-275041-fcdwitxy	110	41	and	and	CC
cord-275041-fcdwitxy	110	42	the	the	DT
cord-275041-fcdwitxy	110	43	start	start	NN
cord-275041-fcdwitxy	110	44	of	of	IN
cord-275041-fcdwitxy	110	45	treatment	treatment	NN
cord-275041-fcdwitxy	110	46	,	,	,
cord-275041-fcdwitxy	110	47	the	the	DT
cord-275041-fcdwitxy	110	48	duration	duration	NN
cord-275041-fcdwitxy	110	49	of	of	IN
cord-275041-fcdwitxy	110	50	admission	admission	NN
cord-275041-fcdwitxy	110	51	,	,	,
cord-275041-fcdwitxy	110	52	and	and	CC
cord-275041-fcdwitxy	110	53	the	the	DT
cord-275041-fcdwitxy	110	54	need	need	NN
cord-275041-fcdwitxy	110	55	for	for	IN
cord-275041-fcdwitxy	110	56	oxygen	oxygen	NN
cord-275041-fcdwitxy	110	57	;	;	:
cord-275041-fcdwitxy	110	58	the	the	DT
cord-275041-fcdwitxy	110	59	different	different	JJ
cord-275041-fcdwitxy	110	60	statistical	statistical	JJ
cord-275041-fcdwitxy	110	61	approach	approach	NN
cord-275041-fcdwitxy	110	62	;	;	:
cord-275041-fcdwitxy	110	63	and	and	CC
cord-275041-fcdwitxy	110	64	the	the	DT
cord-275041-fcdwitxy	110	65	observation	observation	NN
cord-275041-fcdwitxy	110	66	in	in	IN
cord-275041-fcdwitxy	110	67	our	-PRON-	PRP$
cord-275041-fcdwitxy	110	68	work	work	NN
cord-275041-fcdwitxy	110	69	of	of	IN
cord-275041-fcdwitxy	110	70	patients	patient	NNS
cord-275041-fcdwitxy	110	71	from	from	IN
cord-275041-fcdwitxy	110	72	private	private	JJ
cord-275041-fcdwitxy	110	73	hospitals	hospital	NNS
cord-275041-fcdwitxy	110	74	,	,	,
cord-275041-fcdwitxy	110	75	who	who	WP
cord-275041-fcdwitxy	110	76	are	be	VBP
cord-275041-fcdwitxy	110	77	likely	likely	JJ
cord-275041-fcdwitxy	110	78	to	to	TO
cord-275041-fcdwitxy	110	79	have	have	VB
cord-275041-fcdwitxy	110	80	a	a	DT
cord-275041-fcdwitxy	110	81	high	high	JJ
cord-275041-fcdwitxy	110	82	socioeconomic	socioeconomic	JJ
cord-275041-fcdwitxy	110	83	status	status	NN
cord-275041-fcdwitxy	110	84	[	[	-LRB-
cord-275041-fcdwitxy	110	85	41	41	CD
cord-275041-fcdwitxy	110	86	]	]	-RRB-
cord-275041-fcdwitxy	110	87	.	.	.
cord-275041-fcdwitxy	111	1	The	the	DT
cord-275041-fcdwitxy	111	2	safety	safety	NN
cord-275041-fcdwitxy	111	3	of	of	IN
cord-275041-fcdwitxy	111	4	the	the	DT
cord-275041-fcdwitxy	111	5	HCQ	HCQ	NNP
cord-275041-fcdwitxy	111	6	has	have	VBZ
cord-275041-fcdwitxy	111	7	been	be	VBN
cord-275041-fcdwitxy	111	8	questioned	question	VBN
cord-275041-fcdwitxy	111	9	,	,	,
cord-275041-fcdwitxy	111	10	as	as	IN
cord-275041-fcdwitxy	111	11	it	-PRON-	PRP
cord-275041-fcdwitxy	111	12	could	could	MD
cord-275041-fcdwitxy	111	13	negatively	negatively	RB
cord-275041-fcdwitxy	111	14	impact	impact	VB
cord-275041-fcdwitxy	111	15	the	the	DT
cord-275041-fcdwitxy	111	16	immune	immune	JJ
cord-275041-fcdwitxy	111	17	response	response	NN
cord-275041-fcdwitxy	111	18	to	to	IN
cord-275041-fcdwitxy	111	19	the	the	DT
cord-275041-fcdwitxy	111	20	virus	virus	NN
cord-275041-fcdwitxy	111	21	,	,	,
cord-275041-fcdwitxy	111	22	or	or	CC
cord-275041-fcdwitxy	111	23	cause	cause	VB
cord-275041-fcdwitxy	111	24	abnormalities	abnormality	NNS
cord-275041-fcdwitxy	111	25	in	in	IN
cord-275041-fcdwitxy	111	26	the	the	DT
cord-275041-fcdwitxy	111	27	ECG	ECG	NNP
cord-275041-fcdwitxy	111	28	[	[	-LRB-
cord-275041-fcdwitxy	111	29	33	33	CD
cord-275041-fcdwitxy	111	30	,	,	,
cord-275041-fcdwitxy	111	31	42	42	CD
cord-275041-fcdwitxy	111	32	,	,	,
cord-275041-fcdwitxy	111	33	43	43	CD
cord-275041-fcdwitxy	111	34	]	]	-RRB-
cord-275041-fcdwitxy	111	35	.	.	.
cord-275041-fcdwitxy	112	1	However	however	RB
cord-275041-fcdwitxy	112	2	,	,	,
cord-275041-fcdwitxy	112	3	none	none	NN
cord-275041-fcdwitxy	112	4	of	of	IN
cord-275041-fcdwitxy	112	5	the	the	DT
cord-275041-fcdwitxy	112	6	studies	study	NNS
cord-275041-fcdwitxy	112	7	that	that	WDT
cord-275041-fcdwitxy	112	8	we	-PRON-	PRP
cord-275041-fcdwitxy	112	9	have	have	VBP
cord-275041-fcdwitxy	112	10	reviewed	review	VBN
cord-275041-fcdwitxy	112	11	,	,	,
cord-275041-fcdwitxy	112	12	reporting	report	VBG
cord-275041-fcdwitxy	112	13	no	no	DT
cord-275041-fcdwitxy	112	14	benefit	benefit	NN
cord-275041-fcdwitxy	112	15	on	on	IN
cord-275041-fcdwitxy	112	16	HCQ	HCQ	NNP
cord-275041-fcdwitxy	112	17	,	,	,
cord-275041-fcdwitxy	112	18	show	show	VBP
cord-275041-fcdwitxy	112	19	an	an	DT
cord-275041-fcdwitxy	112	20	increased	increase	VBN
cord-275041-fcdwitxy	112	21	mortality	mortality	NN
cord-275041-fcdwitxy	112	22	associated	associate	VBN
cord-275041-fcdwitxy	112	23	with	with	IN
cord-275041-fcdwitxy	112	24	it	-PRON-	PRP
cord-275041-fcdwitxy	112	25	[	[	-LRB-
cord-275041-fcdwitxy	112	26	32	32	CD
cord-275041-fcdwitxy	112	27	]	]	-RRB-
cord-275041-fcdwitxy	112	28	[	[	-LRB-
cord-275041-fcdwitxy	112	29	33	33	CD
cord-275041-fcdwitxy	112	30	]	]	-RRB-
cord-275041-fcdwitxy	112	31	[	[	-LRB-
cord-275041-fcdwitxy	112	32	34	34	CD
cord-275041-fcdwitxy	112	33	]	]	-RRB-
cord-275041-fcdwitxy	112	34	[	[	-LRB-
cord-275041-fcdwitxy	112	35	35	35	CD
cord-275041-fcdwitxy	112	36	]	]	-RRB-
cord-275041-fcdwitxy	112	37	[	[	-LRB-
cord-275041-fcdwitxy	112	38	36	36	CD
cord-275041-fcdwitxy	112	39	]	]	-RRB-
cord-275041-fcdwitxy	112	40	[	[	-LRB-
cord-275041-fcdwitxy	112	41	37	37	CD
cord-275041-fcdwitxy	112	42	]	]	-RRB-
cord-275041-fcdwitxy	112	43	[	[	-LRB-
cord-275041-fcdwitxy	112	44	38	38	CD
cord-275041-fcdwitxy	112	45	]	]	-RRB-
cord-275041-fcdwitxy	112	46	[	[	-LRB-
cord-275041-fcdwitxy	112	47	39	39	CD
cord-275041-fcdwitxy	112	48	]	]	-RRB-
cord-275041-fcdwitxy	112	49	[	[	-LRB-
cord-275041-fcdwitxy	112	50	40	40	CD
cord-275041-fcdwitxy	112	51	]	]	-RRB-
cord-275041-fcdwitxy	112	52	.	.	.
cord-275041-fcdwitxy	113	1	Further	further	JJ
cord-275041-fcdwitxy	113	2	RCTs	rct	NNS
cord-275041-fcdwitxy	113	3	,	,	,
cord-275041-fcdwitxy	113	4	observational	observational	JJ
cord-275041-fcdwitxy	113	5	studies	study	NNS
cord-275041-fcdwitxy	113	6	,	,	,
cord-275041-fcdwitxy	113	7	and	and	CC
cord-275041-fcdwitxy	113	8	summaries	summary	NNS
cord-275041-fcdwitxy	113	9	of	of	IN
cord-275041-fcdwitxy	113	10	both	both	DT
cord-275041-fcdwitxy	113	11	types	type	NNS
cord-275041-fcdwitxy	113	12	of	of	IN
cord-275041-fcdwitxy	113	13	evidence	evidence	NN
cord-275041-fcdwitxy	113	14	to	to	TO
cord-275041-fcdwitxy	113	15	assess	assess	VB
cord-275041-fcdwitxy	113	16	the	the	DT
cord-275041-fcdwitxy	113	17	associations	association	NNS
cord-275041-fcdwitxy	113	18	between	between	IN
cord-275041-fcdwitxy	113	19	HCQ	hcq	NN
cord-275041-fcdwitxy	113	20	and	and	CC
cord-275041-fcdwitxy	113	21	survival	survival	NN
cord-275041-fcdwitxy	113	22	are	be	VBP
cord-275041-fcdwitxy	113	23	necessary	necessary	JJ
cord-275041-fcdwitxy	113	24	.	.	.
cord-275041-fcdwitxy	114	1	Future	future	JJ
cord-275041-fcdwitxy	114	2	studies	study	NNS
cord-275041-fcdwitxy	114	3	could	could	MD
cord-275041-fcdwitxy	114	4	also	also	RB
cord-275041-fcdwitxy	114	5	address	address	VB
cord-275041-fcdwitxy	114	6	at	at	IN
cord-275041-fcdwitxy	114	7	what	what	WP
cord-275041-fcdwitxy	114	8	dosage	dosage	NN
cord-275041-fcdwitxy	114	9	,	,	,
cord-275041-fcdwitxy	114	10	and	and	CC
cord-275041-fcdwitxy	114	11	in	in	IN
cord-275041-fcdwitxy	114	12	what	what	WDT
cord-275041-fcdwitxy	114	13	phase	phase	NN
cord-275041-fcdwitxy	114	14	of	of	IN
cord-275041-fcdwitxy	114	15	the	the	DT
cord-275041-fcdwitxy	114	16	disease	disease	NN
cord-275041-fcdwitxy	114	17	,	,	,
cord-275041-fcdwitxy	114	18	does	do	VBZ
cord-275041-fcdwitxy	114	19	HCQ	HCQ	NNP
cord-275041-fcdwitxy	114	20	lead	lead	VB
cord-275041-fcdwitxy	114	21	to	to	IN
cord-275041-fcdwitxy	114	22	the	the	DT
cord-275041-fcdwitxy	114	23	best	good	JJS
cord-275041-fcdwitxy	114	24	possible	possible	JJ
cord-275041-fcdwitxy	114	25	outcome	outcome	NN
cord-275041-fcdwitxy	114	26	,	,	,
cord-275041-fcdwitxy	114	27	for	for	IN
cord-275041-fcdwitxy	114	28	patients	patient	NNS
cord-275041-fcdwitxy	114	29	with	with	IN
cord-275041-fcdwitxy	114	30	different	different	JJ
cord-275041-fcdwitxy	114	31	past	past	JJ
cord-275041-fcdwitxy	114	32	medical	medical	JJ
cord-275041-fcdwitxy	114	33	histories	history	NNS
cord-275041-fcdwitxy	114	34	[	[	-LRB-
cord-275041-fcdwitxy	114	35	44	44	CD
cord-275041-fcdwitxy	114	36	]	]	-RRB-
cord-275041-fcdwitxy	114	37	.	.	.
cord-275041-fcdwitxy	115	1	The	the	DT
cord-275041-fcdwitxy	115	2	interventional	interventional	JJ
cord-275041-fcdwitxy	115	3	evidence	evidence	NN
cord-275041-fcdwitxy	115	4	on	on	IN
cord-275041-fcdwitxy	115	5	the	the	DT
cord-275041-fcdwitxy	115	6	management	management	NN
cord-275041-fcdwitxy	115	7	of	of	IN
cord-275041-fcdwitxy	115	8	COVID-19	COVID-19	NNP
cord-275041-fcdwitxy	115	9	is	be	VBZ
cord-275041-fcdwitxy	115	10	still	still	RB
cord-275041-fcdwitxy	115	11	limited	limited	JJ
cord-275041-fcdwitxy	115	12	.	.	.
cord-275041-fcdwitxy	116	1	Therefore	therefore	RB
cord-275041-fcdwitxy	116	2	,	,	,
cord-275041-fcdwitxy	116	3	clinicians	clinician	NNS
cord-275041-fcdwitxy	116	4	could	could	MD
cord-275041-fcdwitxy	116	5	acknowledge	acknowledge	VB
cord-275041-fcdwitxy	116	6	the	the	DT
cord-275041-fcdwitxy	116	7	results	result	NNS
cord-275041-fcdwitxy	116	8	presented	present	VBN
cord-275041-fcdwitxy	116	9	in	in	IN
cord-275041-fcdwitxy	116	10	this	this	DT
cord-275041-fcdwitxy	116	11	study	study	NN
cord-275041-fcdwitxy	116	12	.	.	.
cord-275041-fcdwitxy	117	1	The	the	DT
cord-275041-fcdwitxy	117	2	positive	positive	JJ
cord-275041-fcdwitxy	117	3	effect	effect	NN
cord-275041-fcdwitxy	117	4	of	of	IN
cord-275041-fcdwitxy	117	5	HCQ	HCQ	NNP
cord-275041-fcdwitxy	117	6	seems	seem	VBZ
cord-275041-fcdwitxy	117	7	consistent	consistent	JJ
cord-275041-fcdwitxy	117	8	and	and	CC
cord-275041-fcdwitxy	117	9	its	-PRON-	PRP$
cord-275041-fcdwitxy	117	10	use	use	NN
cord-275041-fcdwitxy	117	11	could	could	MD
cord-275041-fcdwitxy	117	12	be	be	VB
cord-275041-fcdwitxy	117	13	considered	consider	VBN
cord-275041-fcdwitxy	117	14	in	in	IN
cord-275041-fcdwitxy	117	15	clinical	clinical	JJ
cord-275041-fcdwitxy	117	16	settings	setting	NNS
cord-275041-fcdwitxy	117	17	.	.	.
cord-275041-fcdwitxy	118	1	HCQ	HCQ	NNP
cord-275041-fcdwitxy	118	2	is	be	VBZ
cord-275041-fcdwitxy	118	3	easy	easy	JJ
cord-275041-fcdwitxy	118	4	to	to	TO
cord-275041-fcdwitxy	118	5	administer	administer	VB
cord-275041-fcdwitxy	118	6	,	,	,
cord-275041-fcdwitxy	118	7	and	and	CC
cord-275041-fcdwitxy	118	8	its	-PRON-	PRP$
cord-275041-fcdwitxy	118	9	use	use	NN
cord-275041-fcdwitxy	118	10	in	in	IN
cord-275041-fcdwitxy	118	11	ambulatory	ambulatory	JJ
cord-275041-fcdwitxy	118	12	patients	patient	NNS
cord-275041-fcdwitxy	118	13	,	,	,
cord-275041-fcdwitxy	118	14	to	to	TO
cord-275041-fcdwitxy	118	15	reduce	reduce	VB
cord-275041-fcdwitxy	118	16	symptoms	symptom	NNS
cord-275041-fcdwitxy	118	17	,	,	,
cord-275041-fcdwitxy	118	18	prevent	prevent	VB
cord-275041-fcdwitxy	118	19	admissions	admission	NNS
cord-275041-fcdwitxy	118	20	,	,	,
cord-275041-fcdwitxy	118	21	decrease	decrease	VB
cord-275041-fcdwitxy	118	22	mortality	mortality	NN
cord-275041-fcdwitxy	118	23	,	,	,
cord-275041-fcdwitxy	118	24	and	and	CC
cord-275041-fcdwitxy	118	25	the	the	DT
cord-275041-fcdwitxy	118	26	transmission	transmission	NN
cord-275041-fcdwitxy	118	27	of	of	IN
cord-275041-fcdwitxy	118	28	the	the	DT
cord-275041-fcdwitxy	118	29	disease	disease	NN
cord-275041-fcdwitxy	118	30	,	,	,
cord-275041-fcdwitxy	118	31	could	could	MD
cord-275041-fcdwitxy	118	32	also	also	RB
cord-275041-fcdwitxy	118	33	be	be	VB
cord-275041-fcdwitxy	118	34	considered	consider	VBN
cord-275041-fcdwitxy	118	35	by	by	IN
cord-275041-fcdwitxy	118	36	clinicians	clinician	NNS
cord-275041-fcdwitxy	118	37	and	and	CC
cord-275041-fcdwitxy	118	38	future	future	JJ
cord-275041-fcdwitxy	118	39	researchers	researcher	NNS
cord-275041-fcdwitxy	118	40	.	.	.
cord-275041-fcdwitxy	118	41	 	 	_SP
cord-275041-fcdwitxy	119	1	The	the	DT
cord-275041-fcdwitxy	119	2	author(s	author(s	NNP
cord-275041-fcdwitxy	119	3	)	)	-RRB-
cord-275041-fcdwitxy	119	4	declare	declare	VBP
cord-275041-fcdwitxy	119	5	that	that	IN
cord-275041-fcdwitxy	119	6	they	-PRON-	PRP
cord-275041-fcdwitxy	119	7	have	have	VBP
cord-275041-fcdwitxy	119	8	no	no	DT
cord-275041-fcdwitxy	119	9	conflict	conflict	NN
cord-275041-fcdwitxy	119	10	of	of	IN
cord-275041-fcdwitxy	119	11	interest	interest	NN
cord-275041-fcdwitxy	119	12	.	.	.
cord-275041-fcdwitxy	120	1	The	the	DT
cord-275041-fcdwitxy	120	2	ethics	ethic	NNS
cord-275041-fcdwitxy	120	3	committee	committee	NN
cord-275041-fcdwitxy	120	4	of	of	IN
cord-275041-fcdwitxy	120	5	HM	HM	NNP
cord-275041-fcdwitxy	120	6	Hospitales	Hospitales	NNP
cord-275041-fcdwitxy	120	7	approved	approve	VBD
cord-275041-fcdwitxy	120	8	this	this	DT
cord-275041-fcdwitxy	120	9	study	study	NN
cord-275041-fcdwitxy	120	10	.	.	.
cord-275041-fcdwitxy	121	1	Data	datum	NNS
cord-275041-fcdwitxy	121	2	were	be	VBD
cord-275041-fcdwitxy	121	3	anonymized	anonymize	VBN
cord-275041-fcdwitxy	121	4	before	before	IN
cord-275041-fcdwitxy	121	5	the	the	DT
cord-275041-fcdwitxy	121	6	authors	author	NNS
cord-275041-fcdwitxy	121	7	could	could	MD
cord-275041-fcdwitxy	121	8	access	access	VB
cord-275041-fcdwitxy	121	9	it	-PRON-	PRP
cord-275041-fcdwitxy	121	10	.	.	.
cord-275041-fcdwitxy	122	1	No	no	DT
cord-275041-fcdwitxy	122	2	results	result	NNS
cord-275041-fcdwitxy	122	3	that	that	WDT
cord-275041-fcdwitxy	122	4	may	may	MD
cord-275041-fcdwitxy	122	5	make	make	VB
cord-275041-fcdwitxy	122	6	patients	patient	NNS
cord-275041-fcdwitxy	122	7	identifiable	identifiable	JJ
cord-275041-fcdwitxy	122	8	are	be	VBP
cord-275041-fcdwitxy	122	9	reported	report	VBN
cord-275041-fcdwitxy	122	10	.	.	.
cord-275041-fcdwitxy	123	1	The	the	DT
cord-275041-fcdwitxy	123	2	study	study	NN
cord-275041-fcdwitxy	123	3	was	be	VBD
cord-275041-fcdwitxy	123	4	conducted	conduct	VBN
cord-275041-fcdwitxy	123	5	in	in	IN
cord-275041-fcdwitxy	123	6	accordance	accordance	NN
cord-275041-fcdwitxy	123	7	with	with	IN
cord-275041-fcdwitxy	123	8	the	the	DT
cord-275041-fcdwitxy	123	9	ethical	ethical	JJ
cord-275041-fcdwitxy	123	10	standards	standard	NNS
cord-275041-fcdwitxy	123	11	as	as	IN
cord-275041-fcdwitxy	123	12	laid	lay	VBN
cord-275041-fcdwitxy	123	13	down	down	RP
cord-275041-fcdwitxy	123	14	in	in	IN
cord-275041-fcdwitxy	123	15	the	the	DT
cord-275041-fcdwitxy	123	16	1964	1964	CD
cord-275041-fcdwitxy	123	17	Declaration	Declaration	NNP
cord-275041-fcdwitxy	123	18	of	of	IN
cord-275041-fcdwitxy	123	19	Helsinki	Helsinki	NNP
cord-275041-fcdwitxy	123	20	and	and	CC
cord-275041-fcdwitxy	123	21	its	-PRON-	PRP$
cord-275041-fcdwitxy	123	22	later	later	JJ
cord-275041-fcdwitxy	123	23	amendments	amendment	NNS
cord-275041-fcdwitxy	123	24	.	.	.
cord-275041-fcdwitxy	124	1	Informed	informed	JJ
cord-275041-fcdwitxy	124	2	consent	consent	NN
cord-275041-fcdwitxy	125	1	This	this	DT
cord-275041-fcdwitxy	125	2	study	study	NN
cord-275041-fcdwitxy	125	3	was	be	VBD
cord-275041-fcdwitxy	125	4	conducted	conduct	VBN
cord-275041-fcdwitxy	125	5	on	on	IN
cord-275041-fcdwitxy	125	6	already	already	RB
cord-275041-fcdwitxy	125	7	available	available	JJ
cord-275041-fcdwitxy	125	8	clincal	clincal	JJ
cord-275041-fcdwitxy	125	9	data	datum	NNS
cord-275041-fcdwitxy	125	10	and	and	CC
cord-275041-fcdwitxy	125	11	informed	informed	JJ
cord-275041-fcdwitxy	125	12	consent	consent	NN
cord-275041-fcdwitxy	125	13	was	be	VBD
cord-275041-fcdwitxy	125	14	not	not	RB
cord-275041-fcdwitxy	125	15	required	require	VBN
cord-275041-fcdwitxy	125	16	.	.	.
cord-275041-fcdwitxy	126	1	Open	open	VB
cord-275041-fcdwitxy	126	2	Access	Access	NNP
cord-275041-fcdwitxy	127	1	This	this	DT
cord-275041-fcdwitxy	127	2	article	article	NN
cord-275041-fcdwitxy	127	3	is	be	VBZ
cord-275041-fcdwitxy	127	4	licensed	license	VBN
cord-275041-fcdwitxy	127	5	under	under	IN
cord-275041-fcdwitxy	127	6	a	a	DT
cord-275041-fcdwitxy	127	7	Creative	Creative	NNP
cord-275041-fcdwitxy	127	8	Commons	Commons	NNP
cord-275041-fcdwitxy	127	9	Attribution	Attribution	NNP
cord-275041-fcdwitxy	127	10	4.0	4.0	CD
cord-275041-fcdwitxy	127	11	International	International	NNP
cord-275041-fcdwitxy	127	12	License	License	NNP
cord-275041-fcdwitxy	127	13	,	,	,
cord-275041-fcdwitxy	127	14	which	which	WDT
cord-275041-fcdwitxy	127	15	permits	permit	VBZ
cord-275041-fcdwitxy	127	16	use	use	NN
cord-275041-fcdwitxy	127	17	,	,	,
cord-275041-fcdwitxy	127	18	sharing	sharing	NN
cord-275041-fcdwitxy	127	19	,	,	,
cord-275041-fcdwitxy	127	20	adaptation	adaptation	NN
cord-275041-fcdwitxy	127	21	,	,	,
cord-275041-fcdwitxy	127	22	distribution	distribution	NN
cord-275041-fcdwitxy	127	23	and	and	CC
cord-275041-fcdwitxy	127	24	reproduction	reproduction	NN
cord-275041-fcdwitxy	127	25	in	in	IN
cord-275041-fcdwitxy	127	26	any	any	DT
cord-275041-fcdwitxy	127	27	medium	medium	NN
cord-275041-fcdwitxy	127	28	or	or	CC
cord-275041-fcdwitxy	127	29	format	format	NN
cord-275041-fcdwitxy	127	30	,	,	,
cord-275041-fcdwitxy	127	31	as	as	RB
cord-275041-fcdwitxy	127	32	long	long	RB
cord-275041-fcdwitxy	127	33	as	as	IN
cord-275041-fcdwitxy	127	34	you	-PRON-	PRP
cord-275041-fcdwitxy	127	35	give	give	VBP
cord-275041-fcdwitxy	127	36	appropriate	appropriate	JJ
cord-275041-fcdwitxy	127	37	credit	credit	NN
cord-275041-fcdwitxy	127	38	to	to	IN
cord-275041-fcdwitxy	127	39	the	the	DT
cord-275041-fcdwitxy	127	40	original	original	JJ
cord-275041-fcdwitxy	127	41	author(s	author(s	NNP
cord-275041-fcdwitxy	127	42	)	)	-RRB-
cord-275041-fcdwitxy	127	43	and	and	CC
cord-275041-fcdwitxy	127	44	the	the	DT
cord-275041-fcdwitxy	127	45	source	source	NN
cord-275041-fcdwitxy	127	46	,	,	,
cord-275041-fcdwitxy	127	47	provide	provide	VB
cord-275041-fcdwitxy	127	48	a	a	DT
cord-275041-fcdwitxy	127	49	link	link	NN
cord-275041-fcdwitxy	127	50	to	to	IN
cord-275041-fcdwitxy	127	51	the	the	DT
cord-275041-fcdwitxy	127	52	Creative	Creative	NNP
cord-275041-fcdwitxy	127	53	Commons	Commons	NNP
cord-275041-fcdwitxy	127	54	licence	licence	NN
cord-275041-fcdwitxy	127	55	,	,	,
cord-275041-fcdwitxy	127	56	and	and	CC
cord-275041-fcdwitxy	127	57	indicate	indicate	VBP
cord-275041-fcdwitxy	127	58	if	if	IN
cord-275041-fcdwitxy	127	59	changes	change	NNS
cord-275041-fcdwitxy	127	60	were	be	VBD
cord-275041-fcdwitxy	127	61	made	make	VBN
cord-275041-fcdwitxy	127	62	.	.	.
cord-275041-fcdwitxy	128	1	The	the	DT
cord-275041-fcdwitxy	128	2	images	image	NNS
cord-275041-fcdwitxy	128	3	or	or	CC
cord-275041-fcdwitxy	128	4	other	other	JJ
cord-275041-fcdwitxy	128	5	third	third	JJ
cord-275041-fcdwitxy	128	6	party	party	NN
cord-275041-fcdwitxy	128	7	material	material	NN
cord-275041-fcdwitxy	128	8	in	in	IN
cord-275041-fcdwitxy	128	9	this	this	DT
cord-275041-fcdwitxy	128	10	article	article	NN
cord-275041-fcdwitxy	128	11	are	be	VBP
cord-275041-fcdwitxy	128	12	included	include	VBN
cord-275041-fcdwitxy	128	13	in	in	IN
cord-275041-fcdwitxy	128	14	the	the	DT
cord-275041-fcdwitxy	128	15	article	article	NN
cord-275041-fcdwitxy	128	16	's	's	POS
cord-275041-fcdwitxy	128	17	Creative	Creative	NNP
cord-275041-fcdwitxy	128	18	Commons	Commons	NNP
cord-275041-fcdwitxy	128	19	licence	licence	NN
cord-275041-fcdwitxy	128	20	,	,	,
cord-275041-fcdwitxy	128	21	unless	unless	IN
cord-275041-fcdwitxy	128	22	indicated	indicate	VBN
cord-275041-fcdwitxy	128	23	otherwise	otherwise	RB
cord-275041-fcdwitxy	128	24	in	in	IN
cord-275041-fcdwitxy	128	25	a	a	DT
cord-275041-fcdwitxy	128	26	credit	credit	NN
cord-275041-fcdwitxy	128	27	line	line	NN
cord-275041-fcdwitxy	128	28	to	to	IN
cord-275041-fcdwitxy	128	29	the	the	DT
cord-275041-fcdwitxy	128	30	material	material	NN
cord-275041-fcdwitxy	128	31	.	.	.
cord-275041-fcdwitxy	129	1	If	if	IN
cord-275041-fcdwitxy	129	2	material	material	NN
cord-275041-fcdwitxy	129	3	is	be	VBZ
cord-275041-fcdwitxy	129	4	not	not	RB
cord-275041-fcdwitxy	129	5	included	include	VBN
cord-275041-fcdwitxy	129	6	in	in	IN
cord-275041-fcdwitxy	129	7	the	the	DT
cord-275041-fcdwitxy	129	8	article	article	NN
cord-275041-fcdwitxy	129	9	's	's	POS
cord-275041-fcdwitxy	129	10	Creative	Creative	NNP
cord-275041-fcdwitxy	129	11	Commons	Commons	NNP
cord-275041-fcdwitxy	129	12	licence	licence	NN
cord-275041-fcdwitxy	129	13	and	and	CC
cord-275041-fcdwitxy	129	14	your	-PRON-	PRP$
cord-275041-fcdwitxy	129	15	intended	intend	VBN
cord-275041-fcdwitxy	129	16	use	use	NN
cord-275041-fcdwitxy	129	17	is	be	VBZ
cord-275041-fcdwitxy	129	18	not	not	RB
cord-275041-fcdwitxy	129	19	permitted	permit	VBN
cord-275041-fcdwitxy	129	20	by	by	IN
cord-275041-fcdwitxy	129	21	statutory	statutory	JJ
cord-275041-fcdwitxy	129	22	regulation	regulation	NN
cord-275041-fcdwitxy	129	23	or	or	CC
cord-275041-fcdwitxy	129	24	exceeds	exceed	VBZ
cord-275041-fcdwitxy	129	25	the	the	DT
cord-275041-fcdwitxy	129	26	permitted	permit	VBN
cord-275041-fcdwitxy	129	27	use	use	NN
cord-275041-fcdwitxy	129	28	,	,	,
cord-275041-fcdwitxy	129	29	you	-PRON-	PRP
cord-275041-fcdwitxy	129	30	will	will	MD
cord-275041-fcdwitxy	129	31	need	need	VB
cord-275041-fcdwitxy	129	32	to	to	TO
cord-275041-fcdwitxy	129	33	obtain	obtain	VB
cord-275041-fcdwitxy	129	34	permission	permission	NN
cord-275041-fcdwitxy	129	35	directly	directly	RB
cord-275041-fcdwitxy	129	36	from	from	IN
cord-275041-fcdwitxy	129	37	the	the	DT
cord-275041-fcdwitxy	129	38	copyright	copyright	NN
cord-275041-fcdwitxy	129	39	holder	holder	NN
cord-275041-fcdwitxy	129	40	.	.	.
cord-275041-fcdwitxy	130	1	To	to	TO
cord-275041-fcdwitxy	130	2	view	view	VB
cord-275041-fcdwitxy	130	3	a	a	DT
cord-275041-fcdwitxy	130	4	copy	copy	NN
cord-275041-fcdwitxy	130	5	of	of	IN
cord-275041-fcdwitxy	130	6	this	this	DT
cord-275041-fcdwitxy	130	7	licence	licence	NN
cord-275041-fcdwitxy	130	8	,	,	,
cord-275041-fcdwitxy	130	9	visit	visit	VB
cord-275041-fcdwitxy	130	10	http://creat	http://creat	NNP
cord-275041-fcdwitxy	130	11	iveco	iveco	NNP
cord-275041-fcdwitxy	130	12	mmons	mmons	NNP
cord-275041-fcdwitxy	130	13	.org	.org	.
cord-275041-fcdwitxy	131	1	/	/	NFP
cord-275041-fcdwitxy	132	1	licen	licen	NNP
cord-275041-fcdwitxy	133	1	ses	ses	NNP
cord-275041-fcdwitxy	133	2	/	/	SYM
cord-275041-fcdwitxy	133	3	by/4.0/.	by/4.0/.	NNP
cord-275041-fcdwitxy	134	1	namin	namin	NNP
cord-275041-fcdwitxy	134	2	g	g	NNP
cord-275041-fcdwitxy	134	3	-	-	HYPH
cord-275041-fcdwitxy	134	4	thecoron	thecoron	NNP
cord-275041-fcdwitxy	134	5	aviru	aviru	NNP
cord-275041-fcdwitxy	134	6	s	s	POS
cord-275041-fcdwitxy	134	7	-	-	HYPH
cord-275041-fcdwitxy	134	8	disea	disea	NNP
cord-275041-fcdwitxy	134	9	se-(covid	se-(covid	.
cord-275041-fcdwitxy	135	1	-2019)-and	-2019)-and	VB
cord-275041-fcdwitxy	135	2	-	-	HYPH
cord-275041-fcdwitxy	135	3	the	the	DT
cord-275041-fcdwitxy	135	4	-	-	HYPH
cord-275041-fcdwitxy	135	5	virus	virus	NN
cord-275041-fcdwitxy	135	6	-that	-that	NN
cord-275041-fcdwitxy	135	7	-	-	:
cord-275041-fcdwitxy	135	8	cause	cause	NN
cord-275041-fcdwitxy	135	9	s	s	NN
cord-275041-fcdwitxy	135	10	-	-	:
cord-275041-fcdwitxy	135	11	it	-PRON-	PRP
cord-275041-fcdwitxy	136	1	WHO	who	WP
cord-275041-fcdwitxy	136	2	(	(	-LRB-
cord-275041-fcdwitxy	136	3	2020	2020	CD
cord-275041-fcdwitxy	136	4	)	)	-RRB-
cord-275041-fcdwitxy	137	1	Coronavirus	Coronavirus	NNP
cord-275041-fcdwitxy	137	2	disease	disease	NN
cord-275041-fcdwitxy	137	3	(	(	-LRB-
cord-275041-fcdwitxy	138	1	COVID-19	covid-19	LS
cord-275041-fcdwitxy	138	2	)	)	-RRB-
cord-275041-fcdwitxy	138	3	Pandemic	Pandemic	NNP
cord-275041-fcdwitxy	138	4	COVID-19	COVID-19	NNP
cord-275041-fcdwitxy	138	5	CORONAVIRUS	CORONAVIRUS	NNP
cord-275041-fcdwitxy	138	6	PANDEMIC	pandemic	NN
cord-275041-fcdwitxy	138	7	Estimating	estimate	VBG
cord-275041-fcdwitxy	138	8	clinical	clinical	JJ
cord-275041-fcdwitxy	138	9	severity	severity	NN
cord-275041-fcdwitxy	138	10	of	of	IN
cord-275041-fcdwitxy	138	11	COVID-19	COVID-19	NNP
cord-275041-fcdwitxy	138	12	from	from	IN
cord-275041-fcdwitxy	138	13	the	the	DT
cord-275041-fcdwitxy	138	14	transmission	transmission	NN
cord-275041-fcdwitxy	138	15	dynamics	dynamic	NNS
cord-275041-fcdwitxy	138	16	in	in	IN
cord-275041-fcdwitxy	138	17	Wuhan	Wuhan	NNP
cord-275041-fcdwitxy	138	18	COVID-19	COVID-19	NNP
cord-275041-fcdwitxy	138	19	:	:	:
cord-275041-fcdwitxy	138	20	learning	learn	VBG
cord-275041-fcdwitxy	138	21	from	from	IN
cord-275041-fcdwitxy	138	22	experience	experience	NN
cord-275041-fcdwitxy	138	23	COVID-19	COVID-19	NNP
cord-275041-fcdwitxy	138	24	:	:	:
cord-275041-fcdwitxy	138	25	risk	risk	NN
cord-275041-fcdwitxy	138	26	of	of	IN
cord-275041-fcdwitxy	138	27	second	second	JJ
cord-275041-fcdwitxy	138	28	wave	wave	NN
cord-275041-fcdwitxy	138	29	is	be	VBZ
cord-275041-fcdwitxy	138	30	very	very	RB
cord-275041-fcdwitxy	138	31	real	real	JJ
cord-275041-fcdwitxy	138	32	,	,	,
cord-275041-fcdwitxy	138	33	say	say	VBP
cord-275041-fcdwitxy	138	34	researchers	researcher	NNS
cord-275041-fcdwitxy	138	35	First	first	JJ
cord-275041-fcdwitxy	138	36	-	-	HYPH
cord-275041-fcdwitxy	138	37	wave	wave	NN
cord-275041-fcdwitxy	138	38	COVID-19	covid-19	JJ
cord-275041-fcdwitxy	138	39	transmissibility	transmissibility	NN
cord-275041-fcdwitxy	138	40	and	and	CC
cord-275041-fcdwitxy	138	41	severity	severity	NN
cord-275041-fcdwitxy	138	42	in	in	IN
cord-275041-fcdwitxy	138	43	China	China	NNP
cord-275041-fcdwitxy	138	44	outside	outside	IN
cord-275041-fcdwitxy	138	45	Hubei	Hubei	NNP
cord-275041-fcdwitxy	138	46	after	after	IN
cord-275041-fcdwitxy	138	47	control	control	NN
cord-275041-fcdwitxy	138	48	measures	measure	NNS
cord-275041-fcdwitxy	138	49	,	,	,
cord-275041-fcdwitxy	138	50	and	and	CC
cord-275041-fcdwitxy	138	51	second	second	JJ
cord-275041-fcdwitxy	138	52	-	-	HYPH
cord-275041-fcdwitxy	138	53	wave	wave	NN
cord-275041-fcdwitxy	138	54	scenario	scenario	NN
cord-275041-fcdwitxy	138	55	planning	planning	NN
cord-275041-fcdwitxy	138	56	:	:	:
cord-275041-fcdwitxy	138	57	a	a	DT
cord-275041-fcdwitxy	138	58	modelling	modelling	NN
cord-275041-fcdwitxy	138	59	impact	impact	NN
cord-275041-fcdwitxy	138	60	assessment	assessment	NN
cord-275041-fcdwitxy	139	1	The	the	DT
cord-275041-fcdwitxy	139	2	global	global	JJ
cord-275041-fcdwitxy	139	3	impact	impact	NN
cord-275041-fcdwitxy	139	4	of	of	IN
cord-275041-fcdwitxy	139	5	COVID-19	COVID-19	NNP
cord-275041-fcdwitxy	139	6	and	and	CC
cord-275041-fcdwitxy	139	7	strategies	strategy	NNS
cord-275041-fcdwitxy	139	8	for	for	IN
cord-275041-fcdwitxy	139	9	mitigation	mitigation	NN
cord-275041-fcdwitxy	139	10	and	and	CC
cord-275041-fcdwitxy	139	11	suppression	suppression	NN
cord-275041-fcdwitxy	139	12	Clinical	clinical	JJ
cord-275041-fcdwitxy	139	13	and	and	CC
cord-275041-fcdwitxy	139	14	microbiological	microbiological	JJ
cord-275041-fcdwitxy	139	15	effect	effect	NN
cord-275041-fcdwitxy	139	16	of	of	IN
cord-275041-fcdwitxy	139	17	a	a	DT
cord-275041-fcdwitxy	139	18	combination	combination	NN
cord-275041-fcdwitxy	139	19	of	of	IN
cord-275041-fcdwitxy	139	20	hydroxychloroquine	hydroxychloroquine	NN
cord-275041-fcdwitxy	139	21	and	and	CC
cord-275041-fcdwitxy	139	22	azithromycin	azithromycin	NNP
cord-275041-fcdwitxy	139	23	in	in	IN
cord-275041-fcdwitxy	139	24	80	80	CD
cord-275041-fcdwitxy	139	25	COVID-19	covid-19	JJ
cord-275041-fcdwitxy	139	26	patients	patient	NNS
cord-275041-fcdwitxy	139	27	with	with	IN
cord-275041-fcdwitxy	139	28	at	at	RB
cord-275041-fcdwitxy	139	29	least	least	JJS
cord-275041-fcdwitxy	139	30	a	a	DT
cord-275041-fcdwitxy	139	31	six	six	CD
cord-275041-fcdwitxy	139	32	-	-	HYPH
cord-275041-fcdwitxy	139	33	day	day	NN
cord-275041-fcdwitxy	139	34	follow	follow	VB
cord-275041-fcdwitxy	139	35	up	up	RP
cord-275041-fcdwitxy	139	36	:	:	:
cord-275041-fcdwitxy	139	37	a	a	DT
cord-275041-fcdwitxy	139	38	pilot	pilot	NN
cord-275041-fcdwitxy	139	39	observational	observational	JJ
cord-275041-fcdwitxy	139	40	study	study	NN
cord-275041-fcdwitxy	139	41	Hydroxychloroquine	Hydroxychloroquine	NNP
cord-275041-fcdwitxy	139	42	and	and	CC
cord-275041-fcdwitxy	139	43	azithromycin	azithromycin	NNP
cord-275041-fcdwitxy	139	44	as	as	IN
cord-275041-fcdwitxy	139	45	a	a	DT
cord-275041-fcdwitxy	139	46	treatment	treatment	NN
cord-275041-fcdwitxy	139	47	of	of	IN
cord-275041-fcdwitxy	139	48	COVID-19	covid-19	NN
cord-275041-fcdwitxy	139	49	:	:	:
cord-275041-fcdwitxy	139	50	results	result	NNS
cord-275041-fcdwitxy	139	51	of	of	IN
cord-275041-fcdwitxy	139	52	an	an	DT
cord-275041-fcdwitxy	139	53	open	open	JJ
cord-275041-fcdwitxy	139	54	-	-	HYPH
cord-275041-fcdwitxy	139	55	label	label	NN
cord-275041-fcdwitxy	139	56	non	non	JJ
cord-275041-fcdwitxy	139	57	-	-	JJ
cord-275041-fcdwitxy	139	58	randomized	randomized	JJ
cord-275041-fcdwitxy	139	59	clinical	clinical	JJ
cord-275041-fcdwitxy	139	60	trial	trial	NN
cord-275041-fcdwitxy	139	61	Design	design	NN
cord-275041-fcdwitxy	139	62	and	and	CC
cord-275041-fcdwitxy	139	63	synthesis	synthesis	NN
cord-275041-fcdwitxy	139	64	of	of	IN
cord-275041-fcdwitxy	139	65	hydroxyferroquine	hydroxyferroquine	NNP
cord-275041-fcdwitxy	139	66	derivatives	derivative	NNS
cord-275041-fcdwitxy	139	67	with	with	IN
cord-275041-fcdwitxy	139	68	antimalarial	antimalarial	JJ
cord-275041-fcdwitxy	139	69	and	and	CC
cord-275041-fcdwitxy	139	70	antiviral	antiviral	JJ
cord-275041-fcdwitxy	139	71	activities	activity	NNS
cord-275041-fcdwitxy	140	1	Structural	structural	JJ
cord-275041-fcdwitxy	140	2	and	and	CC
cord-275041-fcdwitxy	140	3	molecular	molecular	JJ
cord-275041-fcdwitxy	140	4	modelling	modelling	NN
cord-275041-fcdwitxy	140	5	studies	study	NNS
cord-275041-fcdwitxy	140	6	reveal	reveal	VBP
cord-275041-fcdwitxy	140	7	a	a	DT
cord-275041-fcdwitxy	140	8	new	new	JJ
cord-275041-fcdwitxy	140	9	mechanism	mechanism	NN
cord-275041-fcdwitxy	140	10	of	of	IN
cord-275041-fcdwitxy	140	11	action	action	NN
cord-275041-fcdwitxy	140	12	of	of	IN
cord-275041-fcdwitxy	140	13	chloroquine	chloroquine	NNP
cord-275041-fcdwitxy	140	14	and	and	CC
cord-275041-fcdwitxy	140	15	hydroxychloroquine	hydroxychloroquine	NN
cord-275041-fcdwitxy	140	16	against	against	IN
cord-275041-fcdwitxy	140	17	SARS	SARS	NNP
cord-275041-fcdwitxy	140	18	-	-	HYPH
cord-275041-fcdwitxy	140	19	CoV-2	CoV-2	NNP
cord-275041-fcdwitxy	140	20	infection	infection	NN
cord-275041-fcdwitxy	140	21	Should	Should	MD
cord-275041-fcdwitxy	140	22	chloroquine	chloroquine	VB
cord-275041-fcdwitxy	140	23	and	and	CC
cord-275041-fcdwitxy	140	24	hydroxychloroquine	hydroxychloroquine	NN
cord-275041-fcdwitxy	140	25	be	be	VB
cord-275041-fcdwitxy	140	26	used	use	VBN
cord-275041-fcdwitxy	140	27	to	to	TO
cord-275041-fcdwitxy	140	28	treat	treat	VB
cord-275041-fcdwitxy	140	29	COVID-19	COVID-19	NNP
cord-275041-fcdwitxy	140	30	.	.	.
cord-275041-fcdwitxy	141	1	A	a	DT
cord-275041-fcdwitxy	141	2	rapid	rapid	JJ
cord-275041-fcdwitxy	141	3	review	review	NN
cord-275041-fcdwitxy	141	4	Hydroxychloroquine	Hydroxychloroquine	NNP
cord-275041-fcdwitxy	141	5	,	,	,
cord-275041-fcdwitxy	141	6	a	a	DT
cord-275041-fcdwitxy	141	7	less	less	RBR
cord-275041-fcdwitxy	141	8	toxic	toxic	JJ
cord-275041-fcdwitxy	141	9	derivative	derivative	NN
cord-275041-fcdwitxy	141	10	of	of	IN
cord-275041-fcdwitxy	141	11	chloroquine	chloroquine	NN
cord-275041-fcdwitxy	141	12	,	,	,
cord-275041-fcdwitxy	141	13	is	be	VBZ
cord-275041-fcdwitxy	141	14	effective	effective	JJ
cord-275041-fcdwitxy	141	15	in	in	IN
cord-275041-fcdwitxy	141	16	inhibiting	inhibit	VBG
cord-275041-fcdwitxy	141	17	SARS	SARS	NNP
cord-275041-fcdwitxy	141	18	-	-	HYPH
cord-275041-fcdwitxy	141	19	CoV-2	CoV-2	NNP
cord-275041-fcdwitxy	141	20	infection	infection	NN
cord-275041-fcdwitxy	141	21	in	in	IN
cord-275041-fcdwitxy	141	22	vitro	vitro	FW
cord-275041-fcdwitxy	141	23	WHO	who	WP
cord-275041-fcdwitxy	141	24	(	(	-LRB-
cord-275041-fcdwitxy	141	25	2020	2020	CD
cord-275041-fcdwitxy	141	26	)	)	-RRB-
cord-275041-fcdwitxy	142	1	WHO	who	WP
cord-275041-fcdwitxy	142	2	discontinues	discontinue	VBZ
cord-275041-fcdwitxy	142	3	hydroxychloroquine	hydroxychloroquine	NN
cord-275041-fcdwitxy	142	4	and	and	CC
cord-275041-fcdwitxy	142	5	lopinavir	lopinavir	NNP
cord-275041-fcdwitxy	142	6	/	/	SYM
cord-275041-fcdwitxy	142	7	ritonavir	ritonavir	NNP
cord-275041-fcdwitxy	142	8	treatment	treatment	NN
cord-275041-fcdwitxy	142	9	arms	arm	NNS
cord-275041-fcdwitxy	142	10	for	for	IN
cord-275041-fcdwitxy	142	11	COVID-19	COVID-19	NNP
cord-275041-fcdwitxy	142	12	Solidarity	Solidarity	NNP
cord-275041-fcdwitxy	142	13	"	"	''
cord-275041-fcdwitxy	142	14	clinical	clinical	JJ
cord-275041-fcdwitxy	142	15	trial	trial	NN
cord-275041-fcdwitxy	142	16	for	for	IN
cord-275041-fcdwitxy	142	17	COVID-19	covid-19	JJ
cord-275041-fcdwitxy	142	18	treatments	treatment	NNS
cord-275041-fcdwitxy	142	19	Acccessed	Acccessed	NNP
cord-275041-fcdwitxy	142	20	Hydroxychloroquine	Hydroxychloroquine	NNP
cord-275041-fcdwitxy	142	21	and	and	CC
cord-275041-fcdwitxy	142	22	Azithromycin	Azithromycin	NNP
cord-275041-fcdwitxy	142	23	as	as	IN
cord-275041-fcdwitxy	142	24	a	a	DT
cord-275041-fcdwitxy	142	25	Treatment	Treatment	NNP
cord-275041-fcdwitxy	142	26	of	of	IN
cord-275041-fcdwitxy	142	27	COVID-19	covid-19	NN
cord-275041-fcdwitxy	142	28	:	:	:
cord-275041-fcdwitxy	142	29	Results	result	NNS
cord-275041-fcdwitxy	142	30	of	of	IN
cord-275041-fcdwitxy	142	31	an	an	DT
cord-275041-fcdwitxy	142	32	2	2	CD
cord-275041-fcdwitxy	142	33	Open	Open	NNP
cord-275041-fcdwitxy	142	34	-	-	HYPH
cord-275041-fcdwitxy	142	35	Label	Label	NNP
cord-275041-fcdwitxy	142	36	Non	Non	NNP
cord-275041-fcdwitxy	142	37	-	-	NNP
cord-275041-fcdwitxy	142	38	Randomized	Randomized	NNP
cord-275041-fcdwitxy	142	39	Clinical	Clinical	NNP
cord-275041-fcdwitxy	142	40	Trial	Trial	NNP
cord-275041-fcdwitxy	142	41	:	:	:
cord-275041-fcdwitxy	142	42	Response	response	NN
cord-275041-fcdwitxy	142	43	to	to	IN
cord-275041-fcdwitxy	142	44	David	David	NNP
cord-275041-fcdwitxy	142	45	Spencer	Spencer	NNP
cord-275041-fcdwitxy	143	1	Low	low	JJ
cord-275041-fcdwitxy	143	2	dose	dose	NN
cord-275041-fcdwitxy	143	3	of	of	IN
cord-275041-fcdwitxy	143	4	hydroxychloroquine	hydroxychloroquine	NN
cord-275041-fcdwitxy	143	5	reduces	reduce	VBZ
cord-275041-fcdwitxy	143	6	fatality	fatality	NN
cord-275041-fcdwitxy	143	7	of	of	IN
cord-275041-fcdwitxy	143	8	critically	critically	RB
cord-275041-fcdwitxy	143	9	ill	ill	JJ
cord-275041-fcdwitxy	143	10	patients	patient	NNS
cord-275041-fcdwitxy	143	11	with	with	IN
cord-275041-fcdwitxy	143	12	COVID-19	COVID-19	NNP
cord-275041-fcdwitxy	143	13	Outcomes	Outcomes	NNPS
cord-275041-fcdwitxy	143	14	of	of	IN
cord-275041-fcdwitxy	143	15	3737	3737	CD
cord-275041-fcdwitxy	144	1	COVID-19	covid-19	JJ
cord-275041-fcdwitxy	144	2	patients	patient	NNS
cord-275041-fcdwitxy	144	3	treated	treat	VBN
cord-275041-fcdwitxy	144	4	with	with	IN
cord-275041-fcdwitxy	144	5	hydroxychloroquine	hydroxychloroquine	NN
cord-275041-fcdwitxy	144	6	/	/	SYM
cord-275041-fcdwitxy	144	7	azithromycin	azithromycin	NNP
cord-275041-fcdwitxy	144	8	and	and	CC
cord-275041-fcdwitxy	144	9	other	other	JJ
cord-275041-fcdwitxy	144	10	regimens	regimen	NNS
cord-275041-fcdwitxy	144	11	in	in	IN
cord-275041-fcdwitxy	144	12	Marseille	Marseille	NNP
cord-275041-fcdwitxy	144	13	,	,	,
cord-275041-fcdwitxy	144	14	France	France	NNP
cord-275041-fcdwitxy	144	15	:	:	:
cord-275041-fcdwitxy	145	1	a	a	DT
cord-275041-fcdwitxy	145	2	retrospective	retrospective	JJ
cord-275041-fcdwitxy	145	3	analysis	analysis	NN
cord-275041-fcdwitxy	145	4	Treatment	treatment	NN
cord-275041-fcdwitxy	145	5	with	with	IN
cord-275041-fcdwitxy	145	6	hydroxychloroquine	hydroxychloroquine	NN
cord-275041-fcdwitxy	145	7	,	,	,
cord-275041-fcdwitxy	145	8	azithromycin	azithromycin	NNP
cord-275041-fcdwitxy	145	9	,	,	,
cord-275041-fcdwitxy	145	10	and	and	CC
cord-275041-fcdwitxy	145	11	combination	combination	NN
cord-275041-fcdwitxy	145	12	in	in	IN
cord-275041-fcdwitxy	145	13	patients	patient	NNS
cord-275041-fcdwitxy	145	14	hospitalized	hospitalize	VBN
cord-275041-fcdwitxy	145	15	with	with	IN
cord-275041-fcdwitxy	145	16	COVID-19	COVID-19	NNP
cord-275041-fcdwitxy	145	17	Early	Early	NNP
cord-275041-fcdwitxy	145	18	Hydroxychloroquine	Hydroxychloroquine	NNP
cord-275041-fcdwitxy	145	19	Is	be	VBZ
cord-275041-fcdwitxy	145	20	Associated	associate	VBN
cord-275041-fcdwitxy	145	21	with	with	IN
cord-275041-fcdwitxy	145	22	an	an	DT
cord-275041-fcdwitxy	145	23	Increase	increase	NN
cord-275041-fcdwitxy	145	24	of	of	IN
cord-275041-fcdwitxy	145	25	Survival	Survival	NNP
cord-275041-fcdwitxy	145	26	in	in	IN
cord-275041-fcdwitxy	145	27	COVID-19	COVID-19	NNP
cord-275041-fcdwitxy	145	28	Patients	patient	NNS
cord-275041-fcdwitxy	145	29	:	:	:
cord-275041-fcdwitxy	146	1	An	an	DT
cord-275041-fcdwitxy	146	2	Observational	Observational	NNP
cord-275041-fcdwitxy	146	3	Study	Study	NNP
cord-275041-fcdwitxy	146	4	COVID-19	COVID-19	NNP
cord-275041-fcdwitxy	146	5	Outpatients	Outpatients	NNP
cord-275041-fcdwitxy	146	6	-	-	HYPH
cord-275041-fcdwitxy	146	7	early	early	JJ
cord-275041-fcdwitxy	146	8	risk	risk	NN
cord-275041-fcdwitxy	146	9	-	-	HYPH
cord-275041-fcdwitxy	146	10	stratified	stratify	VBN
cord-275041-fcdwitxy	146	11	treatment	treatment	NN
cord-275041-fcdwitxy	146	12	with	with	IN
cord-275041-fcdwitxy	146	13	zinc	zinc	NN
cord-275041-fcdwitxy	146	14	plus	plus	CC
cord-275041-fcdwitxy	146	15	low	low	JJ
cord-275041-fcdwitxy	146	16	dose	dose	NN
cord-275041-fcdwitxy	146	17	hydroxychloroquine	hydroxychloroquine	NN
cord-275041-fcdwitxy	146	18	and	and	CC
cord-275041-fcdwitxy	146	19	azithromycin	azithromycin	NNP
cord-275041-fcdwitxy	146	20	:	:	:
cord-275041-fcdwitxy	146	21	a	a	DT
cord-275041-fcdwitxy	146	22	retrospective	retrospective	JJ
cord-275041-fcdwitxy	146	23	case	case	NN
cord-275041-fcdwitxy	146	24	series	series	NN
cord-275041-fcdwitxy	146	25	study	study	NN
cord-275041-fcdwitxy	147	1	Azithromycin	Azithromycin	NNP
cord-275041-fcdwitxy	147	2	and	and	CC
cord-275041-fcdwitxy	147	3	hydroxychloroquine	hydroxychloroquine	NN
cord-275041-fcdwitxy	147	4	accelerate	accelerate	VB
cord-275041-fcdwitxy	147	5	recovery	recovery	NN
cord-275041-fcdwitxy	147	6	of	of	IN
cord-275041-fcdwitxy	147	7	outpatients	outpatient	NNS
cord-275041-fcdwitxy	147	8	with	with	IN
cord-275041-fcdwitxy	147	9	mild/	mild/	NNP
cord-275041-fcdwitxy	147	10	moderate	moderate	JJ
cord-275041-fcdwitxy	147	11	COVID-19	COVID-19	NNP
cord-275041-fcdwitxy	147	12	Hydroxychloroquine	Hydroxychloroquine	NNP
cord-275041-fcdwitxy	147	13	with	with	IN
cord-275041-fcdwitxy	147	14	or	or	CC
cord-275041-fcdwitxy	147	15	without	without	IN
cord-275041-fcdwitxy	147	16	azithromycin	azithromycin	NN
cord-275041-fcdwitxy	147	17	and	and	CC
cord-275041-fcdwitxy	147	18	in	in	IN
cord-275041-fcdwitxy	147	19	-	-	HYPH
cord-275041-fcdwitxy	147	20	hospital	hospital	NN
cord-275041-fcdwitxy	147	21	mortality	mortality	NN
cord-275041-fcdwitxy	147	22	or	or	CC
cord-275041-fcdwitxy	147	23	discharge	discharge	NN
cord-275041-fcdwitxy	147	24	in	in	IN
cord-275041-fcdwitxy	147	25	patients	patient	NNS
cord-275041-fcdwitxy	147	26	hospitalized	hospitalize	VBN
cord-275041-fcdwitxy	147	27	for	for	IN
cord-275041-fcdwitxy	147	28	COVID-19	covid-19	JJ
cord-275041-fcdwitxy	147	29	infection	infection	NN
cord-275041-fcdwitxy	147	30	:	:	:
cord-275041-fcdwitxy	147	31	a	a	DT
cord-275041-fcdwitxy	147	32	cohort	cohort	NN
cord-275041-fcdwitxy	147	33	study	study	NN
cord-275041-fcdwitxy	147	34	of	of	IN
cord-275041-fcdwitxy	147	35	4642	4642	CD
cord-275041-fcdwitxy	147	36	in	in	IN
cord-275041-fcdwitxy	147	37	-	-	HYPH
cord-275041-fcdwitxy	147	38	patients	patient	NNS
cord-275041-fcdwitxy	147	39	in	in	IN
cord-275041-fcdwitxy	147	40	France	France	NNP
cord-275041-fcdwitxy	147	41	Clinical	Clinical	NNP
cord-275041-fcdwitxy	147	42	Efficacy	Efficacy	NNP
cord-275041-fcdwitxy	147	43	of	of	IN
cord-275041-fcdwitxy	147	44	Chloroquine	Chloroquine	NNP
cord-275041-fcdwitxy	147	45	derivatives	derivative	NNS
cord-275041-fcdwitxy	147	46	in	in	IN
cord-275041-fcdwitxy	147	47	COVID-19	COVID-19	NNP
cord-275041-fcdwitxy	147	48	Infection	Infection	NNP
cord-275041-fcdwitxy	147	49	:	:	:
cord-275041-fcdwitxy	147	50	comparative	comparative	JJ
cord-275041-fcdwitxy	147	51	meta	meta	JJ
cord-275041-fcdwitxy	147	52	-	-	HYPH
cord-275041-fcdwitxy	147	53	analysis	analysis	NN
cord-275041-fcdwitxy	147	54	between	between	IN
cord-275041-fcdwitxy	147	55	the	the	DT
cord-275041-fcdwitxy	147	56	Big	big	JJ
cord-275041-fcdwitxy	147	57	data	datum	NNS
cord-275041-fcdwitxy	147	58	and	and	CC
cord-275041-fcdwitxy	147	59	the	the	DT
cord-275041-fcdwitxy	147	60	real	real	JJ
cord-275041-fcdwitxy	147	61	world	world	NN
cord-275041-fcdwitxy	147	62	Efficacy	Efficacy	NNP
cord-275041-fcdwitxy	147	63	and	and	CC
cord-275041-fcdwitxy	147	64	safety	safety	NN
cord-275041-fcdwitxy	147	65	of	of	IN
cord-275041-fcdwitxy	147	66	chloroquine	chloroquine	NNP
cord-275041-fcdwitxy	147	67	or	or	CC
cord-275041-fcdwitxy	147	68	hydroxychloroquine	hydroxychloroquine	NN
cord-275041-fcdwitxy	147	69	in	in	IN
cord-275041-fcdwitxy	147	70	moderate	moderate	JJ
cord-275041-fcdwitxy	147	71	type	type	NN
cord-275041-fcdwitxy	147	72	of	of	IN
cord-275041-fcdwitxy	147	73	COVID-19	COVID-19	NNP
cord-275041-fcdwitxy	147	74	:	:	:
cord-275041-fcdwitxy	147	75	a	a	DT
cord-275041-fcdwitxy	147	76	prospective	prospective	JJ
cord-275041-fcdwitxy	147	77	open	open	JJ
cord-275041-fcdwitxy	147	78	-	-	HYPH
cord-275041-fcdwitxy	147	79	label	label	NN
cord-275041-fcdwitxy	147	80	randomized	randomize	VBN
cord-275041-fcdwitxy	147	81	controlled	control	VBN
cord-275041-fcdwitxy	147	82	study	study	NN
cord-275041-fcdwitxy	147	83	Hydroxychloroquine	Hydroxychloroquine	NNP
cord-275041-fcdwitxy	147	84	and	and	CC
cord-275041-fcdwitxy	147	85	Tocilizumab	Tocilizumab	NNP
cord-275041-fcdwitxy	147	86	Therapy	Therapy	NNP
cord-275041-fcdwitxy	147	87	in	in	IN
cord-275041-fcdwitxy	147	88	COVID-19	COVID-19	NNP
cord-275041-fcdwitxy	148	1	Patientsan	patientsan	JJ
cord-275041-fcdwitxy	148	2	observational	observational	JJ
cord-275041-fcdwitxy	148	3	study	study	NN
cord-275041-fcdwitxy	148	4	Clinical	clinical	JJ
cord-275041-fcdwitxy	148	5	efficacy	efficacy	NN
cord-275041-fcdwitxy	148	6	of	of	IN
cord-275041-fcdwitxy	148	7	hydroxychloroquine	hydroxychloroquine	NN
cord-275041-fcdwitxy	148	8	in	in	IN
cord-275041-fcdwitxy	148	9	patients	patient	NNS
cord-275041-fcdwitxy	148	10	with	with	IN
cord-275041-fcdwitxy	148	11	COVID-19	COVID-19	NNP
cord-275041-fcdwitxy	148	12	pneumonia	pneumonia	NN
cord-275041-fcdwitxy	148	13	who	who	WP
cord-275041-fcdwitxy	148	14	require	require	VBP
cord-275041-fcdwitxy	148	15	oxygen	oxygen	NN
cord-275041-fcdwitxy	148	16	:	:	:
cord-275041-fcdwitxy	148	17	observational	observational	JJ
cord-275041-fcdwitxy	148	18	comparative	comparative	JJ
cord-275041-fcdwitxy	148	19	study	study	NN
cord-275041-fcdwitxy	148	20	using	use	VBG
cord-275041-fcdwitxy	148	21	routine	routine	JJ
cord-275041-fcdwitxy	148	22	care	care	NN
cord-275041-fcdwitxy	148	23	data	datum	NNS
cord-275041-fcdwitxy	148	24	Observational	observational	JJ
cord-275041-fcdwitxy	148	25	study	study	NN
cord-275041-fcdwitxy	148	26	of	of	IN
cord-275041-fcdwitxy	148	27	hydroxychloroquine	hydroxychloroquine	NNP
cord-275041-fcdwitxy	148	28	in	in	IN
cord-275041-fcdwitxy	148	29	hospitalized	hospitalize	VBN
cord-275041-fcdwitxy	148	30	patients	patient	NNS
cord-275041-fcdwitxy	148	31	with	with	IN
cord-275041-fcdwitxy	148	32	COVID-19	COVID-19	NNP
cord-275041-fcdwitxy	148	33	Association	Association	NNP
cord-275041-fcdwitxy	148	34	of	of	IN
cord-275041-fcdwitxy	148	35	treatment	treatment	NN
cord-275041-fcdwitxy	148	36	with	with	IN
cord-275041-fcdwitxy	148	37	hydroxychloroquine	hydroxychloroquine	NNP
cord-275041-fcdwitxy	148	38	or	or	CC
cord-275041-fcdwitxy	148	39	azithromycin	azithromycin	NN
cord-275041-fcdwitxy	148	40	with	with	IN
cord-275041-fcdwitxy	148	41	in	in	IN
cord-275041-fcdwitxy	148	42	-	-	HYPH
cord-275041-fcdwitxy	148	43	hospital	hospital	NN
cord-275041-fcdwitxy	148	44	mortality	mortality	NN
cord-275041-fcdwitxy	148	45	in	in	IN
cord-275041-fcdwitxy	148	46	patients	patient	NNS
cord-275041-fcdwitxy	148	47	with	with	IN
cord-275041-fcdwitxy	148	48	COVID-19	covid-19	CD
cord-275041-fcdwitxy	148	49	in	in	IN
cord-275041-fcdwitxy	148	50	New	New	NNP
cord-275041-fcdwitxy	148	51	York	York	NNP
cord-275041-fcdwitxy	148	52	State	State	NNP
cord-275041-fcdwitxy	148	53	Hydroxychloroquine	Hydroxychloroquine	NNP
cord-275041-fcdwitxy	148	54	in	in	IN
cord-275041-fcdwitxy	148	55	nonhospitalized	nonhospitalized	JJ
cord-275041-fcdwitxy	148	56	adults	adult	NNS
cord-275041-fcdwitxy	148	57	with	with	IN
cord-275041-fcdwitxy	148	58	early	early	JJ
cord-275041-fcdwitxy	148	59	COVID-19	COVID-19	NNP
cord-275041-fcdwitxy	148	60	:	:	:
cord-275041-fcdwitxy	148	61	a	a	DT
cord-275041-fcdwitxy	148	62	randomized	randomized	JJ
cord-275041-fcdwitxy	148	63	trial	trial	NN
cord-275041-fcdwitxy	148	64	Hydroxychloroquine	Hydroxychloroquine	NNP
cord-275041-fcdwitxy	148	65	with	with	IN
cord-275041-fcdwitxy	148	66	or	or	CC
cord-275041-fcdwitxy	148	67	without	without	IN
cord-275041-fcdwitxy	148	68	azithromycin	azithromycin	NN
cord-275041-fcdwitxy	148	69	in	in	IN
cord-275041-fcdwitxy	148	70	mild	mild	NN
cord-275041-fcdwitxy	148	71	-	-	HYPH
cord-275041-fcdwitxy	148	72	to	to	IN
cord-275041-fcdwitxy	148	73	-	-	HYPH
cord-275041-fcdwitxy	148	74	moderate	moderate	JJ
cord-275041-fcdwitxy	148	75	COVID-19	COVID-19	NNP
cord-275041-fcdwitxy	148	76	Hydroxychloroquine	Hydroxychloroquine	NNP
cord-275041-fcdwitxy	148	77	in	in	IN
cord-275041-fcdwitxy	148	78	patients	patient	NNS
cord-275041-fcdwitxy	148	79	with	with	IN
cord-275041-fcdwitxy	148	80	mainly	mainly	RB
cord-275041-fcdwitxy	148	81	mild	mild	JJ
cord-275041-fcdwitxy	148	82	to	to	IN
cord-275041-fcdwitxy	148	83	moderate	moderate	JJ
cord-275041-fcdwitxy	148	84	coronavirus	coronavirus	NN
cord-275041-fcdwitxy	148	85	disease	disease	NN
cord-275041-fcdwitxy	148	86	2019	2019	CD
cord-275041-fcdwitxy	148	87	:	:	:
cord-275041-fcdwitxy	148	88	open	open	JJ
cord-275041-fcdwitxy	148	89	label	label	NN
cord-275041-fcdwitxy	148	90	,	,	,
cord-275041-fcdwitxy	148	91	randomised	randomised	JJ
cord-275041-fcdwitxy	148	92	controlled	control	VBN
cord-275041-fcdwitxy	148	93	trial	trial	NN
cord-275041-fcdwitxy	148	94	2020	2020	CD
cord-275041-fcdwitxy	148	95	)	)	-RRB-
cord-275041-fcdwitxy	149	1	A	a	DT
cord-275041-fcdwitxy	149	2	randomized	randomized	JJ
cord-275041-fcdwitxy	149	3	trial	trial	NN
cord-275041-fcdwitxy	149	4	of	of	IN
cord-275041-fcdwitxy	149	5	hydroxychloroquine	hydroxychloroquine	NN
cord-275041-fcdwitxy	149	6	as	as	IN
cord-275041-fcdwitxy	149	7	postexposure	postexposure	NN
cord-275041-fcdwitxy	149	8	prophylaxis	prophylaxis	NN
cord-275041-fcdwitxy	149	9	for	for	IN
cord-275041-fcdwitxy	149	10	COVID-19	COVID-19	NNP
cord-275041-fcdwitxy	149	11	Race	Race	NNP
cord-275041-fcdwitxy	149	12	,	,	,
cord-275041-fcdwitxy	149	13	socioeconomic	socioeconomic	JJ
cord-275041-fcdwitxy	149	14	deprivation	deprivation	NN
cord-275041-fcdwitxy	149	15	,	,	,
cord-275041-fcdwitxy	149	16	and	and	CC
cord-275041-fcdwitxy	149	17	hospitalization	hospitalization	NN
cord-275041-fcdwitxy	149	18	for	for	IN
cord-275041-fcdwitxy	149	19	COVID-19	COVID-19	NNP
cord-275041-fcdwitxy	149	20	in	in	IN
cord-275041-fcdwitxy	149	21	English	english	JJ
cord-275041-fcdwitxy	149	22	participants	participant	NNS
cord-275041-fcdwitxy	149	23	of	of	IN
cord-275041-fcdwitxy	149	24	a	a	DT
cord-275041-fcdwitxy	149	25	national	national	JJ
cord-275041-fcdwitxy	149	26	biobank	biobank	NN
cord-275041-fcdwitxy	149	27	Could	Could	MD
cord-275041-fcdwitxy	149	28	chloroquine	chloroquine	VB
cord-275041-fcdwitxy	149	29	/hydroxychloroquine	/hydroxychloroquine	,
cord-275041-fcdwitxy	149	30	be	be	VB
cord-275041-fcdwitxy	149	31	harmful	harmful	JJ
cord-275041-fcdwitxy	149	32	in	in	IN
cord-275041-fcdwitxy	149	33	Coronavirus	Coronavirus	NNP
cord-275041-fcdwitxy	149	34	Disease	Disease	NNP
cord-275041-fcdwitxy	149	35	2019	2019	CD
cord-275041-fcdwitxy	149	36	(	(	-LRB-
cord-275041-fcdwitxy	149	37	COVID-19	COVID-19	NNP
cord-275041-fcdwitxy	149	38	)	)	-RRB-
cord-275041-fcdwitxy	149	39	treatment	treatment	NN
cord-275041-fcdwitxy	149	40	?	?	.
cord-275041-fcdwitxy	150	1	QT	qt	NN
cord-275041-fcdwitxy	150	2	interval	interval	NN
cord-275041-fcdwitxy	150	3	prolongation	prolongation	NN
cord-275041-fcdwitxy	150	4	and	and	CC
cord-275041-fcdwitxy	150	5	torsade	torsade	NNP
cord-275041-fcdwitxy	150	6	de	de	FW
cord-275041-fcdwitxy	150	7	pointes	pointes	FW
cord-275041-fcdwitxy	150	8	in	in	IN
cord-275041-fcdwitxy	150	9	patients	patient	NNS
cord-275041-fcdwitxy	150	10	with	with	IN
cord-275041-fcdwitxy	150	11	COVID-19	COVID-19	NNP
cord-275041-fcdwitxy	150	12	treated	treat	VBN
cord-275041-fcdwitxy	150	13	with	with	IN
cord-275041-fcdwitxy	150	14	hydroxychloroquine	hydroxychloroquine	NN
cord-275041-fcdwitxy	150	15	/	/	SYM
cord-275041-fcdwitxy	150	16	azithromycin	azithromycin	NNP
cord-275041-fcdwitxy	150	17	Optimizing	optimize	VBG
cord-275041-fcdwitxy	150	18	hydroxychloroquine	hydroxychloroquine	NN
cord-275041-fcdwitxy	150	19	dosing	dose	VBG
cord-275041-fcdwitxy	150	20	for	for	IN
cord-275041-fcdwitxy	150	21	patients	patient	NNS
cord-275041-fcdwitxy	150	22	with	with	IN
cord-275041-fcdwitxy	150	23	COVID-19	COVID-19	NNP
cord-275041-fcdwitxy	150	24	:	:	:
cord-275041-fcdwitxy	150	25	an	an	DT
cord-275041-fcdwitxy	150	26	integrative	integrative	JJ
cord-275041-fcdwitxy	150	27	modeling	modeling	NN
cord-275041-fcdwitxy	150	28	approach	approach	NN
cord-275041-fcdwitxy	150	29	for	for	IN
cord-275041-fcdwitxy	150	30	effective	effective	JJ
cord-275041-fcdwitxy	150	31	drug	drug	NN
cord-275041-fcdwitxy	150	32	repurposing	repurposing	NN
cord-275041-fcdwitxy	151	1	Acknowledgements	acknowledgement	NNS
cord-275041-fcdwitxy	151	2	Thank	thank	VBP
cord-275041-fcdwitxy	151	3	you	-PRON-	PRP
cord-275041-fcdwitxy	151	4	to	to	IN
cord-275041-fcdwitxy	151	5	all	all	DT
cord-275041-fcdwitxy	151	6	clinicians	clinician	NNS
cord-275041-fcdwitxy	151	7	and	and	CC
cord-275041-fcdwitxy	151	8	administrators	administrator	NNS
cord-275041-fcdwitxy	151	9	of	of	IN
cord-275041-fcdwitxy	151	10	Hospitales	Hospitales	NNP
cord-275041-fcdwitxy	151	11	HM	HM	NNP
cord-275041-fcdwitxy	151	12	(	(	-LRB-
cord-275041-fcdwitxy	151	13	Spain	Spain	NNP
cord-275041-fcdwitxy	151	14	)	)	-RRB-
cord-275041-fcdwitxy	151	15	on	on	IN
cord-275041-fcdwitxy	151	16	which	which	WDT
cord-275041-fcdwitxy	151	17	data	datum	NNS
cord-275041-fcdwitxy	151	18	this	this	DT
cord-275041-fcdwitxy	151	19	study	study	NN
cord-275041-fcdwitxy	151	20	is	be	VBZ
cord-275041-fcdwitxy	151	21	based	base	VBN
cord-275041-fcdwitxy	151	22	.	.	.
cord-275041-fcdwitxy	152	1	Funding	fund	VBG
cord-275041-fcdwitxy	152	2	Salma	Salma	NNP
cord-275041-fcdwitxy	152	3	Ayis	Ayis	NNP
cord-275041-fcdwitxy	152	4	was	be	VBD
cord-275041-fcdwitxy	152	5	funded	fund	VBN
cord-275041-fcdwitxy	152	6	by	by	IN
cord-275041-fcdwitxy	152	7	the	the	DT
cord-275041-fcdwitxy	152	8	National	National	NNP
cord-275041-fcdwitxy	152	9	Institute	Institute	NNP
cord-275041-fcdwitxy	152	10	for	for	IN
cord-275041-fcdwitxy	152	11	Health	Health	NNP
cord-275041-fcdwitxy	152	12	Research	Research	NNP
cord-275041-fcdwitxy	152	13	(	(	-LRB-
cord-275041-fcdwitxy	152	14	NIHR	NIHR	NNP
cord-275041-fcdwitxy	152	15	)	)	-RRB-
cord-275041-fcdwitxy	152	16	Biomedical	Biomedical	NNP
cord-275041-fcdwitxy	152	17	Research	Research	NNP
cord-275041-fcdwitxy	152	18	Centre	Centre	NNP
cord-275041-fcdwitxy	152	19	based	base	VBN
cord-275041-fcdwitxy	152	20	at	at	IN
cord-275041-fcdwitxy	152	21	Guy	Guy	NNP
cord-275041-fcdwitxy	152	22	's	's	POS
cord-275041-fcdwitxy	152	23	and	and	CC
cord-275041-fcdwitxy	152	24	St	St	NNP
cord-275041-fcdwitxy	152	25	Thomas	Thomas	NNP
cord-275041-fcdwitxy	152	26	'	'	POS
cord-275041-fcdwitxy	152	27	NHS	NHS	NNP
cord-275041-fcdwitxy	152	28	Foundation	Foundation	NNP
cord-275041-fcdwitxy	152	29	Trust	Trust	NNP
cord-275041-fcdwitxy	152	30	and	and	CC
cord-275041-fcdwitxy	152	31	King	King	NNP
cord-275041-fcdwitxy	152	32	's	's	POS
cord-275041-fcdwitxy	152	33	College	College	NNP
cord-275041-fcdwitxy	152	34	London	London	NNP
cord-275041-fcdwitxy	152	35	.	.	.
cord-275041-fcdwitxy	153	1	The	the	DT
cord-275041-fcdwitxy	153	2	views	view	NNS
cord-275041-fcdwitxy	153	3	expressed	express	VBN
cord-275041-fcdwitxy	153	4	are	be	VBP
cord-275041-fcdwitxy	153	5	those	those	DT
cord-275041-fcdwitxy	153	6	of	of	IN
cord-275041-fcdwitxy	153	7	the	the	DT
cord-275041-fcdwitxy	153	8	authors	author	NNS
cord-275041-fcdwitxy	153	9	and	and	CC
cord-275041-fcdwitxy	153	10	not	not	RB
cord-275041-fcdwitxy	153	11	necessarily	necessarily	RB
cord-275041-fcdwitxy	153	12	those	those	DT
cord-275041-fcdwitxy	153	13	of	of	IN
cord-275041-fcdwitxy	153	14	the	the	DT
cord-275041-fcdwitxy	153	15	NHS	NHS	NNP
cord-275041-fcdwitxy	153	16	,	,	,
cord-275041-fcdwitxy	153	17	the	the	DT
cord-275041-fcdwitxy	153	18	NIHR	NIHR	NNP
cord-275041-fcdwitxy	153	19	,	,	,
cord-275041-fcdwitxy	153	20	or	or	CC
cord-275041-fcdwitxy	153	21	the	the	DT
cord-275041-fcdwitxy	153	22	Department	Department	NNP
cord-275041-fcdwitxy	153	23	of	of	IN
cord-275041-fcdwitxy	153	24	Health	Health	NNP
cord-275041-fcdwitxy	153	25	.	.	.